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Lay Summary of Thesis 
My thesis aims to contribute to the understanding of how gene expression is regulated. 
Indeed, a gene can be in an on or off state. A particular interest of mine is the study of DNA 
sequences (enhancers) that orchestrate the regulation of genes. Enhancers have to ability to 
switch on genes located far away in the chromosome. As genes controlled by enhancers are 
often critical for development and lead to severe defects when their activation is defective, it 
is important to understand them precisely. However, how enhancers work is still unclear. 
Knowing that enhancers are often located far from their target genes, a general assumption is 
that their mechanisms of action involves a long-range restructuring of chromatin. Nowadays, 
the established model for distal enhancers implies direct enhancer/promoter interaction with 
a looping out of intervening chromatin. 
 
Using super-resolution imaging, I could study nuclear ultra-structure down to the 100 nm 
range. I monitored long-range chromatin reorganisation upon enhancer-driven activation of 
the Sonic hedgehog gene (Shh). This revealed an increase in nuclear distance between Shh 
and Shh-Brain-Enhancers that is not compatible with the looping model. Furthermore, using 
a synthetic biology approach, I could reveal that Shh-Brain-Enhancers regulate a long-range 
chromatin unfolding to enhance Shh expression, which portrays a unique but new 
mechanism for distal enhancers. 
  






Enhancers are non-coding DNA sequences which are able to activate the expression of a 
gene in a specific tissue manner and at a precise stage during embryonic development.  First 
identified almost 40 years ago, our growing understanding of enhancers has transformed the 
concept of gene regulation to recognise the key role of these sequences in the expression of 
many genes.  Moreover, the identification of human diseases caused by genetic variation in 
non-coding enhancer elements highlights the importance of characterising enhancers in order 
to understand human disease.  However, enhancers are often located far from the promoter 
they influence and the mechanisms through which enhancers govern gene expression remain 
unclear. The most widely accepted model for the action of distal enhancers involves the 
formation of a chromatin loop, in which the enhancer and promoter physically interact at the 
loop base.  The kinetics or molecular basis for the formation of enhancer/promoter loops is 
unknown and it remains unclear whether this mechanism of enhancer communication is 
universal, or indeed whether it is the most pervasive.  The aim of my PhD is to investigate 
further the mechanism of action of distal enhancers in the regulation of developmental genes. 
Using chromatin profiling during the differentiation of embryonic stem cells to neural 
progenitor cells in order to see which Shh enhancer is active in neural progenitor cells 
(NPCs), I report the identification of a novel long-range enhancer for Shh - Shh-Brain-
Enhancer-6 (SBE6) – that is located 100kb upstream of Shh and that is required for the 
proper induction of Shh expression during a neural differentiation programme. SBE6 
enhances Shh expression during the differentiation of neural progenitor cells (NPCs) and is 
active in the brain of developing zebrafish and mouse embryos.  
Next, using a super-resolution 3D-FISH based approach to study the enhancer-driven 
activation of the Sonic hedgehog gene (Shh) I have identified a novel mechanism of long-
range enhancer regulation that is incompatible with the looping model.  Instead, gene 
activation is associated with an increase in nuclear distance between Shh and Shh-Brain-
Enhancers.  Using a synthetic biology approach I have determined that the chromatin 
unfolding is regulated specifically by the Shh-Brain-Enhancer and is mediated by the 
recruitment of transcription factor SIX3 and Poly (ADP-Ribose) Polymerase 1.  Chromatin 
decondensation upon gene activation has been observed previously in Drosophila polytene 





chromosomes.  I suggest an analogous decompaction is driven by Shh-Brain-Enhancer to 
promote the activation of Shh in mouse neural progenitor cells.  This ‘chromatin unfolding’ 
model represents a new mechanism of long-range enhancer-promoter communication in 
addition to the looping and tracking models. 
  





Chapter 1: Introduction 
  





Genes with vital roles in embryonic development have a highly regulated spatial and 
temporal expression pattern.  The primary determinant of this precise tissue specific gene 
expression is believed to be a subset of non-coding regions in the genome called enhancers.  
Enhancers can regulate the promoters of their target genes over very large distances (up to 
1Mb) and can be located upstream, downstream or within the introns of the target gene.   
The growing comprehension of enhancer elements led to a complete redefinition of our 
concept of genetic regulation. First defined over 30 years ago, the mechanisms through 
which enhancers interact with the promoters and regulate target expression remain poorly 
understood despite the widespread acceptance of their crucial role in gene regulation. 
It is commonly thought that when an enhancer is located in the vicinity of the core promoter, 
activation signals spreads between the enhancer and its cognate promoter by tracking or 
linking of proteins, and that distal enhancers are only thought to interact via a direct 
interaction with the core promoter that is enabled by the formation of a stable loop. 
However, it is now clear that more than a linear sequence, an enhancer is part of a wider 
domain that has the ability to regulate gene expression of promoters located in the same 
subdivision of the genome in the 3D nucleus space.  
The growing recognition of the crucial part of enhancer mutations in both Mendelian and 
complex human genetic diseases makes it imperative to fully understand enhancer and their 
mechanisms by which they regulate gene expression. 
  





1.1 Cis-regulatory elements 
During embryonic development, highly specialized tissues are formed via the differentiation 
of cells into different lineages. In order to provide a precise patterning, morphogens undergo 
tight spatially and temporally controlled expression. A subset of noncoding regions of the 
genome called enhancers are the key determinants of precise tissue-specific gene activation. 
These cis-regulatory elements promote gene activation in a position and orientation-
independent manner by recruiting tissue-specific transcription factors, co-activators and 
RNA polymerase II which are components also found to bind to the core promoters of genes 
(Koch et al., 2011).  
The main attributes of cis-regulatory sequences were elucidated from studies dissecting the 
first ever described enhancer e.g. the 72 bp tandem repeat of SV40 DNA, a sequence located 
more than 100 nucleotides upstream from the core early viral promoter. Hence, enhancer 
deletion has been linked with reduced gene expression (Benoist and Chambon, 1981; Gruss 
et al., 1981). In parallel, other equivalent sequences were identified in mammalian cells 
(Banerji et al., 1983; Conrad and Botchan, 1982), including Locus Control Regions (LCR) – 
which define regulatory domains that act as a group of enhancers. The first LCR element 
identified upstream of the human ε, γ, δ and β-globin genes showed all the characteristics of 
the SV40 enhancer including strong clustered DNaseI hypersensitive sites (DHS) and 
distinctive histone marks (Grosveld et al. 1987; reviewed in Li 2002). Enhancer action has a 
highly precise tissue-specific activity (Schirm et al., 1987) and can be associated with other 
diverse promoters. Notably, cis-regulatory sequences that work over substantial distances 
(>10 kb) have been described (Banerji et al., 1981; Mellon et al., 1981; Moreau et al., 1981).  
Chromosomal rearrangements studies have revealed that most of the functional enhancer are 
positioned within a range of ~1 Mb 5’ or 3’ in cis of their cognate promoter (Symmons and 
Spitz, 2013). However, position and orientation do not constrain enhancer action as both 
enhancer reporter assays (Bhatia et al., 2015) and localised transposon hopping (Anderson et 
al., 2014; Symmons et al., 2014) highlight that enhancer that endogenously act at long-range 
are also efficient at short range. Interestingly, many developmental genes are often 
neighbouring to gene deserts. The absence of other adjacent genes could help ensure 
regulatory specificity between enhancer and promoter. For example, artificial integration of 





the β-globin locus control region (LCR) into a gene-rich domain leads to an ectopic 
activation of the adjacent genes (Noordermeer et al., 2008). 
One well studied developmental gene regulated by distal enhancers is the sonic hedgehog 
gene (Shh).  Shh is adjacent to a large gene desert spanning nearly 900 kb which contains a 
number a tissue-specific enhancers regulating its various expression domains (Epstein et al., 
1999; Jeong, 2003, 2006; Sagai et al., 2004, 2009) (Figure Ch1-1). Shh encodes for a 
secreted morphogen that imparts patterns of growth and identity to cells during many stages 
of embryonic development, including neural progenitors throughout ventral regions of the 
developing central nervous system (CNS) (Dessaud et al., 2008; McMahon et al., 2003). Shh 
expression in neuroectodermal lineages is driven by Shh-Brain-Enhancer (SBE2, SBE3, 
SBE4 and SBE5) that are located roughly 300 kb upstream the Shh promoter (Jeong, 2006) 
or 800 kb for SBE5 (Yao et al., 2016). In the same manner, the ZRS (zone of polarizing 
activity regulatory sequence) located about 1 Mb away drives Shh expression during limb 
development (Lettice et al., 2003) revealing that the ZRS is able to bypass both the gene in 
which it is located - Lmbr1- and a neighbouring gene - Rnf32 - in order to activate 
specifically Shh (Figure Ch1-1). The above example reveals that enhancer-promoter 
communication must carry very specific mechanisms of action as enhancers can also be 
positioned with other intervening genes or even located within the introns of nearby genes 
(Noonan and McCallion, 2010). 
  






Figure Ch1- 1 Shh Promoter and tissue-specific enhancers. 
Schematic (top) representing the activity of Shh-tissue-specific enhancers in mouse 
embryo and (bottom) map displaying the genomic locations of genes and enhancers 
in the Shh regulatory domain. Red box show ZRS, Shh limb bud enhancer, in blue 
are enhancers active in floor plate and spinal cord, in gold are enhancers for 
epithelial linings, and purple boxes represent enhancers driving Shh expression in 
the developing brain. Grey arrows represent direction of corresponding gene 
expression.  
  





1.2 Enhancer-promoter communication 
Over the years, several models have emerged regarding the communication between 
enhancers and promoters. Originally considered as an extension of the promoter, regulatory 
element were thought to provide a precise docking site for RNA polymerase II - or other 
components of the transcriptional machinery - followed by tracking of these factors on the 
chromatin fibre until they met and activated the cognate core promoter in a time and 
position-dependent manner (Ptashne and Gann, 1997).  
The tracking model suggests a continuous spreading of the activation signal after proteins are 
recruited to the enhancer. Transcription factors could track along the chromatin fibre towards 
the promoter and associate with the polymerase to activate transcription or chromatin-
remodelling factors spread the activation signal to the promoter (Kolesky et al., 2002). The 
linking model, which to date is sparsely defined, is similar to the tracking model, where the 
bound transcription factor leads to oligomerization of proteins that formed a bridge between 
then enhancer and the promoter (Bulger and Groudine, 1999, 2011; Mahmoudi, 2002) 
(Figure Ch1-2). Studies of spreading models at several loci, such as β-globin, have described 
an unidirectional spread of CBP/p300 histone acetyltransferases, histone acetylation (H3 and 
H4), components of chromatin remodelling complexes (SWI/SNF), or RNA polymerase II 
itself with synthesis of short polyadenylated, intergenic RNAs (Gribnau et al., 2000; Hatzis 
and Talianidis, 2002; Kim and Dean, 2004; Masternak et al., 2003; Spicuglia et al., 2002; 
Wang et al., 2005; Zhao and Dean, 2004; Zhu et al., 2007). These studies associate tracking 
as the primary step for enhancer-promoter interaction and hypothesize the later formation of 
a stable enhancer-promoter loop when tracking is complete (Figure Ch1-2).  
The current widely accepted model for long-range communication implicates direct 
interactions between enhancer- and promoter-bound proteins that connects enhancer and 
promoter with looping out of the intervening chromatin (Su et al., 1991; Tolhuis et al., 2002) 
(Figure Ch1-2).  This looping model may involve a transfer to the cognate promoter of RNA 
polymerase II or activating – or de-repressing – factors such as histone demethylase to 
remove Polycomb complex (Vernimmen et al., 2011).  
Looping of the chromatin would enable a very specific enhancer-promoter communication, 
which illustrates the spatial and specificity of activation of a certain gene by a unique 





enhancer. Recent elegant chromosome engineering experiments have demonstrated that 
imposing direct interaction between the β-globin promoter and its LCR is sufficient to 
generate β-globin activation in erythroid cells, where some other key transcription factors are 
also already bound (Deng et al., 2012, 2014). However, in some other cases enhancer-
promoter direct interaction via chromatin looping may be insufficient for gene activation. It 
seems that chromatin looping for enhancer-promoter direct interaction can appear dynamic 
and cell-type specific (Benko et al., 2009; Simonis et al., 2006; Tolhuis et al., 2002) or more 
stable across cell types occurring in both expressing and non- expressing cells (de Laat and 
Duboule, 2013; Montavon et al., 2011) with transcription being initiated from stable pre-
formed loops through paused polymerase release (Ghavi-Helm et al., 2014). Therefore 
enhancer-promoter loops can be stable across different tissues, even when the gene is not 
expressed, or more dynamic, with loop formation coinciding precisely with gene activation.  
Considering chromatin as a polymer, limiting the diffusion of the fibre by the formation of a 
stable chromatin loop must have a substantial entropic cost. Therefore in theory we could 
predict the stability of a chromatin loop by knowing the size and the strength of binding-
energies of enhancer and promoter-bound proteins. Likewise, for short-range interaction the 
rigidity of the chromatin fibre might prevent direct interaction via chromatin looping, as it 
would require incredibly strong protein interactions, confirming the convenience of the 
tracking model for short-range regulation (Vernimmen and Bickmore, 2015). 






Figure Ch1- 2 Enhancer-promoter communication. 
Enhancer and promoter communication mechanisms. Left - the tracking and linking 
models where neighbouring enhancer anchoring for activating signals that track 
along the chromatin fibre towards the cognate promoter (tracking model- up) or that 
oligomerize and form a protein bridge towards the cognate promoter (linking model - 
down) (Model not applicable for any Shh enhancer so far but is believed to be the 
case for proximal enhancer). Right - the looping model for distal enhancer where 
they directly interact with their cognate promoter by looping out of the intervening 
chromatin region (only shown for ZRS/Shh in that locus). 
  





1.3 Chromatin organisation 
Independently of the model for enhancer-promoter communication, it is clear that enhancers 
impact on genome regulation by modulating the chromatin architecture locally in a linear 
way or more broadly by changing the 3D folding of the locus. 
1.3.1 A linear view of the chromatin state 
In the interphase nucleus, chromatin is organized into functional domains with 
heterochromatin defined as a structure that does not change its condensation state during the 
cell cycle whereas euchromatin can appear decondensed and more thread-like during 
interphase (Augui et al., 2011; Hutchison and Weintraub, 1985; Zorn et al., 1976, 1979). 
Constitutive heterochromatin is localized mainly at the periphery of the nucleus and 
nucleolus (Croft et al., 1999; Kind and van Steensel, 2010), whereas euchromatin is 
distributed within the nucleoplasm and is associated with transcribed regions (Li et al., 2007; 
Lieberman-Aiden et al., 2009; Tanabe et al., 2002). 
However, the nucleus is not a fixed entity and chromatin conformation changes contributing 
to the control of gene expression. Factors considered responsible for these different states are 
involved in the chromatin landscape (Filion et al., 2010). For example the chemical 
modifications of DNA such as methylation that occur without altering the sequence (Suzuki 
and Bird, 2008), the determinant of nucleosomes positioning and  the post-translational 
histone modifications which influence DNA accessibility to activators and thus control gene 
expression (Kouzarides, 2007; Struhl and Segal, 2013), the binding of chromatin remodeller 
or transcription activators like Vp16 or acidic peptide that can decondense and rearrange 
large chromatin region (Belmont et al., 1999; Carpenter et al., 2005; Tumbar et al., 1999). 
Depending on the gene and the cell type, these determinants influence each other resulting in 
different chromatin state. This modularity has consequent effects on gene expression and 
represents a means to respond and adapt to external environmental stimuli. 
More than just the local scale, modifications influencing chromatin structure changes can act 
over a very wide region of tens to hundreds kilobases (Bickmore and van Steensel, 2013; 
Cairns, 2009). Acetylation of histones H3 and H4 has been largely linked with open, 





decondensed and thus active chromatin. A direct role for acetylation in chromatin 
decondensation has been established using incubation with the Histone Deacetylase (HDAC) 
inhibitor TSA (Eskeland et al., 2010a; Tóth et al., 2004). Indeed, acetylation reduces the 
positive electrostatic charge of the core histone and thus decreases the attraction of the 
negatively charged DNA to the histone core leading to a loose conformation and chromatin 
decondensation. In a general manner, acetylation occurs  as one of the primary mechanisms 
for rapid change in gene expression as it can quickly rearrange chromatin upon a sudden 
stimulus such as Drosophila’s polytene chromosomes puffs where rapid gene activation 
corresponds to a quick and massive chromatin decondensation displaying active marks such 
as H4K16ac (Turner et al., 1992).   
However, the chromatin fibre is not just a further linear packaging of the DNA sequence 
than impacts its accessibility in 2D only. The chromatin can fold in more specific ways and 
can also adapt and change the overall 3D shape upon various determinants. 
1.3.2 Chromatin domains and folding 
1.3.2.1 Polycomb domains 
Polycomb chromatin that can form large chromatin domains is described as a repressive type 
of chromatin that primarily regulates genes with developmental functions i.e facultative 
heterochromatin (Sparmann and van Lohuizen, 2006). Polycomb complexes PRC1 and 
PRC2 are well-known transcriptional regulators that have also been described as master 
chromatin architects by forming large domains covered by the H3K27me3 mark (Cao and 
Zhang, 2004; Ku et al., 2008; Pan et al., 2007). The canonical method by which this occurs 
depends on H3K27me3 deposition by PRC2 complex that is then recognised by and recruits 
units of the PRC1 complex to later induce chromatin compaction (Figure Ch1-3). The 
nucleation of a Polycomb complex further spread to cover a wider domain and leads to an 
expanded compaction of the whole domain. Chromatin architecture of some gene and 
enhancers clusters such as the HoxD locus are dictated by the Polycomb complexes 
(Eskeland et al., 2010b; Williamson et al., 2012, 2014).  
Several studies have attempted to categorise chromatin based on the complement of histone 
modifications covering a particular locus and in each case a Polycomb repressed class of 





chromatin has emerged as a distinct class (Filion et al., 2010; Ram et al., 2011; Zhu et al., 
2013). Polycomb complexes are able to change nucleosomes occupancy and are responsible 
for chromatin compaction (Eskeland et al., 2010b; Francis et al., 2004; Ringrose and Paro, 
2004). In vitro and in vivo, the Hox locus has been shown to decompact upon activation and 
to lose polycomb-complex and H3K27me3 marks (Chambeyron et al., 2005; Morey et al., 
2007; Williamson et al., 2012). In some case, enhancers have been associated with active 
removal of polycomb marks on their target genes (Vernimmen et al., 2011). Interestingly, in 
Drosophila, it has been demonstrated that polycomb target genes co-localise and form 
defined domains called polycomb bodies (Bantignies et al., 2011; Hernandez-Munoz et al., 
2005; Pirrotta and Li, 2012). In mammalian cells, there are also strong evidence for the 
formation of a 3D structure regrouping several Polycomb targets in a confine a nuclear space 
(Schoenfelder et al., 2015) (Illingworth, Boyle et al. in preparation). 
  






Figure Ch1- 3 Canonical Polycomb Complex. 
The zinc finger Suz12, Eed, Ezh (SET domain with histone methyltransferase 
activity) and RbAp (histone binding domain) are the component of the PRC2 
complex. PRC2 initiate the targeting of the sequence to be repressed and deposit 
H3K27me3. PRC1 composed of PCGF, PHC, Ring (ubiquitin ligase) and CBX 
(chromodomain that recognise H3K7me3) is required for the compaction of the 
sequence and stabilizing the silencing. However H2AK119Ub by Ring1 is not 
required for chromatin compaction (Eskeland et al., 2010b; Illingworth et al., 2015).  





1.3.2.2 TADs and active hubs 
The recent rise of chromosome conformation capture techniques allowed high throughput 
detection of interactions within chromosomes from the kilobase to the megabase scale. 
Those techniques are based on quantifying interaction between loci in a formaldehyde 
crosslinked cell. The crosslink allows to take a snapshot of the cell, then the genome is 
digested into smaller fragment followed by a ligation step that should favour proximity (in 
the 3D space) ligation. Next, 3D contacts can be quantified after an amplification step. 
The first chromosome conformation capture (3C) experiment quantified one versus one 
interactions. The interaction from two loci at the time is monitored by PCR amplification 
(Dekker et al., 2002). Chromosome conformation capture-on-chip (4C) allows interactions 
detection from a bait sequence to a series of other sequences (one versus many) (Simonis et 
al., 2006). This also use PCR amplification and has been used to reveal specific enhancer-
promoter interactions (Montavon et al., 2011). Chromosome Conformation Capture Carbon 
Copy (5C, many versus many) and Hi-C (all versus all) techniques are based on sequencing 
and quantifying reads. 5C allows to generate an interaction map of an entire region up to 
1Mb (Dostie et al., 2006). The Hi-C technique allows genome-wide interaction mapping by 
combining the detection of sheared biotinylated 3C products by streptavidin beads with in 
depth sequencing (Lieberman-Aiden et al., 2009).  
The use of Chromosome Conformation Capture techniques and its derivatives (3C, 4C, 5C, 
3C-Seq, HiC) unveiled the genome’s folding principles and exposed a repetitive structure of 
self-interacting domains (Bancaud et al., 2009; Lebedev et al., 2005; Lieberman-Aiden et al., 
2009). Thereby, the mammalian genome appears to be confined into a succession of 
topologically associated domains (TADs). Those TADs subdivide the genome into ~1Mb 
domains in which chromatin interactions are enriched compared to inter-domain interactions 
(Figure Ch1-4A)  (Dixon et al., 2012; Jin et al., 2013; Nora et al., 2012) 
Recent work supports a model in which enhancers locate with their cognate promoters within 
the same topologically associated domains (TADs) and the ability of an enhancer to activate 
its target genes declines drastically beyond the TAD border (Anderson et al., 2014; 
Symmons et al., 2014). Furthermore, disrupting TAD boundaries has been shown to be able 
to re-wire enhancer and promoter communication leading to ectopic gene activation 





(Lupiáñez et al., 2015) revealing that TADs functionally compartmentalise the genome to 
facilitate gene regulation. 
This 1Mb size of TAD and maximum distance between enhancer and their cognate promoter 
might arise from the diffusion property of the chromatin itself. Indeed, as chromatin has a 
diffusion coefficient of ~1 x 10-4 µm2.s-1 in living human cells (Chubb et al., 2002), this 
defines a certain limit for enhancer-promoter interactions as it delimits a radius of constraint 
of ~ 0.5 µm. In case of a looping mechanism, enhancer and promoter sequences need to 
probe the space to find each other and for that to occur efficiently, the two sequences should 
be less than 0.5 µm apart which generally represents ~ 1 Mb. Therefore, chromatin motion 
might have provided a selective pressure for the maintenance of those 1Mb compartment. 
Characterization of human chromatin using chromosome conformational capture techniques, 
strongly support the fractal globule structural model of the human genome (Lebedev et al., 
2005; Mirny, 2011). That is to say that the three-dimensional chromatin architecture is 
organized as a repetitive folded entity from an active chromatin hub (Figure Ch1-4C) to a 
TAD (Figure Ch1-4A) to whole chromosome, that is subdivided in several TAD and that 
occupy its own territory (Figure Ch1-4B). However, recent imaging studies highlighted that 
chromosome folding diverge slightly from the ideal fractal-globule model as TADs size can 
vary and that TADs associates into higher compartments of the chromosome that are 
spatially arranged in a polarized fashion (Wang et al., 2016). Those last observations 
corroborate with FISH data that shows human p and q chromosome arms occupying non-
overlapping, polarized chromosome territories (Boyle et al., 2011; Shopland et al., 2006). 
TADs appear to be chromatin domains that define the functional landscapes of enhancers 
(Berlivet et al., 2013; Lupiáñez et al., 2015). Regardless of the mechanism of action, 
activation of gene expression mediated by an enhancer requires the establishment of protein-
protein and protein-DNA complexes. As protein nuclear search depends on the laws of mass 
action, efficient gene activation via protein binding is sensitive to local concentration of both 
proteins and DNA. Therefore chromatin packaging is an important determinant of regulatory 
domains. Recent in vivo analysis of some transcription factors revealed that their prominent 
DNA binding mechanism, facilitated diffusion, seems to be a 3D diffusion alternated with 
1D sliding along the chromatin fibre. A first model is to consider chromatin packaging as 
allowing the clustering of transcription factors binding sites and thus greatly reducing the 





nuclear search space (Chen et al., 2014; Izeddin et al., 2014; Normanno et al., 2015; 
Woringer et al., 2014). Therefore multiple binding site for the same transcription factor on an 
enhancer will induce a local concentration of this same transcription factor. Constraining 
those proteins within the same chromatin hub would enable them to find the cognate 
promoter binding sites more easily and rapidly (Figure Ch1-4C). In this model, enhancer-
promoter specificity relies on shared specificity and high affinity of their binding sites for the 
same transcription factors.  
A second model uses a similar reasoning but with the inverse interpretation – suggesting that 
tight chromatin packaging reduces the nuclear space in which transcription factors are free to 
diffuse - excluded volume effect - (Woringer et al., 2014). Because of its viscoelastic 
properties, compact chromatin domains have been shown to affect chromatin motion and to 
significantly reduce the first encounter time for distant genomic regions (Lucas et al., 2014). 
This is consistent with the observation that pivotal developmental genes, such as Shh, and all 
their tissue-specific enhancers are located consistently within ~1 Mb chromatin domains that 
are physically very compact regardless of the tissue (Lettice et al., 2014; Williamson et al., 
2012), suggesting acquired physical mechanisms for TADs to prevent ectopic activation . 
We can imagine that depending on the cell type and the state of this locus, a chromatin hub 
might be compacted or not to either exclude potential activators binding or in contrary to 
increase the concentration of activators (Figure Ch1-4B).  
  






Figure Ch1- 4 TADs and Chromatin hubs. 
A) Mouse embryonic stem cell (ESC) 5C heatmap revealing domain that self-
interacts more, namely TAD. B) Schematic representation of more compact 
chromatin domains, such as inactive TADs or chromatin hubs, and their viscoelastic 
properties that can constrain chromatin motion and affect the dimensionality of 
transcription factor diffusion, and create either local concentration of transcription 
factors and activators or can physically exclude ectopic activators. C) Enhancers 
may just be constrained within the same nuclear domain (TADs or sub-TADs) as 
their target genes with recruiting protein and chromatin constrained diffusion then 
being sufficient to activate gene expression (Chromatin hubs).  
 





In light of the previous section, how Polycomb interacting domains are related to the TAD 
segregation of chromatin remain unclear. Williamson et al. 2014 showed that the HoxD TAD 
is completely dependent on Polycomb but such mechanism is not true for every TAD.  
Surprisingly, most of the TADs are conserved between different cell lineages even when 
they contain genes that have different activation states and even when the underlying histone 
modifications change in parallel. In a general manner also, TADs structure remains 
unchanged when proteins responsible for H3K9 and H3K27 methylation are removed (Nora 
et al., 2012) but has been shown to change for the HoxD locus (Williamson et al., 2014).  
Most of TADs studies emerged from FISH and “C” data that have low resolution (Dostie and 
Bickmore, 2012). Better sequencing quality and recent super-resolution imaging of TADs 
will perhaps in the future improve our current knowledge of those structures (Giorgetti et al., 
2015). 
Moreover, little is known regarding TADs molecular structures. CCCTC-binding factor 
(CTCF) and cohesin are well-described chromatin folding architects (Merkenschlager and 
Odom, 2013; Nichols and Corces, 2015; Ong and Corces, 2014; Parelho et al., 2008). More 
recently, TADs boundaries have been reported to be enriched for CTCF, cohesin and other 
architectural proteins (Dixon et al., 2012; Jin et al., 2013; Nora et al., 2012; Rao et al., 2014; 
Seitan et al., 2013; Sofueva et al., 2013; Zuin et al., 2014) with CTCF sites orientation 
dictating TADs architecture (Guo et al., 2015). Despite these advances the underlying 
molecular basis remains unclear.  So far all that is known is that CTCF interacting sites are 
strongly shaping the position of TADs (and inner sub-TADs smaller self-interacting region 
contained in a TAD) which are consistent with the known characteristics of CTCF as an 
insulator of enhancer activity (Bell et al., 1999) and with promoting in other cases, long-
range interaction and enhancing transcription (Xu et al., 2011). 
 
  





1.3.2.3 Chromatin extrusion 
At the whole chromosome scale, chromosome territory has been linked with changes in 
conformation and gene activity. Relocation of genes to the periphery or even the outside of 
visible chromosome territory often correlates with their activation status (Mahy et al., 2002; 
Volpi et al., 2000). FISH data and recent Hi-C interaction probing revealed that active and 
inactive domains generally segregate. Inactive domains tend to remain within the 
chromosome territories whereas active domains are less compact, locate to the chromosome 
territory periphery, and are more likely to form inter-chromosomal contacts with other active 
regions (Boyle et al., 2011; Lieberman-Aiden et al., 2009; Sexton et al., 2012; Yaffe and 
Tanay, 2011). 
For example, Hox clusters reside in the internal part of their chromosome territories in 
embryonic stem cells (ESCs) and, upon activation, they loop out and reside outside of their 
chromosome territories. A similar event has been described for the Shh locus regarding the 
ZRS activity in the posterior side of the limb only (Amano et al., 2009) and with ectopic β-
globin LCR (Noordermeer et al., 2008, 2011). However extrusion of the chromosome 
territory is not sufficient to induce gene activation (Morey et al., 2009). With for example the 
human α-globin genes that extend out of their chromosome territory irrespective of 
transcriptional status (Brown et al., 2006).  
The functional role of looping out remain unclear as it does not induce activation per se, but 
as discussed in the previous section, this dynamic of chromosome territory extrusion and 
decondensation could allow more diffusion capacity. This could help to explore a larger 
nuclear space and decrease the first encounter time with transcription factors (Brown et al., 
2008; Schoenfelder et al., 2010; Sutherland and Bickmore, 2009).  
  





A parallel for chromosome extrusion phenomena could be drawn with heat-shock induced 
polytene chromosome puffs in Drosophila. Upon heat shock, Poly(ADP-ribose) polymerase-
1 (PARP1) is strongly activated and parylates e.g. transfer of poly-ADP-ribose on very large 
regions in the polytene chromosome puffs which induce chromatin loosening (Tulin and 
Spradling, 2003; Tulin et al., 2002, 2003). PARP1 has been extensively linked with gene 
expression and regulatory regions (Nalabothula et al., 2015; Ogino et al., 2007; Petesch and 
Lis, 2012). 
PARP1 is a chromatin remodeller that binds DNA via two zinc finger motifs and 
polymerizes long chains of poly (ADP-ribose) (PAR) from nicotinamide-adenine-
dinucleotide (NAD+) to chromatin-associated acceptor proteins, core histones, histone 
variants, post-translationally modified histones, histone H1 or PARP1 itself (Gottschalk et 
al., 2009; Kim et al., 2004; Kraus and Lis, 2003; Petesch and Lis, 2008; Timinszky et al., 
2009) (Figure Ch1-5). 
The main histone acceptor of poly(ADP-ribose) is histone H1, which is then responsible for 
large relaxation of the chromatin architecture as it impairs H1’s ability of compacting 
chromatin (Poirier et al., 1982). Histone H1 does not participate in the formation of the 
nucleosome but binds to the nucleosome and to the linker DNA and regulates the position of 
the nucleosome (Allan et al., 1981; Fan et al., 2005; Woodcock et al., 2006). H1 is the 
fundamental component of nucleosome positioning and stability and therefore an elementary 
architect of the chromatin structure via a very dynamic binding (Allan et al., 1980; Misteli et 
al., 2000; Thoma and Koller, 1977; Xiao et al., 2012). Therefore PARP1 is considered as an 
important chromatin architect as it leads to large scale chromatin loosening (Figure Ch1-5).   
On the whole, chromatin architects encourage chromatin folding of domains following the 
same transcription regime. They compact together regions in the genome that are required to 
be silenced, and reciprocally enhance chromatin unfolding for domains that are to be 
transcribed. 
  






Figure Ch1- 5 Poly(ADP)-ribose Polymerase 1. 
PARP1 transfers poly(ADP)-ribose onto the chromatin and chains of ADP ribose 









1.4 The interesting case of Sonic hedgehog 
Tissue patterning is governed amongst other things by a subset of genes that encode 
signalling molecules called morphogens. Sonic hedgehog (Shh) as an important morphogen 
is tightly regulated by a group of enhancers. As shown in Figure Ch1-1, enhancers are 
positioned in a Shh regulatory domain that spans a large gene desert of 1Mb in the human 
genome, nearly 900 kb in the mouse and 1.4Mb in the opossum genome (Anderson and Hill, 
2014; Epstein et al., 1999; Jeong, 2003, 2006; Lettice et al., 2002, 2003; Sagai et al., 2004, 
2009; Yao et al., 2016).  
SHH is a secreted signalling protein that imparts patterns of growth and identity to cells 
during many stages of embryonic development such as the developing central nervous 
system and the limb buds (Dessaud et al., 2008; Lettice et al., 2002, 2003; McMahon et al., 
2003; Riddle et al., 1993).In limb buds, Shh is active in the zone of polarising activity (ZPA). 
From this posterior side of the limb to the anterior side, Shh is expressed as a gradient. If this 
gradient is disturbed it leads to ectopic expression of Shh in the anterior limb and will result 
in digit duplications which is the cause of congenital malformations such as preaxial 
polydactyly (PPD) (Riddle et al., 1993). Genetic analysis demonstrated that mutations in 
intron 5 of the Lmbr1 gene lead to this ectopic Shh activation and thus to PPD (Lettice et al., 
2002, 2003).  This conserved region was named ZPA Regulatory Sequence (ZRS). 
Moreover, deletions and point mutations of the ZRS in mice, humans, cats and chickens all 
disrupted Shh and led to PPD or other limb defects (Furniss et al., 2008; Lettice et al., 2003, 
2008; Maas et al., 2011; Sagai, 2005) confirming that the role of this enhancer is greatly 
conserved and establishing Shh as a text-book model for enhancer activity.  
Shh is also very important in patterning the central nervous system (CNS) and brain. Shh is 
critical for a proper brain formation and also a Shh dorso-ventral gradient patterns the 
identity of motor neurons (Balaskas et al., 2012) (Figure Ch1-6A). 
Regarding the brain, most of the known Shh neural enhancers have been identified through 
transgenic reporter assays in mouse. Shh-floor-plate enhancer-1 (SFPE1), -8kb from Shh 
transcription start site (TSS), SFPE2 and Shh-brain-enhancer-1 (SBE1) – both in the 2nd 
intron of Shh, show activity respectively in the ventral spinal cord (floorplate) and hindbrain 
or in the ventral midbrain, ventroposterior diencephalon and the Zona limitans intrathalamica 





(ZLI) (Epstein et al., 1999; Jeong, 2003). Using BAC clones as reporter constructs, an 
enhancer trap assay that screened 1 Mb of the Shh regulatory region revealed Shh brain 
enhancer-2 (SBE2), SBE3 and SBE4 driving Shh expression in the ventral forebrain (ventral 
diencephalon for SBE2, ventral telencephalon for SBE4) (Jeong, 2006). More recently, using 
first pattern comparison from enhancer-reporter assay data base and motif recognition of 
similar enhancer sequence, a new SBE1-like ZLI enhancer has been annotated, SBE5 (Yao 
et al., 2016) (Figure Ch1-1). 
Perturbation of Shh cis-regulation leads to severe defects in mammals. When the action of 
cis-regulatory regions is disrupted by translocations separating SBE2, 3 and/or 4 from Shh, it 
leads to a haplo-insufficiency phenotype similar to those resulting from autosomal dominant 
mutations in the coding region of Shh and cause diverse holoprosecencephaly –midline 
cleavage defect) (HPE) phenotypes (Figure Ch1-6B) (Belloni et al., 1996; Dubourg et al., 
2007; Roessler et al., 1996). Additionally, a SBE2 point mutation results in loss of enhancer 
activity in the hypothalamus and causes HPE (Jeong et al., 2008). Together these cases 
highlight the importance of reporting and understanding new cis-regulatory elements, 
particularly in the context of understanding developmental disease.  







Figure Ch1- 6 Shh Signalling in a brain and gradient in the Vertebrate Neural 
Tube. 
A) Left, Shh expression pattern in the developing mouse embryo and right, gradient 
from the notochord (Nc) and floor-plate of the spinal cord to the dorsal side of the 
neural tube leading to identity of motor neurons. B) Midline cleavage defect in 
various cases of holoprosencephaly (HPE).  





1.5 PhD Aims 
Most of the documentation about enhancer-promoter loops come from the strong detection 
of enhancer-promoter ligation products in the Chromosome Conformation Capture (3C) 
technique and its derivatives (4C, 5C, Hi-C etc.) (Montavon et al., 2011; Palstra et al., 2003; 
Tolhuis et al., 2002). Unfortunately, these “C” techniques are generated on a whole 
population and only reveal the average conformation and not the frequency of those 
interactions.  
One of the first limitations of these techniques is the lack of information regarding a transient 
or stable conformation. Imaging technique such as fluorescence in situ hybridisation (FISH) 
allow the precise distribution of distances and thus interaction frequencies to be determined, 
as each allele is imaged separately. FISH has been used to study enhancer-promoter looping 
(Lettice et al., 2014; Williamson et al., 2012) and it could in some cases, when the 
frequencies observed are low, argue in favour of a more transient enhancer-promoter loop 
instead (Williamson et al., 2012).  
Furthermore, recent side-by-side 5C and FISH comparison established that in some cases 
these techniques are not able to reproduce the same result, with physical proximity inferred 
from 5C heatmaps not observed by imaging (Williamson et al., 2014) and increased spatial 
co-localisation by FISH not reflected by increase of 3C signal detections (Williamson et al., 
2016). 
 We could suppose that “C” techniques are powerful tools to study 3D folding of the 
chromatin as they reveal stable direct interactions. FISH could indicate in theory not only 
physical proximity by chromatin folding but also physical proximity due to condensation of 
the chromatin fibre into higher order structures (Figure Ch1-7). Therefore combining both 
techniques could allow having a better insight of the overall chromatin topology but also 
local chromatin fibre organisation. 
  







Figure Ch1- 7 5C heatmap and 3D-FISH contradictions. 
Centre, schematic representation of a region with one promoter and two enhancers. 
The promoter is able to crosslink with Enhancer 1 due to a direct physical interaction 
that allows further detection of ligation products between those two sequences. But 
the promoter does not crosslink with Enhancer 2 (outside the orange circle 
representing 5C crosslink radius) as the two sequences do not directly interact due 
to higher chromatin fibre organisation. However, even though both these sequences 
are located far away from the promoter in genomic terms, they both show a strong 
co-localisation signal by FISH as the 3D-FISH interprobe distance is the same 
(orange arrow). Left, 5C heatmap illustrating differential interaction between 
Enhancer 1, promoter and Enhancer 2. Right, 3D-FISH representing same 
distances for each couple of probes. 
  





Combining both tools, studies of Shh-ZRS communication showed that ZRS activate Shh 
following the looping model (Amano et al., 2009; Williamson et al., 2016).  
Shh is an important Polycomb target and its conformation in non-expressing cells such as 
ESCs is very compact. The Shh regulatory domain is contained in a single TAD with Shh 
located at one border and the series of enhancers located upstream its TSS in the TAD. Shh 
TAD comprises several CTCF sites that interact together and shape inner-TAD interactions 
(Williamson, Lettice et al., unpublished). Shh-ZRS has been well studied, however, how Shh 
brain enhancers activate Shh remain unknown.  
The aim of my PhD is to dissect how Shh communicates with its active neural enhancer 
during differentiation. SBE2 has a known effect on cases of holoprosenchapaly linked with 
missexpression of Shh, however, how SBE2 interacts with Shh is unknown. Understanding 
the mechansim by which SBE2 activates Shh will help us to conceive why a single point 
mutation in one of its transcription factor binding site (SIX3) leads to major deregulation of 
Shh expression. 
To answer the aim, I used a differentiation system from embryonic stem cells (ESCs) where 
Shh is not active to neural progenitor cells (NPCs) where Shh is activated to follow 
enhancer-promoter communication using microscopy and molecular biology techniques. In 
Chapter 2, I annotated a new distal Shh enhancer active in NPCs named Shh-brain-enhancer-
6 (SBE6). Chapter 3 describes how I first observed a surprising interaction between Shh and 
its brain enhancer. Chapter 4 describes the dissection and analysis of the observation made in 
Chapter 3 using synthetic techniques. Chapter 5 presents the mechanism(s) involved in this 
unique interaction. Finally Chapter 6 will be the discussion of all my work and conclusion of 
this thesis. 
  





Chapter 2: Shh-Brain-Enhancer 
6 (SBE6), a novel long-range 
enhancer driving Shh 
expression in neural progenitor 
cells  





2.1 Chromatin signatures of enhancers 
In order to expose crucial transcription factor binding sites (TFBSs), enhancers and 
promoters share properties of chromatin structure including increased chromatin 
accessibility, the presence of chromatin modifications associated with open chromatin and 
the transcription of short non-coding RNAs.   
Traditionally DNAse-I hypersensitive site (DHS) mapping has been used to identify 
potential active enhancers by measuring the accessibility of DNA to nuclease digestion 
(Gross and Garrard, 1988).  More recently, accessibility of DNA to Tn5 transposition forms 
the basis of ATAQ-seq (Buenrostro et al., 2013) which gives similar maps of chromatin 
accessibility following a more straightforward experimental procedure.  Together these 
approaches identify potential regulatory elements in vivo. 
Complementing chromatin accessibility data, a host of posttranslational modifications of 
histone proteins have been correlated with enhancer activity (Heintzman et al., 2009; 
Pradeepa et al., 2016; Roh et al., 2007, 2005; Taylor et al., 2013).  Developmental enhancers 
are pre-marked by H3K4me1 and show a gain of H3K27ac when they become active (Calo 
and Wysocka, 2013). The H3 acetyltransferase p300 and other HATs also binds at 
enhancers, as well as promoters (Heintzman et al., 2007, 2009; Krebs et al., 2011). The 
correlation between the histone modifications and enhancer activity is sufficiently close that 
these marks are now used to identify potential enhancers in the genome (Bonn et al., 2012), 
independent of chromatin accessibility data. 
Even though new genetic approaches can clearly identify bone fide active enhancers in a 
genomic region (Bonn et al., 2012), they are unlikely to be capable of identifying all such 
elements comprehensively (Pradeepa et al., 2016; Taylor et al., 2013). Approaches for 
functionally describing new regulatory elements remain time-consuming, as enhancer 
reporter assay has to be done in a case-by case manner.  However, molecular approaches 
including chromatin accessibility, histone modifications and transcription can give a strong 
indication for predicting enhancer activity in vivo which can then be tested on a case-by-case 
basis. 





In order to precisely study Shh and its brain-enhancer, I chose to establish which neural 
enhancers for Shh are activated in a traceable ex vivo differentiation system. I therefore used 
a mouse embryonic stem cell (ESC) line - 46c that contains a GFP reporter knocked in to the 
Sox1 locus (Abranches et al., 2009; Pollard et al., 2006; Ying et al., 2003), that allows the 
purification by FACS of Sox1-GFP+ve neuroepithelial progenitor cells (NPCs). Sox1-GFP+ve 
positive NPC appear after day 3 of N2B27 differentiation, and from day 3 to 7, expression of 
Shh and Nestin increase whilst Oct4 mRNA levels progressively decrease (Figure Ch2 -1). 
  






Figure Ch2- 1 N2B27 Neural Differentiation. 
A) Schematic showing N2B27 differentiation of Sox1-GFP–ve 46c mouse embryonic 
stem cells (ESC) into; first primitive ectoderm as Oct4 levels decrease and 
Fibroblast growth factor 5 (FGF5) levels rise, and then further into neuroectoderm as 
FGF5 levels start to decrease and Sox1-GFP+ve neural progenitor cells (NPC) 
increase. B) qRT-PCR showing mean ± standard error of the mean (s.e.m.) levels of 
log2 Oct4, Nestin and Shh mRNA levels in ESC and NPCs after 5 and 7 days of 
differentiation. Expression levels are relative to Gapdh and normalised to one 
biological replicate of data from ESCs. Data are from 2 biological replicates and 
technical triplicates.  





2.2 Analysis of histone modification changes 
in the Shh regulatory region during neural 
differentiation 
Using native chromatin immunoprecipitation (ChIP) on chip using genomic microarrays that 
tile the whole regulatory region of Shh, Betül Hemikoglu-Balkan, a post-doc in the lab, 
assayed histone modifications H3K4me1 and H3K27ac in ESCs where Shh is not expressed 
and in day 5 Sox1-GFP+ve NPCs were Shh is expressed. The ChIP-on-chip microarrays have 
been processed by Graeme Grimes (IGMM Bioinformatics). Surprisingly, we found little 
change in the assayed histone modifications over the well-known Shh-brain-enhancers 
(SBE2, 3 and 4) (Figure Ch2-2A). Our attention got caught particularly by a small highly 
conserved region located around a 100 kb upstream of the Shh TSS that has no evidence of 
active enhancer marks in ESC but gains both H3K4me1 and H3K27ac marks upon neural 
differentiation (Figure Ch2-2).   
In silico analysis of this region performed by Philippe Gautier - IGMM Bioinformatics core - 
allowed us to identify two smaller regions (~1kb) under this ChIP peak, corresponding 
broadly to regions with higher conservation in Vertebrates and visualized in the “Vertebrate 
Multiz Alignment & Conservation/Multiz Alignments and Conserved elements” tracks in the 
UCSC genome browser. This resulted in two “core regions” that are strongly conserved in 
mammals and birds – though not fish -. I named these putative NPC enhancer SBE6.1 (mm9 
co-ordinates Chr5: 28889688-28890461, 96048bp upstream of Shh TSS) and SBE6.2. Chr5: 
28893935-28895000, 100295bp away from Shh) (Figure Ch2-2B).  
Searching for transcription factor binding sites (TFBS) on those two sequences using 
rVISTA algorithm, Jaspar and RSAT scans to align the mouse and human orthologous 
sequences, with the default sequence aligner (LAGAN) and default parameters, allowed us 
to confirm the presence of binding sites of known forebrain transcription factors such as 
ETV1, SP8, VAX1 and DLX6 (Nord et al., 2015) (Table 1).  
Interestingly SBE6.1 sequence is entirely included in a recently described lung and gut 
regulatory element for Shh expression in mouse embryos called SLGE (chr5: 28889230-





28890979) (Tsukiji et al., 2014), raising a question of multiple regulatory activity in this 
enhancer. SBE6.2 has not previously been identified or studied. 
  






Figure Ch2- 2 Chip-on-chip for developmental enhancer marks on the Shh 
regulatory region. 
A) Mouse chromosome 5 mm9 (chr5:28,782,000-29,702,000) view of log2  
H3K4me1 and H3K27ac ChIP on ESC and day 5 NPC relative to input revealing a 
region that displays huge gain of enhancer marks in NPC indicated as neural 
enhancer candidate with grey arrow. Black arrows indicate well-known Shh brain 
enhancers and arrowheads point at regions undergoing gain that are not further 
investigated here. B) Zoom on the region (chr5:28,885,000-28,900,000) with 
conservation tracks displaying two smaller core regions named SBE6.1 spanning 
partially Shh lung and gut enhancer (SLGE) and SBE6.2 highlighted in grey. 












predicted site sequence 
MA0761.1 ETV1 5.477 0.81918712 AGAGGAAGGG 
MA0761.1 ETV1 6.665 0.84161589 GAAGGAAGTA 
MA0722.1 VAX1 6.22 0.85945793 CTCATGAA 
MA0722.1 VAX1 5.993 0.8530141 TTCATGAG 
MA0882.1 DLX6 4.104 0.82019633 TCAATGAG 
MA0722.1 VAX1 5.676 0.84401544 CTCATTGA 
MA0722.1 VAX1 6.194 0.85871987 TCAATGAG 
MA0722.1 VAX1 5.696 0.84458318 CTAAAGAC 
MA0761.1 ETV1 5.067 0.81144656 GAAGGATGTG 
MA0747.1 SP8 8.565 0.84123614 CACAACCCCACT 
MA0747.1 SP8 8.342 0.83709184 CCCTCCCCCACC 
MA0761.1 ETV1 4.847 0.80729308 AAGGGAAGTT 
MA0747.1 SP8 6.623 0.80514545 AGCACTCCCCTC 
MA0882.1 DLX6 4.159 0.82162245 CCCATTTC 
MA0761.1 ETV1 5.94 0.8279283 TCAGGAAGAG 
MA0070.1 PBX1 9.456 0.82183775 AGATCACTCAAG 
MA0722.1 VAX1 4.258 0.80376278 CACATGAC 
 
 












predicted site sequence 
MA0882.1 DLX6 4.778 0.83767285 ACAATAAA 
MA0722.1 VAX1 4.603 0.81355627 TTTATTGT 
MA0747.1 SP8 7.915 0.82915635 TCCACCCCTACA 
MA0722.1 VAX1 4.873 0.82122074 CAAATGGC 
MA0722.1 VAX1 4.775 0.81843882 TTCATTTC 
MA0882.1 DLX6 3.662 0.80873546 CATATTAT 
MA0722.1 VAX1 4.144 0.80052667 TAAATCAC 
MA0747.1 SP8 9.031 0.84989642 GTCACACCCCCA 
MA0722.1 VAX1 5.718 0.84520769 CTTATGAC 
 
Table 1 Jaspar scores for forebrain TFBS in SBE6.1 and SBE6.2 in mouse. 
  





Two other sequences beyond SBE3 also show a gain of active enhancer marks (arrowheads 
in Figure Ch2-2A). To look for evidence that these sequences are potential regulatory 
elements that are active in the brain, I examined regulatory segmentation built from 
ChromHMM or Segway using ENCODE data from various tissues such as E14.5 mouse 
brain. I could distinctly visualize known and unknown enhancers at the Shh regulatory 
region (Figure Ch2-3). This first confirmed the activity of SBE2, SBE3 and SBE4 in the 
mouse brain, which is not striking in the H3K27ac ChIP on NPCs (Figure Ch2-2). This also 
confirmed the overlapping of SLGE and SBE6.1 as these sequences seem to be active in 
epithelial linings but also in the brain (Figures Ch2-3 & Ch2-4). 
But the most astonishing observation is that the Shh regulatory region muss possess 
hundreds of yet non-annotated brain enhancer as looking at a better resolution, even peak #2 
- but not peak #1 - from Figure Ch2-2 and Ch2-3 seems to be a putative brain enhancer 
(Figure Ch2-4).  
Using this regulatory segmentation on Ensembl browser I could see that both peak#1 and 
peak#2 are predicted to be much shorter brain enhancer, therefore I focussed on SBE6.1 and 
SBE6.2 to carry comprehensive characterisation of their enhancer activity. 
  






Figure Ch2- 3 Chromatin state discovery and characterization (ChromHMM) in 
mouse and human Shh regulatory region. 
Ensembl mus musculus version 84.38 (GRCm38.p4) view of chr5:28456840-
29050000 with regulatory feature tracks from ChromHMM. Grey arrowheads 
indicate previously described enhancers and two putative sequences indicated in 
Figure Ch2-2. Colour code from ChromHMM with purple for poised promoter, red for 
active promoter, bright green for weak transcription and orange for strong 
enhancers. 
  






Figure Ch2- 4 Chromatin state discovery and characterization (ChromHMM) in 
SBE6.1, SBE6.2 and peak #2. 
A) Ensembl mus musculus version 84.38 (GRCm38.p4) view of SBE6.1 with 
regulatory feature tracks from ChromHMM B) Ensembl mus musculus version 84.38 
(GRCm38.p4) view of SBE6.2 with regulatory feature tracks from ChromHMM C) 
Ensembl mus musculus version 84.38 (GRCm38.p4) view of putative peak #2 with 
regulatory feature tracks from ChromHMM.  





2.3 Exploring the enhancer activity of SBE6.1 
and SBE6.2 
2.3.1 Zebrafish reporter assay 
To test the putative enhancer activity of SBE6.1 and SBE6.2, I used a zebrafish Tol2 
transposon based enhancer-reporter transgenic assay in which the test element is juxtaposed 
to a minimal promoter driving the expression of a reporter gene, which encodes for eGFP or 
mCherry. This reporter assay in zebrafish has been shown be able to detect the expected 
expression pattern for wild-type and mutated enhancers (Bhatia et al., 2015; Jeong et al., 
2008).  
Shipra Bhatia, a post-doc in our lab helped me designing the primers (listed in Chapter 7) to 
amplify and clone the putative enhancer in plasmids containing either GFP or mCherry 
reporter gene. Together we cloned four constructs; SBE6.1-GFP, SBE6.2-mCherry, SBE6.1 
negative control-mCherry and SBE6.2 negative control-GFP. The sequences used as 
negative controls are located the same distance away from Shh TSS as SBE6.1 and SBE6.2 
(96048bp and 100295bp downstream of Shh TSS, in the opposite direction). We also cloned 
SBE4-GFP in order to visualize a positive brain enhancer but the data has not been acquired 
for this condition. Together with Shipra Bhatia, I built the different constructs, injected 
transient zebrafish embryos and Shipra Bhatia then bred the F0 transgenic animals to make 
stable transgenic lines. Together, we performed the confocal imaging of the transient and 
stable transgenic embryos. 
Using this assay, SBE6.1 enhancer activity was detected mainly in the ventral part of the 
developing forebrain of the zebrafish embryos in four independent transgenic lines, with 
some punctual signal I dorsal part. However SBE6.2 failed to drive a consistent reporter 
gene expression with forebrain specific activity noted in only one out of the four independent 
transgenic lines generated (Figure Ch2-5 and Table 2).   






Figure Ch2- 5 SBE6.1 and SBE6.2 enhancer reporter assay during zebrafish 
development. 
Confocal imaging of zebrafish embryos displaying Tol2 reporter assay with GFP and 
mCherry revealing respectively where SBE6.1 and SBE6.2 drive expression in 
transient injections after 30 or 54 hours post injection (hpi) (two left panels) and in 
stable transgenic lines 48 and 72 hours post fertilization (hpf) (two right panels). 
SBE5.1 and SBE5.2 show enhancer activity in the zebrafish forebrain (FB). Reporter 
gene expression is detected in the rostral hypothalamus (RH) and caudal 
hypothalamus (CH) of the forebrain (FB) in ventral and dorsal views. 
  






* Species of origin: Mus musculus 
# Model organism for reporter transgenic assay: Danio rerio 
 
Table 2 Cis-Regulatory Element (CRE) driven transgene expression sites in F1 












Sites of reporter 
expression 




activity of the 
CRE observed 
in 100% of 
transgenic 
lines analysed 
Shh-SBE6.1 eGFP 4 
Forebrain 
(4/4; 100%) 
Pectoral fin (1/4; 25%) 
Heart (1/4; 25%) 
Retina (1/4; 25%) 
Forebrain 
Shh-SBE6.2 
 mCherry 4 
Forebrain (1/4; 25%) 
Otic vesicle (1/4; 25%) 
Olfactory placode (1/4; 
25%) 
Neural tube (1/4; 25%) 
None 
Shh-SBE6.1-
negative ctrl mCherry 2 Faint ubiquitous signal None 
Shh-SBE6.2-
negative ctrl eGFP 3 
Notocord (1/3; 33%) 
Heart (1/3; 33%) 
Ubiquitous (1/3; 33%) 
None 





2.3.2 Mouse LacZ reporter assay 
As only SBE6.1 showed a consistent activity in the developing brain of the vertebrate 
embryo, I pursued my investigations using only SBE6.1. With the help of Shipra Bhatia I 
constructed a SBE6.1-LacZ construct in order to have a clearer indication of SBE6.1 
enhancer activity in the developing mouse brain. The cloning of genomic regions containing 
the putative enhancer, generation of enhancer-reporter constructs and generation and further 
analysis of transgenic lines was carried out as previously described by Shipra and I (Ravi et 
al., 2013). Shipra Bhatia took care of establishing two stable lines with the help of David 
Read from Ian Adams’s team. I performed the LacZ staining of the embryos. Unfortunately 
of those two lines; only one consistently expressed LacZ and from that unique line I 
managed to get only one embryo displaying LacZ staining (Figure Ch2-6). 
With the help of Laura Lettice and Paul Devenney in Robert Hill’s team, we also performed 
transient injection of the SBE6.1-LacZ construct into mouse embryos (Figure Ch2-6). The 
team of the CBS-IGMM transgenic Facility performed injections for both stable and 
transient assays. Laura and Paul revealed the LacZ staining from transient injection at stage 
E11.5. However, here again the construct gave a very low number of positive transgenic 
animals. Unfortunately from transient injection we also managed to visualize a proper LacZ 
signal in only one embryo. Subsequent analysis of that SBE6.1 in mouse LacZ reporter assay 
also revealed the enhancer activity in the developing brain of the mouse embryo but in that 
case expression is recorded in the mesencephalon (midbrain) of the mouse (Figure Ch2-6). 
SBE6.1 also showed activity in the floor plate of the spinal cord of the mouse embryo as 
well as in superficial diencephalon cells (Figure Ch2-6).  
It is hard to conclude anything concrete from only two mouse transgenics. However the 
strong similarities between those two embryos could reassure us that SBE6.1 enhancer is 
active in the developing vertebrate brain with a variation from a forebrain pattern in the 










Figure Ch2- 6 Ch2-6 SBE6.1-LacZ reporter assay in mouse developing embryo 
stage E11.5. 
Top, external view of the LacZ staining SBE6.1  stable (left) and transient 
transgenics (right). Arrowhead pointing at signal in the superficial forebrain (FB), 
near the limit with the midbrain (MB). Bottom left, Shh in situ in mouse embryo 
E11.5 displaying Shh expression in the forebrain (telencephalon, diencephalon), 
(FB), midbrain (caudal diencephalon and zona limitans intrathalamica) (MD) and 
(ZLI), and hindbrain (HB). Middle, sagital section of the transient embryo with 
arrowhead pointing at SBE6.1-LacZ staining in the mouse midbrain and left, 
transversal section of the spinal cord with SBE6.1-LacZ signal in the floor-plate. 






Figure Ch2- 7 (An) other enhancer(s) driving Shh expression in the midbrain. 
Adapted from Figure 1 Maintenance of Shh expression is dependent on SBE1 
of (Jeong et al., 2011). Grey arrowheads point at faint residual Shh expression in the 
midbrain in wild-type embryos or after SBE1 deletion. Shh in situ hybridization in 
wild type, Shh ΔSBE1/ΔSBE1, and Shh ΔSBE1/– mouse embryos at various stages of 
development (E8.5, E10.5, E11.5 and E12.5). hb, hindbrain; hyp, hypothalamus; 
mge, medial ganglionic eminence; mb, midbrain; pret, pretectum; preth, 
prethalamus; thal, thalamus; zli, zona limitans intrathalamica. 
 
 





The different results from SBE6.1 transgenic assays in zebrafish and mouse, forebrain vs. 
midbrain is difficult to explain. From a conservation point of view the mouse result should 
be more representative of SBE6 activity as it is not at all conserved in zebrafish. Thus the 
difference of activity pattern could be due to the fact that zebrafish proteins might recognize 
SBE6.1 as forebrain like transcription factor binding site in opposition to the mouse where 
the activation will be more accurate. 
Comparing my data on SBE6.1 with published transgenic data for SBE1 (Jeong et al., 2011 
Figure 1), another Shh midbrain enhancer active in caudal mesencephalon and currently 
thought to be the unique enhancer driving Shh expression in those tissues, it seems that the 
complete Shh midbrain expression is driven by yet another unknown Shh brain enhancers as, 
after SBE1 deletion, a faint residual Shh expression remains in the midbrain (Figure Ch2-7) 
(Jeong et al., 2011). 
This could further indicate SBE6.1 activity in the midbrain, as the pattern is highly similar, 
or the other midbrain enhancer could reside somewhere else in the Shh regulatory region, as 
Figure Ch2-3 identifies many other non-annotated enhancer are active in the mouse brain. 
  





2.4 Role of SBE6.1 and SBE6.2 during neural 
cell differentiation 
In order to determine the role of SBE6.1 and SBE6.2 in their native genomic context, I used 
CRISPR/Cas9 to generate homozygous SBE6.1-/- and SBE6.2 -/- cell lines the 46c ESC 
genome (Figure Ch2-8). The guide RNAs were designed to delete the entire SBE6.1 or 
SBE6.2 sequence highlighted in grey in Figure Ch2-8. The PAM sequences were oriented 
divergently from the sequence to be deleted in order for the wild-type Cas9 from the pX458 
plasmid to efficiently generates double strand breaks and chew DNA on the outside of the 
sequence. 
I was able to generate two independent homozygote SBE6.1 -/- cell lines as well as three 
independent homozygote SBE6.2 -/- cell lines. For each condition, the independently 
generated clones displayed a reduction in the size of a PCR fragment amplified across the 
region, consistent with a homozygote deletion (Figure Ch2-8). The homozygote deletions 
have been further confirmed by sequencing. 






Figure Ch2- 8 Genomic PCR of SBE6.1-/- and SBE6.2 -/- ESC lines. 
A) Illustration showing the SBE6.1 and SBE6.2 sequences with the gRNA targeting 
for deletions using CRISPR/Cas9 and primers used for genotyping. B) Left, Gel 
showing PCR amplification of SBE6.1 sequence in SBE6.1-/- ESC clone 1 and 2. 
Right, Gel showing PCR amplification of SBE6.2 sequence in SBE6.2-/- ESC clone 
1, 2 and 3, independently generated displaying. Band size measured with 1kb+ DNA 
ladder (Invitrogen). 
  





By deleting SBE6.1 and SBE6.2 in ESC, I could study the direct effect of these deletions on 
Shh expression and delineate if those enhancers are specific to Shh activation in NPCs. 
Neural differentiation into Sox1-GFP+ve NPCs was not disturbed in either deletion cell line, 
as judged by the proportion of Sox1-GFP+ve NPCs recovered after FACS and quantitative 
RT-PCR for Oct4 and Nestin mRNAs (Figure Ch2-9A). NPCs differentiated from the 
SBE6.1-/- deleted cell lines failed to activate Shh expression to a similar level to wild type 
cells (Figure Ch2-9B). In contrast, average Shh mRNA levels in NPC differentiated from 
SBE6.2 -/- ESCs were marginally reduced relative to wild type but this was not statistically 
significant (Figure Ch2-9B). 
I therefore concluded that SBE6.1 directly enhances Shh expression in NPC.  






Figure Ch2- 9 Shh expression levels in neural precursor cells (NPC) derived 
from ESC lines with SBE6.1 or SBE6.2 deletions. 
A) qRT-PCR showing mean (± s.e.m.) log2 mRNA levels of pluripotency marker 
Oct4 and neural marker Nestin in wild-type ESC, NPC and SBE6.1-/- (left) or 
SBE6.2-/- (right) derived NPC, relative to Gapdh and normalized to ESC mRNA 
levels. B) qRT-PCR showing means (± s.e.m.) of relative Shh mRNA levels in wild 
type neural precursor stem cells (NPC) and in cell lines deleted for SBE6.1 (left) or 
SBE6.2 (right) relative to Gapdh and normalised to wild-type ESC. SBE6.1-/- data is 
from 5 biological replicates. SBE6.2-/- data are from 3 biological replicates. Statistical 
analysis of Shh expression differences was done using a one tailed student t-test.  
Shh are significantly reduced in NPCs derived from SBE6.1-/- cell lines (p-value = 
0.012).  
  





2.5 Role of SBE6.1 and SBE6.2 in vivo 
Using the same CRISPR/Cas9 system and the same guide RNAs, with the help of Hemant 
Bengani a post-doc in David Fitzpatrick’s team, I deleted SBE6.1 and SBE6.2 in mouse 
embryos by directly injecting the transcribed gRNA and Cas9 plasmid into zygotes using the 
same constructs as for the cell lines deletions. Hemant transcribed the gRNA plasmid into 
RNA and the team of the CBS-IGMM transgenic Facility co-injected the RNA and the 
plasmid into mouse embryos. 
I recovered E10.5 and E11.5 embryos, genotyped to isolate homozygote deleted embryos 
and performed in situ hybridisation for Shh mRNA on those. None of the deleted embryos 
showed a noticeable reduction of Shh pattern in the brain (Figure Ch2-10). As SBE6.2 does 
not have a clear enhancer activity based on the zebrafish reporter assay and cell lines 
deletion, it is unsurprising that SBE6.2 deletion in mouse embryos does not cause 
disturbance on the Shh patterning of the brain.  
Regarding SBE6.1, the analysis of embryos deletions is trickier as the zebrafish and mouse 
reporter assay suggested different zones of activity for the brain. Regardless of SBE6.1 
forebrain or midbrain activity, other Shh enhancers such as SBE2 or SBE3 for the forebrain 
and SBE1 for the midbrain will be active and lead to a proper Shh pattering. Indeed, as 
shown in Figure Ch2-9, SBE6.1 deletion leads to a decrease of Shh expression in NPC but 
not to a total reduction, indicating that another brain enhancer is probably co-activating Shh. 
Thus it can be expected that SBE6.1 deletion in embryos would not significantly disturb Shh 
patterning. Moreover, if we consider the mouse-LacZ data to be correct, it indicates that 
SBE6.1 might have a very small and discontinuous domain of action, which makes it even 
harder to notice in an in situ hybridisation as the staining signal can vary from an embryo to 
the other and even from the left or the right side of the brain sagittal cut. 
Taken together it seems that SBE6.1 enhancer activity is important in NPC differentiation in 
order to reach a proper Shh levels but other Shh brain enhancers might help to keep a proper 
patterning of Shh in the developing mouse brain. 
  






Figure Ch2- 10 Shh in situ hybridisation of Wild-type, SBE6.1 -/- and SBE6.2 -/- 
mouse embryos at stage E11.5. 
Macroscope images of E11.5 mouse brain sagittal cut displaying for each case left 
and right side of the plane. For each condition, at least 8 embryos from 2 biological 
replicates (2 different placentas) were analysed. 
  






By combining molecular biology techniques to identify active enhancer histone marks and in 
silico analysis to investigate conservation, accessibility and to score transcription factor 
binding site probability I could annotate two new putative enhancer elements for Shh that are 
active in the neural lineage. By then using classic developmental biology including enhancer 
reporter assays in zebrafish and mouse embryos, I could evaluate the function of those 
sequences. Interestingly only SBE6.1 was able to drive consistently expression in the 
forebrain of the developing zebrafish and mouse embryos. By using CRISPR/Cas9 to create 
with homozygote deletions I could confirm that only SBE6.1 is important for a proper Shh 
activation in NPC but does not lead to a strong Shh mispatterning in the developing mouse 
embryos indicating perhaps some level of redundancy. 
It is first interesting to note that the coordinates of SBE6.1 overlap those reported for the Shh 
lung and gut epithelium regulatory element SLGE (Tsukiji et al., 2014), emphasizing  that 
further analysis will be necessary to determine the critical transcription factor binding sites 
needed to drive enhancer function in different developmental settings. Important sequences 
required for enhancer function work in assemblies of transcription factor motifs (Yao et al., 
2016). SBE6.1 and SLGE motifs may be intermingled but still specific to a precise tissue and 
stage of development, or may be overlapping to various extents. There are several examples 
of cis-regulatory elements with activity in multiple tissues or different cell lineages. For 
example, the global control region (GCR) 5’ of HoxD contains regulatory information 
capable of driving expression in the CNS and in the limb (Spitz et al., 2003). Similarly, point 
mutations causing Aniridia have shown that disruption of single transcription factor binding 
sites can disable the ability of an enhancer to drive expression in one tissue, lens, whilst 
retaining enhancer activity elsewhere in development, hindbrain, diencephalon (Bhatia et al., 
2013). 
Regarding SBE6.2, it is curious to remark that well known SBE2, SBE3 and SBE4 
enhancers are not displayed as activated using our ChIP-chip data, but this highly conserved 
sequence called SBE6.2 displays a tremendous gain of histone marks without driving 
consistently a reporter expression or being critical for Shh expression in NPC. This confirms 
the crucial need of deciphering in details the role of sequences carrying enhancer signatures. 





We cannot judge an enhancer function only based on the genome-wide mapping of enhancer 
signatures but we need downstream developmental biology assays to decipher the function 
of a sequence. 
The main aim of this Chapter was to inform me on which Shh brain enhancer should I focus 
for my thesis. Unfortunately our Chip-on-chip data did not allow me to conclude strongly on 
which of the known Shh-brain-enhancers are active in NPCs differentiated from ESCs. As 
no NPCs histone mark profiling data is publicly available, I did a broad comparison with the 
Shh regulatory elements in human to try to answer this aim. It is first interesting to note that 
our ChIP from NPC is more comparable with human neurospheres (neural stem cell culture) 
as it is the condition that strongly reveals enhancers mark for SBE6 position and that 
SBE6/SLGE appears to be similarly strongly co-localising in human (Figure Ch2-11).  
  






Figure Ch2- 11 Chromatin state discovery and characterization (ChromHMM) 
in human Shh regulatory region. 
Roadmap epigenome browser view of human Shh locus on Hg19 (chr7:155595558-
156100554). Arrowheads indicate corresponding enhancers in human genome. 
 
  





In Chapter 2 I have revealed that SBE6.1, now named SBE6, is a cis-regulatory sequence 
located around 100kb upstream of Shh TSS that drives Shh expression in the mouse 
developing forebrain and is crucial for correct Shh mRNA levels in NPC.  
As SBE6 seem to be the most active enhancer in our NPCs, I will follow Shh communication 
with SBE6 as well as the other known brain enhancers SBE4, SBE2 and SBE3. As SBE5 
was published late in my PhD (Yao et al., 2016), I was unable to follow SBE5 precisely as 
our laboratory does not have a fosmid probe for SBE5, however as it is very close from the 
ZRS fosmid probe (≈ 30 kb), following the ZRS will give us a good indication of this SBE5 
behaviour in our model. 
 
  





Chapter 3: Analysing Shh 
promoter-enhancer interactions 
using imaging and 5C 
  






As discussed in the Chapter 1, despite the fact that enhancers have been studied for over 
thirty years, and that their central role in correct patterning of gene expression has been well 
established, concrete evidence for their mechanisms of action are still lacking. 
Several models have been proposed to describe the interaction of enhancers with their target 
gene promoter. Either the enhancer is used as a secondary docking site for activators or it 
interacts directly with the promoter by looping of the chromatin.  The first step towards 
understanding how an enhancer regulates a gene is to establish its mechanism of interaction, 
and then using this information we can subsequently question how this interaction controls 
gene expression. 
Recent Chromosome Conformation Capture techniques have been crucial to investigate 
enhancer-promoter interactions. 3C and 4C have been widely used to test a precise candidate 
promoter-enhancer interaction or to look from a bait e.g. the promoter, which enhancer does 
it interact with (Ghavi-Helm et al., 2014; Montavon et al., 2011; Palstra et al., 2003; Tolhuis 
et al., 2002). More recently developed, Capture-C allows a focused assessment of 3D 
genomic interactions at high resolution (Davies et al., 2015; Hay et al., 2016; Hughes et al., 
2014) and 5C and Hi-C can be used for a general mapping of a larger region or even 
genome-wide (Jin et al., 2013; Sanyal et al., 2012). 
I decided to first use an imaging approach to investigate the mechanisms for distal enhancers 
and promoter interaction at the Shh locus. The main idea behind this approach is to visualize 
and follow enhancer-promoter communication when the gene is off and once the gene is 
expressed using candidate enhancers. After assessing the interaction between those 
enhancers and promoter by imaging I will see which of the Chromosome Conformation 
Capture technique would be more appropriate to further investigate the communication. 
For imaging enhancer-promoter communication, fluorescence in situ hybridisation (FISH) 
on fixed cells has been the predominant method applied. By measuring the spatial separation 
between the promoter and the enhancer probes, information on the chromatin organisation 
can be established. Indeed, the mean-squared interprobe distances (d2) between two FISH 
probes generally has a linear relationship to the genomic distance that separates them, 





consistent with a random-walk polymer behaviour (van den Engh et al., 1992). Thus one can 
compare chromatin compaction following different conditions, between different sequences 
in the same cell type (Yokota et al., 1997), at different stages of differentiation or in different 
tissues for the same locus (Chambeyron and Bickmore, 2004; Morey et al., 2007) 
Therefore FISH is an essential tool to monitor enhancer-promoter communication. By 
monitoring the interprobe distance between a probe at the promoter and a probe at the 
enhancer, I can assess how the enhancer is positioned relative to its target promoter in active 
cells and so gain some insight into possible models of enhancers action. If enhancer-
promoter distances increase, it means that the chromatin architecture has become less tightly 
packaged whereas if the distance decreases it means that the enhancer comes into the vicinity 
of the promoter upon activation, consistent with a looping model (Chapter 1). 
Previous work from Iain Williamson and Betül Hemikoglu-Balkan on the Shh locus in 
embryonic stem cells (ESC), neural progenitor cells (NPC) and limb cells revealed that Shh 
was a peculiar locus as even in non-expressing cells, the structure of the chromatin of this 
locus is very compact (Williamson et al., 2016). This resulted in having to deal with very 
small interprobe distances. Considering that the widefield microscope is limited by the 
diffraction of light and gives a resolution of 250nm in x-y and 600 nm in Z, I had to consider 
the right optical methods to image my FISH data. 
  





3.2 Imaging of the Shh locus by light 
Microscopy and by Super-resolution optical 
microscopy 
When imaged in 3D, a sub diffraction limited object – such as a FISH signal -produces a 
complex image that is dependent on the point spread function (PSF) of the microscope. The 
shape of the PSF is due to the diffraction in the microscope optical system and also depends 
on the fluorescent dye used for imaging, thus, it can be physically predicted and 
mathematically described. By setting a PSF for each dye and entering the microscope 
parameters into specific software, the image can be treated by deconvolution to improve the 
image sharpness (Figure Ch3-1A). 
Mouse embryonic stem cells (ESC) that do not express Shh were then differentiated for 
seven days into neural progenitor cells (NPC) where Shh is expressed. Here also, I used the 
Sox1-GFP cell line to work on a homogeneous neural lineage. I first optimized FISH for the 
Shh locus and its brain-enhancer in 46c ESCs and derived NPCs. I compared direct and 
indirect labelling of the fosmid probes, using either directly fluorescently labelled d-UTP or 
biotin/ digoxigenin labelled d-UTP with detection using fluorescently labelled streptavidin or 
anti-digoxygenin antibody. I also monitored the offset created by the size of the probe and 
the resolution of the microscope and the most precise way of imaging data on a widefield 
microscope followed by image deconvolution. 
By co-hybridising a Shh probe labelled separately with either FITC or Texas Red and 
labelled either directly or indirectly, I found that after deconvolution, direct probe labelling 
gave a more precise co-localisation of the two probes and less background than indirect 
labelling using Digoxigenin/Biotin-UTP (Figure Ch3-1A). I also established that the offset 
between the two Shh probe signals was smaller when z stacks are collected for one color – 
one channel – first and then switching to the other color rather than for each z stack (z step 
120 nm) sequentially imaging the colors (Figure Ch3-1B&C). This is probably due to the 
very good quality of the Piezo stage used, as it memorizes its position and is able to go back 





to precisely that same position with another imaging channel, whereas switching channels 
when at the same z plane might introduce small vibrations. 
  






Figure Ch3- 1 Optimizing FISH image acquiring for a better resolution. 
A) Raw and Deconvolved images after FISH with indirect (Digoxigenin-dUTP) and 
direct labelled probe (Fluorescein (5,6 Carboxyfluorescein)-dUTP). Scale bar = 5µm. 
B) Assessing the most accurate way of microscope acquisition by a superposition 
test. Imaging channel first through the depth or stopping at each z stack and 
switching channels of Shh labelled in two colours. Scale bar = 1µm. C) Table 
showing centroid distances between direct labelled Shh-red (Carboxy-X-Rhodamine 
(ROX)-dUTP) and Shh-green (Fluorescein (5,6 Carboxyfluorescein)-dUTP) 
measured from images acquired using channel first setting or Z stack first setting. 





After optimizing the FISH in ESC and NPC, using direct labelling probes and sequential 
single channel z stack collection, I first performed FISH on ESC and differentiated NPCs to 
study Shh and its various enhancers in the region. The fosmid probes used are shown in 
Figure Ch3-2A.  
These first results, aquired by widefield deconvolution microscopy, showed no significant 
changes in the distribution of inter-probe distances between Shh and control probes (Dpp6 
and Control) located on the other side of Shh from its regulatory region, or between Shh and 
the limb-enhancer ZRS during during the differentiation of ESCs to NPCs (upper row: 
Figure Ch3-2B & Table 3). Surprisingly inter-probe distances between Shh and the SBE6 
(SBE6 fosmid probe spans SBE6.1 and SBE6.2 enhancers) and SBE4 neural enhancer (but 
not SBE2/3), seem to increase in NPCs compared with ESCs (lower row: Figure Ch3-2B & 
Table 3). However, many of the interprobe distances imaged were below the diffraction limit 
of conventional widefield microscopy (usual resolution in xy ≈  250 nm). 






Figure Ch3- 2 3D-FISH of the Shh regulatory region by conventional wide-field 
microscopy. 
A) Schematic Shh regulatory region map. Genes are shown as black boxes and 
fosmid probes as grey boxes. B) Boxplots representing squared interprobe distance 
(d2,(µm)2) around the Shh locus for 50-100 pairs of probes between Shh and Dpp6, 
ZRS, CTRL, SBE6, SBE4 and SBE2/3 fosmids. Asterisks on FISH data represent 
Mann-Whitney U test significance between ESC and NPC day 7 populations, ** for 
p-values <0.01.  





ESC-NPC Day7 Shh-Dpp6 Shh-CTRL Shh-ZRS 
 
8.40E-02 6.80E-01 5.70E-02 
ESC-NPC Day7 Shh-SBE5 Shh-SBE4 Shh-SBE2/3 
 
1.32E-03 1.47E-02 1.17E-01 
  
1.81E-02 
 Table 3 P-values from ESC and NPC Mann-Whitney U tests on FISH distances 
distribution acquired on a widefield microscope  
Exact p-values of Mann-Whitney U tests significance between ESC and NPC day7 
FISH distances distribution revealing the number of replicates. 
  





I therefore concluded that, in order to use FISH to examine the chromosome conformation 
around Shh in relation to the newly described enhancer SBE6  (Chapter 2) and especially to 
ZRS or SBE2/3 that display prominent small distances, it was necessary to image the nuclei 
at a higher resolution than can be achieved by conventional light microscopy.  
Recently, new super-resolution microscopy techniques have opened new possibilities to 
study nuclear ultra-structure using light down to the 100 nm resolution for xy.  
Functional super resolution techniques use experimental tricks to reconstruct an image from 
locating precisely a signal at the time. Photo-activated localization microscopy (PALM) and 
stochastic optical reconstruction  (STORM) use an on-off signal – a blinking due to 
instability in the fluorophore - to precisely locate point by point the signal and reconstruct 
and image. SIM is part of the “true” resolution techniques, where the physical environment 
is used to compute direct information from the data. By illuminating the sample with 
patterned light and modulating the illumination, the patterns interacts with the fluorescent 
probes and generate Moire fringes. From those interference patterns, extra information can 
be deduced and the image is computationally restored (Gustafsson, 2000). Moreover SIM 
has been proven to be fully compatible with FISH (Markaki et al., 2012).  
Therefore with the use of 3D-SIM followed by automated image analysis software, I 
visualized and analysed the chromatin reorganisation upon enhancer-driven Shh activation 
using FISH 
  





3.3 Chromatin reorganisation upon brain 
enhancer-driven Shh activation 
Imaging nuclei from ESCs and differentiated neural precursor stem cells (NPC) where Shh is 
expressed by 3D-Structured Illumination Microscopy (3D-SIM) using the same set of 
fosmids as for the widefield imaging (Figure Ch3-3A) revealed an increased nuclear distance 
between Shh and the SBE6 (Figure Ch3-3B) and between and SBE4 upon Shh activation – 
confirming the results from wide-field deconvolution (Figure Ch3-3C & Table 4). As for 
conventional microscopy, nuclear distances between Shh-SBE2/3, Shh-ZRS and Shh-CTRL 
remain the same upon differentiation (Figure Ch3-3C & Table 4).  This result is highly 
surprising, as distal enhancers have been extensively described as forming a loop upon 
activation of their cognate genes, which should be seen as decreasing interprobe distances.  
My data, showing that the whole region between Shh and up to SBE4 undergoes a large-
scale decompaction upon activation, is a new, and surprising result as it is not compatible 
with the looping model for enhancer-promoter communication.  






Figure Ch3- 3 3D-FISH of the Shh regulatory region using 3D-SIM.  
A) Similar fosmid map as in Figure Ch3-2A. B) 3D-SIM image illustrating Shh-SBE6 
distance increase in NPC after seven days of differentiation. Scales bars are 5µm 
top image and 1µm bottom image. C) Boxplots representing squared interprobe 
distances between Shh and CTRL, SBE6, SBE4, SBE2/3 and ZRS fosmids. 
Asterisks on FISH data represent Mann-Whitney U test significance between ESC 
and NPC day 7 populations, ** for p-values <0.01.  
  







Shh-CTRL Shh-SBE2/3 Shh-ZRS Shh-SBE6 Shh-SBE4 
 4.32E-01 6.44E-01 5.94E-01 3.78E-12 3.68E-05 
  5.29E-02 3.88E-01 8.21E-05 3.61E-04 
  4.93E-01 6.56E-01 2.01E-02  
  9.46E-01  2.48E-03  
    8.16E-04  
    1.39E-04  
    3.78E-12  
    2.75E-03  
    1.39E-04  
    2.58E-09  
    3.33E-02  
Table 4 P-values from ESC and NPC Mann-Whitney U tests on FISH distances 
distribution acquired on a 3D-SIM 
Exact p-values of Mann-Whitney U tests significance between ESC and NPC day7 
FISH distances distribution revealing the number of replicates. 
  





3.4 Time course of neural differentiation  
It may be possible that 7 days of differentiation is too late to observe enhancer-Shh promoter 
looping – it may have occurred earlier in the differentiation programme. I therefore 
performed a differentiation time course from ESC to NPCs (day 3 to day 7). qRT-PCR 
shows that Shh mRNA levels are already increased at day 3 of differentiation and continue to 
increase from day 4 to 7 (Figure Ch3-4A). FISH over this same time-course showed that the 
Shh-SBE6 inter-probe distances increase consistently from day 4 onwards with two of three 
NPC day 3 replicates showing significant distance increases between (Figure Ch3-4B & 
Table 5).  
Therefore the distance increase – chromatin unfolding - between Shh and the SBE6 enhancer 
seem to appear progressively in the population from day 4 of differentiation, but this may not 
be necessary for the initial stages of Shh expression as in day 3 cells where Shh is expressed 
at low levels, there is not always a measureable chromatin unfolding as assayed by FISH. 






Figure Ch3- 4 Neural Differentiation characterisation.  
A) qRT-PCR showing means (± s.e.m) log2 mRNA levels of Shh, Oct4 and Nestin 
relative Gapdh and normalized to ESCs in one biological replicate. B) Left, Boxplots 
showing Shh-SBE6 squared interprobe distances in populations corresponding to 
the expression data. Right, Boxplots showing Shh-SBE6 squared interprobe 
distances for two other NPC day 3 biological replicates. Asterisks on FISH data 
represent Mann-Whitney U test significance between NPC and ESC populations, * 
for p-values <0.05 and ** for p-values <0.01.  
 
 












NPC Day4 1.07E-02 
NPC Day5 2.40E-05 
NPC Day6 6.68E-04 
 
Table 5 P-values from ESC and NPC Mann-Whitney U tests on Shh-SBE6 FISH 
distances distribution at various stages of neural differentiation 
Exact p-values of Mann-Whitney U tests significance between ESC and NPC day 3, 
day 4, day 5 or day 6 Shh-SBE6 FISH distances distribution revealing the number of 
replicates. 
  





However, even if the Shh-SBE6 distance increase is progressive during the differentiation 
time course, it might not be homogenous. Indeed, a small sub-group of cells in the 
population might even be looping with the promoter and trigger gene activation, when the 
other group is in a relaxed conformation after maybe having looped. Moreover, Shh 
expression may also not be uniform in the cell population. To test the relationship between 
chromatin conformation and Shh expression I could, in theory, perform RNA-DNA FISH 
where one could directly observe simultaneous transcription and correlate it or not with a 
Shh-SBE6 distance increase. Unfortunately Shh is a very small gene (≈ 8 kb) with only two 
introns and so detecting its nascent transcript by RNA FISH would be difficult. Indeed, a 
previous postdoc in the lab was unable to detect Shh mRNA by RNA FISH. Therefore I used 
another method, qRT-PCR to monitor Shh expression at the single cell level to assess if the 
Sox1+ve NPC population is homogenous regarding Shh expression or not. 
  





3.5 Understanding Shh expression and 
chromatin compaction at single cell level 
SHH has been shown to promote the survival of Sox1+ve mouse ESC derived NPCs and also 
to influence the determination of human ESCs toward neural lineages (Cai et al., 2008; Wu 
et al., 2010). Therefore I would expect that in my Sox1+ve NPC population, Shh would be 
expressed quite homogeneously. 
In order to confirm that, I performed single cell qRT-PCR on Sox1+ve sorted NPCs and I 
could observe that the population of cells expressing Shh – albeit at low levels - is quite 
homogenous at NPCs day 3 and day 4 of differentiation with a general shift toward higher 
and more variable levels of mRNA production by day 7 (Figure Ch3-5A). Analysing the 
distribution of Shh-SBE6 FISH distances amongst the population from the Figure Ch3-4B 
(left) revealed that the Shh-SBE6 distance increase concerns the cell population in general 
with a broad shift towards higher distances with no evidence of a sub-group of cells with 
shorter (<200nm) distances that would be indicative of an enhancer-promoter loop. (Figure 
Ch3-5B). Also, without being statistically significant, at the population level in the day 3 
replicate, the distribution of inter-probe distances is already slightly shifted to larger 
distances and becomes significant at day 4, and keeps on increasing, with in parallel 
decreasing p-values relative to ESCs. 
  






Figure Ch3- 5 NPC are a homogenous population. 
A) Upper pane, Kernel density plots showing Shh mRNA expression of single NPC 
(96 cells) relative to Gapdh and normalised to expression in ESCs at day 3, day 4 
and day 7 of differentiation. Lower panel, Kernel density plots for biological replicate 
showing Shh mRNA expression of single NPC relative to Gapdh and normalised to 
expression in ESCs at day 3 and day 7 of differentiation. B) Kernel density plots 
displaying Shh-SBE6 FISH distance distribution in µm in undifferentiated ESCs and 
at day 3, day4 and day 7 of NPC differentiation for FISH displayed in Figure Ch3-4B 
(left). Asterisks on FISH data represent Mann-Whitney U test significance between 
NPC and ESC populations, ** for p-values <0.01. Kernel density is arbitrary 
measured by the R software based on the size of the population and the values in 
order to select the appropriate binning for frequency, it is thus comparable with an 
arbitrary frequency unit.  





Therefore the distance increase between Shh and its brain-enhancer seems to appear 
continuously and homogeneously in the differentiating NPC population from day 4 of 
differentiation. This result argues against the concept of long-range enhancer-promoter 
looping. 
  





3.6 Enhancer driven chromatin unfolding 
SBE6.1 -/- (SBE6-/-) derived NPCs failed to efficiently activate Shh expression (Figure Ch2-
9). To test if the SBE6 enhancer is also required for the chromatin unfolding between Shh 
and SBE6 seen upon the neural differentiation of wild-type ESCs, I performed FISH on day 
7 of Sox1+ve NPC differentiated from SBE6.1 -/- and SBE6.2  -/- cell lines described in 
Chapter 2 section 2.5.  SBE6.1 -/- derived NPCs failed in contrast to recapitulate the Shh-
SBE6 nuclear distance increases (Figure Ch3-6A & Table 6), correlating with the loss of 
their Shh enhancer activity described in Chapter 2. Whereas SBE6.2 -/- NPCs, which still 
activate Shh (Figure Ch3-6), do recapitulate the Shh-SBE6 distance increase seen in wild-
type NPCs (Figure Ch3-6B & Table 6), meaning that the loss of chromatin unfolding is not 
due to a deletion of any genomic region. 
Taken together these results suggest that the chromatin unfolding between Shh and SBE6 
observed by FISH is linked with Shh-Brain-Enhancer SBE6.1 activity. As also highlighted 
by the qRT-PCR and FISH data, Shh seems to be expressed at basal levels in day 3 NPC and 
in NPC lacking SBE6.1, and chromatin unfolding of this locus seems to be linked not with 
this basal level of Shh expression, but with the enhanced expression of Shh mRNA. 
 






Figure Ch3- 6 Enhancer driven chromatin unfolding. 
A) Boxplots representing Shh-SBE6 distances FISH data on NPC derived from three 
independently generated SBE6.1-/- cells (SBE6-/-) and one second biological 
replicate for SBE6.1-/-  Line 1. B) Boxplots representing Shh-SBE6 distances FISH 
data on NPC derived from three independently generated SBE6.2-/- cells. Asterisks 
on FISH data represent Mann-Whitney U test significance between NPC and ESC 
populations, * for p-values <0.05 and ** for p-values <0.01.  
 





















   
Table 6 P-values from ESC and SBE6 KO NPC Mann-Whitney U tests on Shh-
SBE6 FISH distances distribution 
Exact p-values of Mann-Whitney U tests significance between ESC and SBE6.1-/- 
or SBE6.2-/- NPCs Shh-SBE6 FISH distances distribution revealing the number of 
replicates.  





3.7 Chromatin conformation capture carbon-
copy (5C) 
As a complement to FISH, chromatin organization studies have recently been undertaken 
using the Chromosome Conformation Capture (3C) techniques and its derivatives (4C, 5C, 
3C-Seq, capture-C, HiC) (Dekker et al., 2002; Dostie et al., 2006; Hughes et al., 2014; 
Lieberman-Aiden et al., 2009; Simonis et al., 2006; de Wit and de Laat, 2012). Ligation 
frequencies are measured between two distal sequences that have been captured together in 
the same formaldehyde cross-linked complex, and are used to infer the spatial proximity of 
the two sequences in the fixed nuclei. These methods have been used to identify 
topologically associated domains (TADs) that are separated by boundaries often enriched for 
CTCF, cohesin and other architectural proteins (Dixon et al., 2012; Jin et al., 2013; Nora et 
al., 2012; Rao et al., 2014; Seitan et al., 2013; Sofueva et al., 2013; Zuin et al., 2014). 
However, FISH and 3C methods do not always produce concordant results and so both 
methods should be validated against each other in order to draw firm conclusions 
(Williamson et al., 2014, 2016). 
I therefore performed Chromatin Conformation Capture Carbon Copy (5C) in ESC and NPC 
on the Shh region to see if imaging data could be transposed in terms of the interaction 
frequencies of the chromatin and also if Shh is strongly interacting i.e. looping, with an 
element that I have not considered in my imaging studies as Chapter 2 revealed many more 
putative Shh-brain-enhancer not yet annotated.  
The appearance of a TAD boundary that starts before Shh and ends before Nom1 seems to be 
consistent between ESC and NPC, and consistent with previously published HiC data from 
mouse ESC (Dixon et al., 2012; Williamson et al., 2016) (Figure Ch3-7A).  Moreover FISH 
and 5C observation indicate that Shh TAD seems to be consistently closed by a “loop” 
formed with sequence spanning the ZRS and Shh both in cells expressing and non-
expressing Shh (Shh and ZRS are in a constrained nuclear space with 3D distances much 
smaller than what is expected from their genomic position, however specific co-localisation 
occur only in expressing cells) (Williamson et al., 2016) (Figure Ch3-2B, Ch3-3C, Ch3-7A 
& Ch3-8A). 





Analysing the 5C heatmaps with a first degree of zooming in the Shh regulatory region 
revealed that the sequence spanning Shh seems indeed to interact with ZRS but do not seem 
to strongly interact more with SBE5 or ZRS in NPC, which is more precisely seen by FISH 
(Figure Ch3-7B & Ch3-8B, Ch3-3C). 
Zooming in and comparison between ESC and NPC heatmaps also reveal the loss of a strong 
interaction between a region upstream Shh and another sequence near Rnf32 on the far right 
(Figure Ch3-7C). This strong interaction corresponds to two CTCF sites that are interacting 
in ESC. By CTCF Chip performed by Betül Hemikoglu-Balkan, we could see that the CTCF 
peak upstream Shh, indeed disappeared upon differentiation into NPC (Figure Ch3-9) 
therefore explaining the loss of interaction between this sequence and the other CTCF peak 
on the far right. 
This loss of CTCF interaction could be linked to the chromatin opening up upon NPC 
differentiation that I have seen by FISH. Further comparison of the profiles could highlight 
also a possible broad decompaction surrounding SBE6 and SBE4 sequences pointed by 
arrows and arrowhead (Figure Ch3-7C & Ch3-8C). Most importantly, this first set of 5C data 
shows that Shh is not interacting with a missed enhancer or any other sequence upon 
activation in NPC (Figure Ch3-7 & Ch3-8).  
  






Figure Ch3- 7 Chromatin conformation capture carbon-copy (5C) heat-maps of 
the Shh regulatory region in ESC and NPC. 
A) 5C heatmaps of ESC and two biological replicate of NPCs beyond Shh regulatory 
region with 5kb binning and smoothing with the median of 7 surrounding interactions 
frequencies revealing a TAD of the Shh regulatory region. 5C heatmap of each 
biological replicates has been created from the average reads from sequencing 
technical replicates. B) 5C heatmaps of the Shh regulatory region (chr5:28750000-
29750000) with 5kb binning and smoothing with the median of 5 surrounding 
interactions frequencies. C) Zoomed 5C heatmaps on the Shh regulatory region 
(chr5:28750000-29450000 in ucsc mm9) with 5kb binning and smoothing with the 
median of 3 surrounding interactions frequencies. Black arrows highlights the 
differences with ESCs and grey arrowhead show CTCF sites.  






Figure Ch3- 8 Chromatin conformation capture carbon-copy (5C) heatmaps of 
the Shh regulatory region in ESC and NPC for biological replicates. 
A) 5C heatmaps of ESC and NPC biological replicates beyond Shh regulatory 
region with 5kb binning and smoothing with the median of 7 surrounding interactions 
frequencies revealing a TAD of the Shh regulatory region. 5C heatmap of each 
biological replicates has been created from the average reads from sequencing 
technical replicates. B) 5C heatmaps of the Shh regulatory region (chr5:28750000-
29750000) with 5kb binning and smoothing with the median of 5 surrounding 
interactions frequencies. C) Zoomed 5C heatmaps on the Shh regulatory region 
(chr5:28750000-29450000 in ucsc mm9) with 5kb binning and smoothing with the 
median of 3 surrounding interactions frequencies. Black arrows highlights consistent 
differences and grey arrowheads points at CTCF sites. 
  






Figure Ch3- 9 CTCF and Rad21 ChIP-chip. 
UCSC Genome browser view of chr5:28,750,000-29,400,000 mm9 displaying log2 
CTCF and Rad21 ChIP relative to input on Shh regulatory region on ESCs and 
NPCs and after Tales-Vp64 transfection in ESC, three biological replicates 
combined. Arrowheads represent enhancer location SBE6, SBE2. 
  





Appearance or disappearance of strong direct enhancer-promoter interaction can usually be 
detected by comparing enhancer-promoter ligation products in different conditions using the 
Chromosome Conformation Capture (3C) technique and its derivatives (4C, 5C, Hi-C etc.) 
(Jin et al., 2013; Montavon et al., 2011; Palstra et al., 2003; Tolhuis et al., 2002). However 
establishing any other type of further analysis such as general chromatin conformation 
changes are much harder to base on these assays. First, as these assays only give an average 
interaction frequency in the population, if the interaction is not constrained (precise 
interaction between sequences versus a broad sequence with a broad sequence), such as the 
distance increase observed, the distances are distributed in a wide range of possibilities 
which will not be represented by chromosome conformation capture techniques. Overall it 
appears that “C” techniques are best able to detect strong and stable interactions that will not 
be diluted amongst the population. As the Shh-SBE6 distances distribution spans a wide 
range of states (Figure Ch3-5B), we could presume that the interaction between Shh and its 
brain-enhancer upon activation will hardly been seen on 5C heat-maps as the distance is not 
stable enough to lead to a consistent ligation product. 
  






This Chapter showed that using FISH and super-resolution microscopy, upon neural 
activation, Shh and its brain-enhancer seem not to follow the popular enhancer-promoter 
looping model. On the contrary, the locus shows a large enhancer-dependent chromatin 
unfolding that is continuous and homogenous amongst the population in differentiating 
NPCs. 
It remains possible that I do not observe a loop due to limitations in the 3D SIM technique at 
this highly compact locus.  In the following chapter I go on to explore this possibility to 
confirm the unexpected observation of enhancer mediated chromatin unfolding. 
  





Chapter 4: Using a synthetic 
biology approach to study 
enhancer-promoter interaction 
  





4.1 How to measure a chromatin loop? 
As described in the previous chapters, direct enhancer-promoter interaction has been 
traditionally established by imaging (Amano et al., 2009; Ronshaugen and Levine, 2004; 
Schoenfelder et al.) or “C” techniques (Deng et al., 2012; Ghavi-Helm et al., 2014; 
Vernimmen et al., 2007). However, in our highly compact locus, both techniques did not 
reveal a looping of the chromatin that would indicate a direct interaction between Shh and a 
brain-enhancer.  
In order to confidently refute the looping model for this locus in the neural context, I would 
need to be able to visualise a chromatin-looping event as a positive control. 
Using a synthetic biology approach, recent chromosome engineering experiments at the β-
globin locus have established that imposing a direct interaction between an enhancer and its 
cognate promoter by chromatin looping is sufficient to promote gene expression in erythroid 
cells provided that the correct transcription factors are available (Deng et al., 2012, 2014).  
By forcing the targeting of the self-association domain (SA) of LIM domain-binding protein 
1 (LDB1) – a key transcription factor- via an engineered zinc finger protein to the LCR, β-
globin expression was upregulated and a chromatin loop viewable by 3C (Figure Ch4-1). 
Recent follow-up experiment suggests that the enhanced globin expression is due to an 
increased frequency of transcriptional bursts and not to an increase in burst size, revealing a 
highly dynamic interaction (Bartman et al., 2016). 
  






Figure Ch4- 1 Schematic representation of the LDB1 dimerization. 
LDB1 dimerization induces a loop via a direct interaction of the LCR and the β-
globin promoter and that is enough to induce gene activation (Deng et al., 2012, 
2014). 
  





4.2 Using a synthetic approach based on TAL 
effectors 
Transcription activator-like effector (TALE) proteins are DNA-binding proteins (from a 
plant pathogen) that contain a tandem repeat sequences called repeat-variable di-residues 
(RVDs) where a simple cipher governs DNA binding of the repeat residues (Moscou and 
Bogdanove, 2009).  
Thus TALEs can be engineered to bind any DNA sequence required with high levels of 
specificity. These DNA-binding proteins can then be fused to any factor to force its 
recruitment to a sequence of interest. This approach has been used to activate transcription or 
to unfold chromatin structure at specific gene promoters in mouse ES cells (Therizols et al., 
2014) 
I designed a TALE to bind the Shh promoter (tShh) and two of the Shh-Brain-Enhancer 
(tSBE6 for SBE6.1 and tSBE2). These were then fused to the self-association domain (SA) 
of LIM domain-binding protein 1 (LDB1) (Figure Ch4-2A).  
By introducing two TALEs-LDB1 into ESCs, Shh and the SBE6/SBE2 enhancer could 
interact directly via dimerization of the LDB domain. FISH observation showed that the 
looping did indeed occur upon tShh-LDB1 and either tSBE6-LDB1 or tSBE2-LDB1 co-
transfection since the inter-probe distance decreased significantly compared to the eGFP 
transfection controls (Figure Ch4-2B & Table 7).  
However, simply inducing looping did not lead to Shh expression compared to the negative 
control, eGFP transfected cells (Figure Ch4-2C). This is not surprising since the action of 
LDB1 in activating β-globin still requires the presence of other erythroid transcription 
factors – i.e. GATA1.  
Proceeding to a four-color 3D-FISH, to probe the sequence in between the direct-interaction, 
I could confirm TALE-LDB1 co-transfection do not trigger a general aggregate of the 
chromatin (Figure Ch4-3A, B & Table 7).   
  






Figure Ch4- 2 Tale-LDB1 induces direct interaction between Shh and its Brain-
enhancers. 
A) Schema representing Tale-LDB1 targeting sequence and constructs with map of 
targeting sites. Self-cleaving (2A) peptide allows parallel expression of eGFP and 
isolation of TAL-expressing cells by fluorescence-activated cell sorting (FACS). 
RVD, repeat variable diresidue is displayed with one-letter abbreviations for amino 
acids. B) Tale-LDB1 forcing the looping between Shh and SBE6 or SBE2. Boxplots 
representing Shh-SBE2/3 FISH squared interprobe distances after tShh+tSBE2-
LDB1 transfection. Right, Boxplots representing squared interprobe distances for 
Shh-SBE6 or SBE6-SBE2/3 after tShh+tSBE6-LDB1 or tSBE6+tSBE2-LDB1. C) 
qRT-PCR displaying means (± s.e.m) log2 mRNA levels of Shh relative to Gapdh 
after direct interaction in ESC between Shh and its Brain-enhancer SBE6 or SBE2 
for three biological replicates normalized to eGFP plasmid transfection in ESCs as 
negative control.  






Figure Ch4- 3 Tale-LDB1 triggers a direct interaction between Shh and SBE2 
and a looping out of the intervening chromatin. 
A) Boxplots representing squared interprobe distances of 4 colour FISH for Shh-
SBE2/3, Shh-SBE6, SBE6-SBE2/3 after tShh+tSBE2-LDB1. Asterisks on FISH data 
represent Mann-Whitney U test significance between Tale-LDB1 and eGFP 
transfected populations, ** for p-values <0.01. B) 4-Color FISH representing that 
Tale-LDB1 co-transfection leads to a precise dimerization and Illustration of loop 
formation with Tale-LDB1.  
  






Shh-SBE6 Shh-SBE2/3 SBE6-SBE2/3 
tShh+tSBE2- LDB1 0.1666 4.3E-06 0.8953 
 
0.4571 0.01661 0.1976 
  
0.0003 
 tShh+tSBE6- LDB1 0.0217 




Table 7 P-values from eGFP and Tale-LDB1 transfected ESC Mann-Whitney U 
tests on FISH distances distribution 
Exact p-values of Mann-Whitney U tests significance between eGFP and Tale-LDB1 
transfected cells revealing the number of replicates.  





Therefore FISH is able to detect chromatin loops if they are deliberately generated.  This 
supports my conclusion that during normal Shh activation in neural differentiation the simple 
enhancer-promoter looping model does not apply.  
These data highlight that in order to understand enhancer-promoter interactions individual 
loci need to be specifically investigated, and that there is no universal mechanism of 
enhancer action at a distance. 
  





4.3 Creating an enhancer bypass in ESC 
TALE fused to transcription factors or repressors have been extensively used in recent years 
to modulate artificially gene expression. TALE-activators and TALE-repressors have been 
successfully used to activate or repress gene expression when targeted to their respective 
enhancer elements by recruiting Vp64 – Four repeats of the small viral acidic protein Vp16 
that can strongly activate genes when bound to them (Therizols et al., 2014; Zhang et al., 
2011) - or recruiting KRAB protein to a specific promoter, the targeted gene could be 
artificially repressed (Cong et al., 2012).  
As transcription and the associated supercoiling is known to remodel large chromatin 
domains and to change chromatin compaction (Matsumoto and Hirose, 2004; Naughton et 
al., 2013), it is possible that the chromatin reorganisation I had seen using FISH during NPC 
differentiation just occurs passively as the consequence of Shh activation. Targeting Vp64 
directly to the Shh promoter, I should be able to activate Shh expression without the 
involvement of any Shh enhancers. By fusing tShh to Vp64 (tShh-Vp64) (Figure Ch4-4A) it 
is possible to artificially activate Shh in ESC at similar levels as found in NPC day seven 
without triggering differentiation (Figure Ch4-4B&C). However, expression of tShh-Vp64 
did not lead to the same nuclear distance increases as observed in NPC during endogenous 
Shh activation (Figure Ch4-5A Left & Table 8).  
I then activated the Shh-brain-enhancer SBE6 and SBE2 using tSBE6-Vp64 and tSBE2-
Vp64 alongside a co-transfection of both tSBE6-Vp64+tSBE2-Vp64. All succeeded to 
activate Shh in ESC, though not to the same extent as with tShh-Vp64 (Figure Ch4-4B).  
Shh expression levels show that combinations of Tale-Vp64 targeted to Shh regulatory 
region can activate Shh without inducing neural differentiation as Oct4 and Nestin remains at 
similar levels as in ESC (Figure Ch4-4C). 
However, none of the single Tale-transfections led to the same nuclear distance increase as 
seen during the endogenous activation of Shh during differentiation.  





Surprisingly, only the co-activation of SBE6 and SBE2 via the co-transfection of tSBE6-
Vp64+tSBE2-Vp64 led to a significant distance increases between Shh and SBE6 (Figure 
Ch4-5A & Table 8).  
The FISH interprobe distance between Shh and SBE2/3 after Tale-Vp64 transfections did 
not show any nuclear distance change which shows that this chromatin unfolding is similar 
to that observed during endogenous neural differentiation (Figure Ch4-5B). I could also 
control that this effect is specific to Vp64 recruitment and not just due to Tale protein 
targeting. Recruiting two Tales-Deltas, i.e. Tales without any fusion domain, does not 
recapitulate the distance increase (Figure Ch4-5C). 
  






Figure Ch4- 4 Shh Enhancer Bypass in ESC using Tale-Vp64 1. 
A) Schema representing Tale-Vp64 targeting sequence and constructs with map of 
targeting sites. B) qRT-PCR displaying means (± s.e.m) log2 mRNA levels of Shh 
relative to Gapdh after activation in ESC with Tale-Vp64 for three biological 
replicates normalized to eGFP transfection. C) qRT-PCR displaying means (± s.e.m) 
log2 mRNA levels of Shh, Oct4 and Nestin relative Gapdh and normalized to ESCs 
in one biological replicate.  
  






Figure Ch4- 5 Shh Enhancer Bypass in ESC using Tale-Vp64 2. 
A) Boxplots representing Shh-SBE6 squared interprobe distances after Tale-Vp64 
transfections. B) Boxplots representing Shh-SBE2/3 squared interprobe distances 
after Tale-Vp64 transfections. C) Boxplots representing Shh-SBE6 squared 
interprobe distances after Tale-Vp64 and Tale-Delta (no protein fused) transfections. 
  







tShh-Vp64 5.10E-02 3.11E-01 
 
3.27E-01 4.25E-01 
tSBE6-Vp64 3.64E-01 9.75E-01 
 
2.91E-01  
tSBE2-Vp64 4.47E-01 7.68E-01 















tSBE6+tSBE2-Δ 2.28E-01  
 
Table 8 P-values from eGFP and Tale-Vp64 transfected ESC Mann-Whitney U 
tests on FISH distances distribution 
Exact p-values of Mann-Whitney U tests significance between ESC and Tale-Vp64 
transfected ESCs revealing the number of replicates. 
  





To determine whether the activators position matters, that is to say if only activating a 
known enhancer element was required, I also designed a new Tale for a site located between 
Shh and SBE6 (50kb from Shh) that does show any evidence of enhancer function 
(H3K4me1/H3K27ac) during ES-NPC differentiation (Figure Ch4-6A). This Tale-Vp64 
(called NE – for Non-Enhancer) was able to activate Shh expression alone or together with 
tSBE6-Vp64 or tSBE2-Vp64 (Figure Ch4-6B). However, once again none of the single Tale-
transfections led to the same nuclear distance increase as seen during the endogenous 
activation of Shh. Only the co-targeting of multiple Tale-Vp64s to the Shh regulatory region 
(tNE-Vp64+tSBE6-Vp64, tNE-Vp64+tSBE2-Vp64 and tSBE6-Vp64+tSBE2-Vp64) led to a 
significant distance increases between Shh and SBE6 (Figure Ch4-6C & Table 9). 
Therefore the nuclear distance increase between Shh and SBE6 is a direct effect of Shh 
activation mediated by activators positioned in its regulatory region. 
  






Figure Ch4- 6 Shh Enhancer Bypass in ESC using tNE-Vp64. 
A) Schema representing Tale-Vp64 targeting sequence and constructs with map of 
targeting sites. B) qRT-PCR displaying means (± s.e.m) log2 mRNA levels of Shh 
relative to Gapdh after activation in ESC with Tale-Vp64 for three biological 
replicates normalized to eGFP transfection. C) Boxplots representing Shh-SBE6 
squared interprobe distances after Tale-Vp64 transfections.  
  













Table 9 P-values from eGFP and Tale-Vp64 transfected ESC Mann-Whitney U 
tests on FISH distances distribution 
Exact p-values of Mann-Whitney U tests significance between ESC and Tale-Vp64 
transfected cells revealing the number of replicates. 
  





Linking recruitment of Vp64 and chromatin unfolding, my data led me to think that 
transcription activator concentration may be important for chromatin unfolding, as it requires 
VP64 at both SBE6 and SBE2. To test this I recruited Vp128 (twice the amount of Vp64) 
and could demonstrate that one Vp128 targeted to SBE6 or SBE2 is sufficient to enhance 
Shh activation and to lead to the nuclear distance increase (Figure Ch4-7 & Table 10). 
These results indicate that the amount of activator protein matters for the chromatin 
unfolding to occur, which could happen endogenously by multiple enhancers recruiting more 
than one activator. 
  






Figure Ch4- 7 Tale-Vp128 is enough and sufficient to activate and unfold the 
chromatin. 
A) Top, Tale-Vp128 constructs targeting the Shh promoter and the SBE6 and SBE2 
enhancers. Bottom, qRT-PCR showing mean (± s.e.m) log2 mRNA levels of Shh 
relative to Gapdh and normalized to eGFP-transfected cells for Tales-Vp128 and 
Vp64 for three (Tales-Vp128) and two (Tales-Vp64) biological replicates. B) 
Boxplots representing Shh-SBE6 squared interprobe distances after FISH on Tale-
Vp128 transfected ESC. Asterisks on FISH data represent Mann-Whitney U test 
significance between Tale-Vp128 and eGFP transfected populations, ** for p-values 
<0.01.  
  















Table 10 P-values from eGFP and Tale-Vp128 transfected ESC Mann-Whitney 
U tests on FISH distances distribution 
Exact p-values of Mann-Whitney U tests significance between ESC and Tale-Vp128 
transfected cells revealing the number of replicates. 
  





4.5 Artificially blocking the chromatin unfolding 
In order to have a first idea of the nature of the chromatin unfolding induced by Shh 
enhancer activation, I next used the binding of CTCF on NE (tNE-CTCF)- a known enhancer 
insulator (Bell et al., 1999) to see if it could prevent the Shh-SBE6 distance increase and, if 
so, if that affected Shh activation. A ChIP for CTCF confirmed the protein recruitment on 
NE sequence (Ch4-9A). Interestingly, after a co-transfection of tNE-CTCF together with the 
Enhancer-Tale-Vp64, Shh-SBE6 squared interprobe distance remained unchanged compared 
to eGFP transfected ESCs; suggesting that the binding of a Tale-CTCF between Shh and 
SBE6 could block chromatin unfolding (Figure Ch4-8B & Table 11). This would be 
consistent with a tracking model in which a change in chromatin is propagated between 
enhancer and promoter along the length of the chromatin fibre. I was able to reproduce the 
same effect as observed with tNE-CTCF, using tNE without any fusion (tNE-Delta, Tale 
without any protein fused) (Figure Ch4-8B & Table 11). However the introduction of tNE-
Vp64 alongside tSBE6+tSBE2-Vp64 does not block the chromatin unfolding, indicating a 
specific action of blocking agent from tNE-CTCF or tNE-Delta (Figure Ch4-9B). These 
results indicate that the chromatin unfolding can be blocked if a protein bound in between is 
not an activator as tNE-Vp64 did not disturbed the chromatin unfolding.  
Interestingly the binding of tNE-CTCF or tNE-Delta between SBE6 and Shh significantly 
decreased Shh activation but did not abolish it (Figure Ch4-8C). Single cell qRT-PCR 
showed that some cells still expressed Shh. Analysis of the population distribution on Shh 
mRNA levels revealed that this is due to a heterogeneous distribution of the population 
(Figure Ch4-8D). This indicates that Shh expression levels may be dependent on the number 
of plasmid each cells received, even if the majority will still have the three plasmids and 
neither show a distance increase nor Shh mRNA production. 
Together these results show that interfering with the chromatin unfolding upon co-activation 
of SBE6.1 and SBE2 via adding a protein complex such as Tale-Delta or Tale-CTCF in 
between, does not lead to a proper Shh activation. Indicating perhaps that the brain-enhancer 
communication model might follow a tracking-like mechanism.  
  






Figure Ch4- 8 Artificially blocking the chromatin unfolding. 
A) tNE-CTCF and tNE-Delta (Δ) constructs with map of the Tales targeting. B) 
Boxplots representing Shh-SBE6 squared interprobe distances upon co-transfection 
with activators and blocker. C) qRT-PCR displaying means (± s.e.m) log2 mRNA 
levels of Shh relative to Gapdh after co-transfection with activators and blocker 
normalized to eGFP transfection for four (tNe-CTCF) and three (tNE-Δ)  biological 
replicates.  Asterisks represent p-values for one-tailed Student t-test between 
conditions. ** for p-values <0.01 and * for p-values <0.05. D) Kernel density plots 
showing Shh mRNA expression of single tSBE6+tSBE2-Vp64 cells with and without 
tNE-CTCF relative to Gapdh and normalised to expression in eGFP transfected 
ESC.   






Figure Ch4- 9 Vp64 in between Shh and Shh-Brain-Enhancer does not perturb 
the unfolding. 
A) CTCF ChIP qPCR on NE sequence after tNE-CTCF transfection. qPCR has been 
normalised to input and Actin sequence for one biological replicate. B) Left panel 
shows boxplots representing Shh-SBE6 squared interprobe distances after FISH on 
Tale-Vp64 transfected ESC with and without tNE-Vp64. Asterisks on FISH data 
represent Mann-Whitney U test significance between Tale-Vp64 and eGFP 
populations, ** for p-values <0.01. Right, qRT-PCR showing means (± s.e.m) log2 
mRNA levels of Shh relative to Gapdh and normalized to eGFP transfected cells for 
Tales-Vp64 for two biological replicates.   
















Table 11 P-values from eGFP and Tale-Vp64/Tale-Δ/Tale-CTCF transfected ESC 
Mann-Whitney U tests on FISH distances distribution  
Exact p-values of Mann-Whitney U tests significance between ESC and Tale 
transfected ESCs revealing the number of replicates. 
  





4.6 5C Chromatin conformation capture 
carbon-copy (5C) on ESC with Tale-Vp64 
As in the previous chapter (Chapter 3, Section 3.7), I wanted to see if 5C could reveal, and 
perhaps confirm, the chromatin unfolding induced at the Shh regulatory domain by Vp64s 
recruitment. 
5C heat-maps of Tale-Vp64 transfected ESC confirmed the observation of a Shh TAD closed 
by a loop formed with sequence spanning the ZRS and Shh both in cells expressing and non-
expressing Shh (Williamson et al., 2016) (Figure Ch3-7A, Ch3-8A, Ch4-10A and Ch4-11A). 
With the first degree of zooming in the Shh regulatory region, the 5C heat-maps also confirm 
that the sequence spanning Shh interacts with the ZRS independently of the expressing state 
of Shh and the chromatin unfolding (the Shh-SBE6 distance observed by FISH) (Figure Ch4-
10B and Ch4-11B). 
Deeper zoom and comparison between ESC and NPC heat-maps (Figure Ch4-10C) and 
various Tale-Vp64 transfected ESC 5C heat-maps did not reveal the loss of at the CTCF 
interaction as shown in NPC (Figure Ch3-7C, Ch3-8C, Ch4-10C and Ch4-11C). Therefore 
the CTCF loss of interaction is not the principal component of the chromatin unfolding as 
this interaction remains in tSBE6-Vp64+tSBE2-Vp64 (Figure Ch4-10C).  
However, the broad loss of interaction in the region between Shh and SBE6 pointed by an 
arrowhead seems to be consistent in all replicates undergoing chromatin unfolding (Figure 
Ch3-7C & Ch4-10C). Moreover, these 5C heat-maps support our view that Shh is not 
interacting with a missed enhancer or any other sequence upon activation in NPC or Tale-
Vp64s (Figure Ch3-7, Ch3-8, Ch4-10 and Ch4-11).  
However, as previously concluded, 5C heat-maps in that case are more qualitative than 
quantitative, therefore I can only use them to test that no other chromatin conformation is 
occurring in that locus that contradict our view. 
 






Figure Ch4- 10 Chromatin conformation capture carbon-copy (5C) heat-maps 
of the Shh regulatory region in ESC after Tale-Vp64 transfection. 
A) 5C heat-maps beyond Shh regulatory region (chr5:28317087-30005000) with 5kb 
binning and smoothing with the median of 7 surrounding interactions frequencies. B) 
5C heat-maps of the Shh regulatory region (chr5:28750000-29750000) with 5kb 
binning and smoothing with the median of 5 surrounding interactions frequencies. C) 
5C heat-maps of the Shh regulatory region (chr5:28750000-29450000) with 5kb 
binning and smoothing with the median of 3 surrounding interactions frequencies of 
a biological replicate. Black arrows highlights the differences with ESCs observed in 
Figure Ch3-7 and grey arrowhead show CTCF sites. 
  






Figure Ch4- 11 Chromatin conformation capture carbon-copy (5C) heatmaps 
of the Shh regulatory region in tSBE6+tSBE2-Vp64 biological replicate. 
A) 5C heatmaps beyond Shh regulatory region (chr5:28317087-30005000) with 5kb 
binning and smoothing with the median of 7 surrounding interactions frequencies. B) 
5C heatmaps of the Shh regulatory region (chr5:28750000-29750000) with 5kb 
binning and smoothing with the median of 5 surrounding interactions frequencies. C) 
5C heatmaps of the Shh regulatory region (chr5:28750000-29450000) with 5kb 
binning and smoothing with the median of 3 surrounding interactions frequencies of 
a biological replicate. Black arrows highlights the differences with ESCs observed in 
Figure Ch3-7 and grey arrowhead show CTCF sites. 
  






Together these data suggest that the Shh activation that occurs upon its brain-enhancer 
activation from SBE6 and SBE2, promotes a large chromatin unfolding of a 100kb domain 
that can be blocked by recruiting a large protein complex such as Tale-Delta or Tale-CTCF, 
and that this is linked with enhancement of Shh expression.  
Thus, Shh neural enhancer-promoter communication seems to be mediated by a spreading or 
tracking of an activation signal through the intervening chromatin region that induces 









Chapter 5: Analysing the 










5.1 Which Factor is responsible for the 
chromatin unfolding? 
5.1.1 Supercoiling, a physical twist leading to chromatin 
unfolding? 
DNA supercoiling occurs endogenously as is an intrinsic consequence of DNA distortion. It 
has been previously described as critical for regulating gene expression and DNA replication 
(Dorman, 1991). DNA supercoiling can change chromatin fibre conformation and inter-
probe distances measured by FISH (Naughton et al., 2013). I therefore tested whether the 
chromatin folding I have detected in the previous two Chapters might be due to negative 
supercoiling (underwound DNA structure). Bleomycin is an antibiotic that introduces DNA 
strand breaks and that therefore releases supercoiling (Naughton et al., 2013). 
Although this data has been repeated only once, it seems that releasing the torsional stress 
with bleomycin does not relax chromatin structure in the Shh-SBE6 region in ESC nor in 
NPC (Figure Ch5-1). There is no significant difference between NPC and treated NPC, as 
nicking DNA did not release any distortion, and the chromatin unfolding is still significant 
upon treatment in NPC.  
However, without being significant, the data between ESC and ESC treated could indicate 
that bleomycin treatment might still have an effect on FISH inter-probe distances as the 
distribution becomes slightly more spread. This could be due to a perhaps overwound DNA 
structure of this loci in ESCs that is lost during differentiation participating in the Shh-SBE6 
chromatin unfolding without being the leading mechanism. 
Therefore this preliminary result indicates that DNA supercoiling is not the primary 
determinant of the chromatin structure rearrangement upon neural differentiation.  






Figure Ch5- 1 Effect of Supercoiling on the NPC chromatin unfolding. 
Boxplots representing Shh-SBE6 squared interprobe distances in ESC and NPC 
treated or not treated with bleomycin that releases supercoiling. N=1. 
  





5.1.2 Recruiting endogenous transcriptional co-activators, 
Mediator and p300 
As Vp16 is an ectopic (viral) transcriptional activator, I next wanted to determine if 
recruiting endogenous transcriptional activators and co-activators could reproduce my 
results.  
Vp16 is known to interact with the Mediator complex, which is a known co-activator of 
transcription (Allen and Taatjes, 2015; Yin et al., 2014). Mediator has several binding 
partners such as RNA polymerase II (Kim et al., 1994), Vp16 (Vojnic et al., 2011), and 
transcription factors (Taatjes, 2010). By ChIP, it is found at active enhancer and promoters 
and it might be involve in chromatin structure as it can work alongside cohesin to rearrange 
chromatin upon enhancer driven gene activation (Kagey et al., 2010; Visel et al., 2009).  
I focused on Med25, a subunit of the tail domain of Mediator that has the ability to bind 
Vp16, and therefore which could be recruited upon Tale-Vp64 transfection. I fused my Tales 
with the N-terminal Von Willebrand factor A domain (VWA domain) of Med25 that is 
responsible for Mediator binding and thus could recruit the whole Mediator complex (Figure 
Ch5-2A & Ch5-3A). I showed that using tShh-VWA, tSBE6-VWA and tSBE2-VWA, I 
could reproduce all my previous data generated with Tale-Vp64 (Figure Ch5-2B & Ch5-3B 
and Table 12).  
However, Med25-VWA recruitment induces very low levels of mRNA expression for Shh 
but also Ptn and Nrp1 using Tales targeting their promoter (Therizols et al., 2014) (Figure 
Ch5-3C). Indeed, mRNA levels are considerably inconsistent and reach similar amplitude 
than mRNA levels after a Tale-Δ	transfection (Figure Ch5-3D). This could indicate that the 
role in this context might principally be to remodel chromatin rather than to activate 
expression per se. 






Figure Ch5- 2 Recruitment of the VWA domain of Med25, a subunit of Mediator 
complex. 
A) Tale-VWA constructs and targeting. B) Boxplots representing Shh-SBE6 squared 
interprobe distances upon co-transfection with Tale-VWA and blocker.  
  






Figure Ch5- 3 Mediator Complex recruitment. 
A) Left- Med12 ChIP qPCR on Shh promoter sequence in NPC or after 
tSBE6+tSBE2-VWA transfection. Right- Med12 ChIP-chip in NPC or after 
tSBE6+tSBE2-VWA transfection view on SBE2 sequence. B) qRT-PCR displaying 
means (± s.e.m) log2 mRNA levels of Shh relative to Gapdh after co-transfection 
with Tale-VWA normalized to eGFP transfection for four biological replicates. C) 
qRT-PCR showing means (±s.e.m) log2 mRNA levels of Shh, Ptn and Nrp1 relative 
to Gapdh and normalized to eGFP transfected cells for Tales-Vp64 and Tales-VWA 
for one biological replicate. D) qRT-PCR showing means (±s.e.m) log2 mRNA levels 
of Shh relative to Gapdh and normalized to eGFP transfected cells for Tales-Vp64 
and Tales-Δ for one biological replicate.   





The p300, a histone acetyl-transferase (HAT), is known to catalyse acetylation of lysine 27 
of histone H3 (H3K27ac) and strongly occupies active enhancer (Visel et al. 2009). 
Moreover, it has been recently demonstrated that recruiting p300 to enhancers using the 
dCas9 from the CRISPR system was enough to trigger gene activation of their cognate 
promoter (Hilton et al., 2015). Cas9 is an RNA-guided DNA endonuclease from a type II 
CRISPR system, a bacterial immune system that directs the degradation of foreign nucleic 
acids. dCas9 is a dead version of the endonuclease. Small guide RNAs (sgRNA) could then 
guide dCas9 lacking endonuclease activity to desired DNA sequences (Gilbert et al., 2013; 
Qi et al., 2013). Like Tales-Vp64, dDCas9-Vp160 (ten repeats of Vp16) had also been used 
to activate endogenous sequences  (Cheng et al., 2013). Recently, the catalytic core domain 
of p300 has been fused to a catalytically dead Cas9 (dCas9–p300Core), dCas9–p300Core, 
and was able to activate transcription when targeted to promoters and even when targeted to 
enhancers (Hilton et al., 2015). Thus p300 may be able to activate gene expression through 
catalysing H3K27ac marks at proximal and distal regulatory sequences. 
I used the dCas9-p300Core from Hilton et al., 2015 to compare with the levels of activation 
obtained by Tales-Vp64 in the Shh context. I used one guide RNA on SBE6 and one on 
SBE2 with dCas9-p300Core (cSBE6-p300 and cSBE2-p300). 
Preliminary results indicate that cShh-p300, cSBE6-p300 and cSBE2-p300 fail to lead to Shh 
activation but cSBE6+cSBE2-p300 transfection still led to the nuclear distance increase 
between Shh and SBE6 (Figure Ch5-4 & Table 12). 
This result strongly supports my data previously discussed in Chapter 4, that is to say that a 
double activation mark is needed to promote the chromatin unfolding. As p300 is already a 
known marker of active enhancers I did not pursue the investigation of p300 targeting. 
  






Figure Ch5- 4 Recruitment of p300Core via dCas9 and one gRNA on SBE6 and 
SBE2. 
A) qRT-PCR displaying means (± SEM) log2 mRNA levels of Shh relative to Gapdh 
after co-transfection with p300 normalized to eGFP transfection for three biological 
replicates. B) Boxplots representing Shh-SBE6 squared interprobe distances upon 
co-transfection with dCas9-p300 and SBE6 and SBE2 guide RNA.   



















Table 12 P-values from eGFP and Tale-VWA or dCas9-p300 transfected ESC 
Mann-Whitney U tests on FISH distances distribution 
Exact p-values of Mann-Whitney U tests significance between ESC and Tale-VWA 
or dCas9-p300 revealing the number of replicates. 
  





5.1.3 Recruiting an endogenous transcription factor: SIX 
homeobox 3 (SIX3) recruitment to SBE2 leads to 
chromatin unfolding without activating Shh 
Point mutation of a SIX homeobox 3 (SIX3) transcription factor binding domain in SBE2 or 
a mutation of SIX3 that reduced its binding affinity have been shown to affect Shh 
expression in the forebrain and to lead to severe cases of Holoprosencephaly (HPE) (Geng et 
al., 2008; Jeong et al., 2008). Therefore there is a direct link between SIX3 binding at SBE2 
and Shh expression in the forebrain. I therefore investigated whether SIX3 binding could be 
sufficient to activate Shh using Tale-based recruitment to Shh promoter, SBE6 or SBE2 
(Figure Ch5-5A & Ch5-5B).  
The recruitment of Tale-SIX3 is not able to lead to consistent Shh activation, but leads to the 
chromatin unfolding only when bound to SBE2. (Figure Ch5-5C & Table 13). Furthermore, 
as previously shown, introducing tNE-CTCF was enough to prevent the chromatin to unfold 
when co-transfected with tSBE2-SIX3.  
These results reveal a crucial role for SIX3 binding on SBE2, as impairing its binding would 
probably prevent chromatin unfolding in the natural context and thus would not be able to 
enhance Shh expression (Figure Ch5-5D). 






Figure Ch5- 5 SIX3 recruitment allows chromatin unfolding and enhanced Shh 
expression when activators are present. 
A) tSBE2-SIX3 construct and targeting map. B) qRT-PCR showing means (± s.e.m) 
of log2 mRNA levels of Shh relative to Gapdh after Tale-Vp64 or Tale-SIX3 and both 
transfections in ESC in two biological replicates normalized to eGFP. C) Boxplots 
representing Shh-SBE6 squared interprobe distances after tSBE2-SIX3 and tNE-
CTCF transfections. Asterisks on FISH data represent Mann-Whitney U test 
significance between tSBE2-SIX3 and eGFP populations, ** for p-values <0.01. D) 
qRT-PCR showing medians (± s.e.m) of log2 mRNA levels of Shh relative to Gapdh 
after tSBE2-SIX3, tSBE6-Vp64 and both transfections in ESC in thirteen (tSBE2-
SIX3), eleven (tSBE6-Vp64) and nine (tSBE2-SIX3+tSBE6-Vp64) biological 
replicates normalized to eGFP. Asterisks represent p-values for one-tailed Student t-
test between conditions. * for p-values <0.05.  
 

















Table 13 P-values from eGFP and Tale-SIX3 transfected ESC Mann-Whitney U 
tests on FISH distances distribution 
Exact p-values of Mann-Whitney U tests significance between ESC and Tale-SIX3 
revealing the number of replicates.  





5.2 Investigating chromatin marks that might 
contribute to chromatin unfolding 
Overall my results highlight a visible level of chromatin decompaction over a 100kb region 
5’ of Shh that occurs upon brain-enhancer activation of Shh during neural differentiation and 
upon ectopic recruitment of activators and co-activators to the gene desert upstream of Shh. 
As the chromatin unfolding can be blocked with an introduction of Tale-Delta or Tale-CTCF 
in the intervening region, my data is consistent with a long-range tracking mechanism and a 
spreading of altered chromatin structure.  
5.2.1 Spreading of H3K27ac? 
As the unidirectional spreading of the CBP/p300 histone acetyl-transferases and the histone 
H3 acetylation have been previously involved with promoter activation via tracking 
mechanisms from their enhancer recruitment (Gribnau et al., 2000; Hatzis and Talianidis, 
2002; Kim and Dean, 2004; Masternak et al., 2003; Spicuglia et al., 2002; Wang et al., 2005; 
Zhao and Dean, 2004), I first investigated H3K27ac tracking in our system. 
I performed a time lapse after co-transfection of Tale-Vp64 targeted to Shh-brain enhancer to 
monitor the increase of nuclear distance. It appears that only 18h after Tale-Vp64 
transfection, the chromatin unfolding becomes significant (Figure Ch5-6).  I then performed 
H3K27ac ChIP 18h after transfection of Tale-Vp64s. 
H3K27ac Chip-chip revealed no spreading of acetylation marks in NPC and no tendency of 
spreading in Tale-Vp64 transfected cells (Figure Ch5-7). On the contrary, the acetylation 
marks are precisely deposited on the active enhancer and Shh promoter or gene body. We 
can also note the discrete acetylation on the site where Tale-Vp64 binds, certainly due to the 
recruitment of p300 via Vp16 (Kundu et al., 2000). 
Therefore p300 does not appear to be involved in the spreading of the signal of the 
chromatin unfolding. 
 







Figure Ch5- 6 Chromatin unfolding becomes specific 18h after transfections 
Boxplots representing Shh-SBE6 squared interprobe distances after tSBE6+tSBE2-
Vp64 2h, 4h, 18h and 24h after transfections. Asterisks on FISH data represent 
Mann-Whitney U test significance between Tale-Vp64 18h or 24h compared to 2h 
after transfection, ** for p-values <0.01. 
  






Figure Ch5- 7 H3K27ac does not spread along the Shh Regulatory region. 
UCSC Genome browser view of chr5:28,750,000-29,400,000 build mm9 displaying 
log2 H3K27ac ChIP relative to input chromatin on Shh regulatory region on ESCs 
and NPCs and after Tales-Vp64 transfection in ESC, one biological replicate. 
Arrowheads represent enhancer location SBE6, SBE2.  





5.2.2 Spreading of RNA Polymerase II? 
RNA polymerase II and TBP tracking on the chromatin fibre has been previously established 
between the HS2 enhancer of the LCR and the epsilon-globin promoter (Zhu et al., 2007). 
Indeed, RNA polymerase II can track along the intervening DNA and induce the synthesis of 
short, polyadenylated RNAs.  
I isolated RNA from the nuclei of ESC and NPCs to prevent the dilution of the potential non-
coding intervening transcripts by cytoplasmic mRNA and the degradation by the exosome. I 
then assayed the distribution of these transcripts using microarrays that tile the entire Shh 
regulatory region.  
However comparison of eGFP-transfected cells with NPC and other Tale-Vp64 transfected 
cells did not reveal any evidence of tracking of RNA pol II by hybridising RNA on chip 
(Figure Ch5-8). 
Together these analyses indicate that some other kind of protein complex is involved in the 
spreading of the chromatin-unfolding signal 






Figure Ch5- 8 No nascent transcripts emerge from the SBEs to Shh. 
UCSC Genome browser view of chr5:28,750,000-29,400,000 build mm9 displaying 
log2 absolute nuclear RNA on chip for ESC and NPC on 3 biological replicates 
combined. Arrowheads represent enhancer location SBE6, SBE2.  





5.2.3 Decompaction via removal of Polycomb marks? 
Previous work in the Bickmore lab has demonstrated that in absence of PRC1 and PRC2 
Polycomb components, there is visible chromatin decompaction chromatin at Polycomb 
target genes, and that this is due to a non-catalytic function of PRC1 (Eskeland et al. 
2010). Polycomb-mediated repression has been extensively linked with methylation of the 
Lys 27 of histone H3 (H3K27me3) (Cao and Zhang, 2004).  
Shh is a known Polycomb target gene in ESC as revealed by ENCODE ChIP-seq data 
(Hawkins et al., 2010) 
Performing Chromatin ImmunoPrecipitation on arrays tiling the whole Shh region (ChIP-on-
chip), for the Polycomb mark H3K27me3, and for H3K27ac associated with active 
chromatin revealed that interestingly Shh, when active, does not significantly lose its 
H3K27me3 marks (Figure Ch7-9). However activation of Shh via Vp64 tethered at SBE6.1 
or SBE2 leads to a more extensive domain of H3K27ac that spreads across Shh and the 
wider genomic region (Figure Ch5-7) indicating that there must be some loss of H3K27me3. 
To further complement that view, I used a Ring1b-/- cell line that is deficient in Polycomb 
machinery and that has been used to link Ring1b knock out with Polycomb loci 
decompaction (Eskeland et al., 2010b).  
FISH on wild type (WT) and Ring1b-/- ESCs transfected or not with Tale-Vp64s showed that 
co-transfection of the tSBE6-Vp64+tSBE2-Vp64 in Ring1b-/- ESCs does not lead to a 
significant decompaction compared to Ring1b-/- ESCs. However, the decompaction between 
WT and Ring1b-/- ESC is not as strong as the one that occurs upon Shh-Brain-Enhancer 
activation with Tale-Vp64s. Consistently with this data, FISH inter-probe distances 
measured in Ring1b-/- ESC are significantly smaller than distances measured after Tale-
Vp64s transfection in WT ESCs, affirming that the nuclear distance increase observed in 
Ring1b-/- ESC is not comparable in term of amplitude with the once occurring in neural 
differentiation (Figure Ch5-10). Furthermore ESC Ring1b-/- transfected with the cocktail of 
Tale-Vp64 could show a distance increase compared to the ESC WT control (Figure Ch5-
10).  
 








Figure Ch5- 9 Polycomb marks do not disappear upon Shh activation during 
neural differentiation or Tale-Vp64 activation. 
UCSC Genome browser view of chr5:28,750,000-29,400,000 build mm9 displaying 
log2 H3K27me3 ChIP relative to input on Shh regulatory region after Tales-Vp64 





transfection in ESC or in NPC, two biological replicate displayed A and B. 
Arrowheads represent enhancer location SBE6, SBE2. 
 
Figure Ch5- 10 Absence of Polycomb marks does not explain the chromatin 
unfolding. 
Boxplots representing Shh-SBE6 squared interprobe distances after Tale-Vp64 
transfections in wild-type ESC (WT) or in Ring1b-/- ESC. Asterisks on FISH data 
represent Mann-Whitney U test significance between populations. 
  





As for the bleomycin experiment, this experiment indicates that the loss of Polycomb marks 
on the Shh locus might take part in the chromatin unfolding between Shh and SBE6, but is 
not the primary determinant. Together these data point toward the fact that Polycomb 
machinery solely cannot explain the chromatin unfolding that occurs upon Shh-brain-
enhancer activation. 
  





5.2.4 Poly (ADP-ribose) polymerase-1 (PARP1) 
Given that the chromatin decompaction I detected does not seem due to loss of Polycomb, I 
looked for other chromatin-modifying systems that have been associated with large-scale 
chromatin decompaction. 
PARP1 has been shown to be involved in chromatin remodelling and gene expression (Tulin 
A et al., 2003, Ogino H et al., 2007). Indeed PARP1 can act on chromatin structure resulting 
in changes in gene expression using different mechanisms. It alters chromatin structure by 
competing with histone H1 and nucleosome binding (Kim et al., 2004; Krishnakumar and 
Kraus, 2010; Krishnakumar et al., 2008) or by acting as a chromatin remodeller and 
PARylates core histones, histone H1 or other chromatin architectural proteins (Gottschalk et 
al., 2009; Petesch and Lis, 2008; Timinszky et al., 2009). PARP1 is also associated with 
active histone modifications and is bound to regulatory regions (Nalabothula et al., 2015; 
Ogino et al., 2007). Moreover PARP1 has been shown to associate with p300 and the 
Mediator complex (Hassa et al., 2001, 2005; Pavri et al., 2005). Therefore PARP1 is a good 
candidate regarding Shh region chromatin unfolding as it has been also linked with 
chromatin loosening of very large regions (Tulin and Spradling, 2003; Tulin et al., 2002, 
2003) with its spreading linked with nucleosome loss at heat shock loci (Petesch and Lis, 
2008, 2012). 
I therefore examined the effect of fusing PARP1 to my previously designed Tale (Figure 
Ch5-11A). 
Targeting PARP1 to the Shh promoter or to its brain-enhancers leads to inconsistent Shh 
activation but does lead to chromatin unfolding only when targeted to the Shh regulatory 
region (on SBE6 or SBE2) but not to the Shh promoter (Figure Ch5-11B&C and Table 14).  
As previously shown with Tale-SIX3, PARP1 mediated chromatin unfolding could be 
blocked by tNE-CTCF (Figure Ch5-11B & Table 14).  






Figure Ch5- 11 Poly(ADP-rybosyl)ation mediated by PARP1 recapitulates the 
specific chromatin unfolding. 
A) Tales-PARP1 constructs and targeting map. B) Boxplots representing Shh-SBE6 
squared interprobe distances after Tale-PARP1 transfections. Asterisks on FISH 
data represent Mann-Whitney U test significance between Tales and eGFP 
transfected populations, ** for p-values <0.01. C) qRT-PCR showing medians (± 
s.e.m) of log2 mRNA levels of Shh relative to Gapdh after Tale-PARP1 transfection 
in ESC in five biological replicates normalized to eGFP transfection. 
  





 Shh-SBE6 Shh-SBE2/3 
tShh-PARP1 2.65E-01  
 6.30E-02  
tSBE6-PARP1 1.23E-03 5.86E-01 
tSBE2-PARP1 5.54E-04 6.48E-01 
 2.38E-05  
tNE-CTCF+tSBE6-PARP1 1.06E-01  
tNE-CTCF+tSBE2-PARP1 8.83E-01  
 
Table 14 P-values from eGFP and Tale-PARP1 transfected ESC Mann-Whitney 
U tests on FISH distances distribution 
Exact p-values of Mann-Whitney U tests significance between ESC and Tale-
PARP1 revealing the number of replicates.  





The role of PARP1 in retinoic acid receptor-mediated gene activation is independent of its 
catalytic activity (Pavri et al., 2005). To determine whether the catalytic activity of PARP1 is 
required for chromatin unfolding, I treated Tale transfected cells with Olaparib – a known 
PARP inhibitor- (Bundred et al., 2013).  
Using this drug treatment on tSBE2-SIX3 or tSBE2-PARP1 transfected cells prevented 
specific chromatin unfolding on treated cells. The treatment only prevented Shh-SBE6 
distance increase to occur but did not reduced all chromatin distances in general as Shh-
SBE2/3 distances remained the same (Figure Ch5-12A & Table 15). 
I could also show that in NPC day seven, a treatment of 1h with Olaparib also prevented the 
distance increase, as if the chromatin structure established upon differentiation collapsed 
after Olaparib treatment, without altering Shh-SBE2/3 distances (Figure Ch5-12B & Table 
15). Therefore the catalytic activity of PARP1 is essential for maintaining the chromatin 
unfolding between Shh and SBE6 in NPC. 
  






Figure Ch5- 12 SIX3 mediates chromatin unfolding in NPC via PARP1 catalytic 
activity. 
A) Left, Boxplots representing Shh-SBE6 squared interprobe distances for tSBE2-
SIX3 with and without Olaparib treatment and tSBE2-PARP1 after Olaparib 
treatment as a control. Right, Boxplots representing Shh-SBE2/3 squared interprobe 
distances for tSBE2-SIX3 with and without Olaparib treatment and tSBE2-PARP1 
after Olaparib treatment. B) Left, Boxplots representing Shh-SBE6 squared 
interprobe distances for NPC with and without Olaparib treatment. Right, Boxplots 
representing Shh-SBE2/3 squared interprobe distances for NPC with and without 
Olaparib treatment. Asterisks on FISH data represent Mann-Whitney U test 
significance between Tales or NPC and eGFP transfected or ESC populations, ** for 
p-values <0.01.  
  





 Shh-SBE6 Shh-SBE2/3 
tSBE2-SIX3 Olaparib 2.04E-01 3.13E-01 
 6.29E-01 3.96E-01 
 
9.97E-01 9.67E-01 
tSBE2-PARP1+Olaparib 4.17E-01 2.66E-01 
 8.16E-01 3.16E-01 
 
6.80E-01 7.64E-01 
NPC Day7 Olaparib 7.99E-01 9.03E-01 
 5.46E-01 1.00E+00 
 9.46E-01 5.10E-01 
 
Table 15 P-values from eGFP and Olaparib treated Tale-SIX3/Tale-PARP1 
transfected ESC or NPC Mann-Whitney U tests on FISH distances distribution  
Exact p-values of Mann-Whitney U tests significance between ESC and Tale-
PARP1 revealing the number of replicates. 
  





The Belmont peptide is a small acidic peptide DELQPASIDP that can decondense chromatin 
without triggering gene transcription (Carpenter et al., 2005) or RNA polymerase II 
recruitment (Therizols et al., 2014). It has been previously successfully fused to Tales to 
target chromatin decondensation at Nrp1 and Ptn loci in ESC (Therizols et al., 2014). 
However, the mechanisms of action of the Belmont Peptide remains unknown. To assess if 
the effect of the Olaparib treatment are specific to PARP1 in the Shh-SBE6 locus, I recruited 
the ‘Belmont Peptide’ (BP) (Figure Ch5-13A). Unlike PARP1, the Belmont Peptide led to a 
Shh-SBE6 nuclear distance increase when targeted to Shh promoter or SBE2 confirming that 
the ability of PARP1 to unfold the chromatin only when targeted to Shh regulatory region is 
specific (Figure Ch5-13B & Table 16). Moreover Olaparib treatment is specific to SIX3 and 
PARP1 as Belmont Peptide mediated decondensation is not altered upon treatment (Figure 
Ch5-13B & Table 16). 
Taken together, the Olaparib treatment experiments confirm the role of PARP1 in Shh-SBE6 
chromatin unfolding upon SIX3 binding during neural differentiation. 
Now that PARP1 seems to regulate this chromatin unfolding using its catalytic activity, it 
seems that this chromatin decondensation upon gene activation is analogous to the one 
previously observed in Drosophila polytene chromosomes where PARP1 mediates the 
chromatin loosening of the polytene puffs (Tulin and Spradling, 2003).   
 
  






Figure Ch5- 13 Belmont peptide decompaction is not disturbed by Olaparib.  
A) Tales-BP constructs and targeting map. B) Left, Boxplots representing Shh-SBE6 
squared interprobe distances after tShh-BP or tSBE2-BP transfections with and 
without Olaparib treatment. Right, Boxplots representing Shh-SBE2/3 squared 
interprobe distances for tSBE2-BP with and without Olaparib treatment. Asterisks on 
FISH data represent Mann-Whitney U test significance between Tales- BP and 
eGFP transfected or ESC populations, ** for p-values <0.01.  
  






 Shh-SBE6 Shh-SBE2/3 
tShh-BP 3.05E-03  




tSBE2-BP Olaparib 3.12E-05 2.33E-01 
 
7.46E-10 3.84E-01 
   
   
 
Table 16 P-values from eGFP and Tale-BP transfected ESC Mann-Whitney U 
tests on FISH distances distribution 
Exact p-values of Mann-Whitney U tests significance between ESC and Tale-BP 
treated or not with Olaparib revealing the number of replicates. 
  





5.2.5 State of the intervening chromatin  
The Shh-SBE6 chromatin unfolding I have described has been mainly illustrated using 3D-
FISH with two fosmid probes, using the inter-probe distances as a measurement of 
chromatin compaction. Parameters associated with these distances can give some 
information about the state of the intervening chromatin polymer (Sachs et al., 1995). 
However, this does not describe thoroughly the state of the intervening chromatin. I was 
expected from the various ChIP-on-chip for histone modifications that I will learn more 
about the state of the chromatin. To try to get more detailed information in the nature of the 
Shh-SBE6 chromatin, I used 2D FISH with Shh probe together with a BAC probe spanning 
the Shh regulatory region approximately from where NE is located (50kb upstream of Shh) 
and until SBE4 –thus spanning SBE6 (Figure Ch5-14A). It seems a good region to monitor 
as it is Shh-SBE6 and Shh-SBE4 distances that increase and that might undergo less 
interaction according to the various 5C heat-maps. 
I observed four types of signal, either a single point (as a normal FISH signal is), a double 
point, a string (an extended signal) that could be a sign of a rather linear chromatin 
decondensation and a puff which is represented usually by several dots (Figure Ch5-14B). 
The quantification of 2D-FISH signals for ESC, tSBE6+tSBE2-Vp64 transfected ESCs 
(Vp64s that lead to the chromatin unfolding), tSBE2-PARP1 (PARP1) and tSBE2-PARP1 
with Olaparib treatment (Olaparib) showed a striking increase of “puff” signals in conditions 
that undergo the chromatin unfolding i.e. Vp64s and PARP1 (Figure Ch5-14C & Table 17). 
As the double signal and string signal are constant amongst the different conditions, it is 
clear that the chromatin unfolding switch from a proper single signal to a puff signal. 
Therefore it is legitimate to consider this chromatin unfolding similar to the polytene puff 
observed in Drosophila.  
  






Figure Ch5- 14 2D FISH of the intervening chromatin. 
A) Scheme showing the position of the BAC RP24-323C22 spanning chr5: 
28,832,721-29,003,817 in mm9 with arrowheads indications SBE6 and SBE4 
enhancer positions. B) 2D FISH with Shh fosmid probe in red and the BAC directly 
labelled in green, the FISH signal can be seen in four different states, either a single 
point, a double point both categorized as “single point” or the signal is as a string 
shape or several dots assimilated to a “puff”. C) Quantification of the different states 
of FISH signals (technical triplicate) between ESC, tSBE6+tSBE2-Vp64 transfected 
ESCs (Vp64s), tSBE2-PARP1 (PARP1), and tSBE2-PARP1 treated with Olaparib 
(Olaparib). N=200 alleles. 
  






Table 17 Fisher tests significance between ESC, tSBE6+tSBE2-Vp64 (Vp64s), 
tSBE2-PARP1 (PARP1) and Olaparib treatment on tSBE2-PARP1 transfected 
cells (Olaparib).  
  
 
ESC Vp64s PARP1 Olaparib 
Total Counts Single 
points 527 243 229 356 
Total Counts Puffs 130 285 223 212 
p-value to ESC X 0 0 0 
p-value to Vp64 X X 0.158423 0 
p-value to PARP1 X X X 0.00013 






In this Chapter, I first showed that the Shh-SBE6 chromatin unfolding can be recapitulated 
by recruiting endogenous factors such as Mediator, p300 and SIX3 to the Shh-Brain-
Enhancers.  
After observing that synthetically targeting CTCF to the intervening region impaired the 
Shh-SBE6 chromatin unfolding, I investigated a possible long-range spreading mechanism 
and which know chromatin remodeller could be responsible for this large restructuration of 
the chromatin.  
I looked at supercoiling, spreading of known chromatin factors like p300 or RNA 
polymerase II or removal of Polycomb marks and none of those well-known remodeller 
seem to be the primary determinant of the Shh-SBE6 chromatin unfolding I described. 
By looking at other chromatin binding proteins linked with massive decompaction and 
oligomerization or spreading, I isolated PARP1 as a potential candidate. By recruiting 
PARP1 directly and also blocking its catalytic activity using Olaparib, I showed that the Shh-
SBE6 chromatin unfolding is mediated by SIX3 and PARP1 catalytic activity. 
Taken together these results bring into light a new mechanism of promoter activation 
mediated by its enhancer activity. This result might be very specific to this locus in this 
peculiar environment, but it shows that probably many more diverse mechanisms apply for 











Chapter 6: Shh regulatory 
region insulation 
  





6.1 Enhancer activation domain and insulation 
Insulating enhancer action has been considered to be an important function of higher order 
genome organization. Especially TADs and TAD boundaries. As discussed in the Chapter1, 
3D chromatin conformation could form -as the nucleolus- as self-organising structures that 
make reactions more efficient by allowing elevated local concentrations.  
It seems that whatever the mechanism, insulator elements or chromosomal rearrangement 
were able to force and direct the activation signal to a precise promoter element, thus, the 
idea that the activation signal is constrained in a certain area quickly arose. It seems now 
clear that more than a simple sequence, enhancers operate in a chromatin domain. Strikingly, 
it has been shown that an insulated enhancer is instead able to activate transcription from a 
non-insulated promoter localized in the same domain. Which demonstrates that the 
transcription factors binding ability on the enhancer remains and that the specificity of 
enhancer action might rely on the chromatin domain itself (Cai and Levine, 1995; Scott et 
al., 1999) 
Therefore boundary or insulator elements seem to define precise chromatin areas where 
regulatory elements are active. Work on association rates of transcription factors and other 
DNA binding proteins revealed that kinetics of protein binding can be ruled by the local 
packaging of chromatin. Indeed in a facilitated diffusion model, transcription factors engage 
a first step of 3D diffusion-based exploration that depends on physical and chemical 
properties of the local nuclear environment such as chromatin exclusion volume and will be 
concentration-dependent and later operate as a second step a local 1D sliding along the 
chromatin fibre to efficiently search for targets (Chen et al. 2014, Woringer et al. 2014, 
Normanno et al. 2015). 
The role of CTCF as enhancer insulator is quite unclear, although it has been shown to 
prevent enhancer action (Bell et al., 1999). CTCF is also extensively linked with TAD 
formation and therefore guiding the wiring of enhancer-promoter communication (Chapter 
1). Therefore I decided to use CTCF during my project to insulate the enhancer action. 
However, in this case the surprising role of Tale-Delta or Tale-CTCF in preventing the 
chromatin unfolding is quite hard to fully understand.  





In my use of Tale-Delta and Tale-CTCF, both protein ensembles acted as insulators, 
therefore we cannot conclude on the role of CTCF itself but perhaps more on the Tale 
binding per se. Interestingly in this case Tale binding alone - or with CTCF - prevents 
tracking or spreading of the chromatin unfolding i.e. the probable parylation of the chromatin 
but not tracking of activators as previously described. So maybe in this case, the Tale or 
CTCF action is not representing a classic insulation of the enhancer activity as previously 
postulated e.g preventing tracking of the activation signal. 
I also wanted to test whether the decompaction induced by the Belmont Peptide, which is 
known to be induced by coactivator proteins such as histone acetylases recruitment via the 
activators' short acidic-hydrophobic peptide motifs (Carpenter et al., 2005; Tumbar et al., 
1999), could be also stopped by CTCF. Using tNE-CTCF and tSBE2-BP, I could see that the 
decompaction led by the small acidic peptide is not disturbed by CTCF binding (Figure Ch6-
1 & Table 18). This data is consistent with the lack of evidence for large histone acetylases 
recruitment and spreading upon differentiation or Tale-Vp64s targeting in the Shh regulatory 
region (Chapter 5). 
Therefore the insulator role of tNE-CTCF during the chromatin unfolding remain quite 
surprising. 
CTCF insulator activity can be regulated by poly(ADP-ribosyl)ation via PARP1 (Farrar et 
al., 2010, 2011; Guastafierro et al., 2013). Furthermore CTCF poly(ADP-ribosyl)ation 
imparts its chromatin insulator properties as lack of PAR due to 3AB treatment abrogated its 
insulator function (Yu et al., 2004). Using tNE-CTCF and tSBE2-PARP1 or tSBE6-PARP1 
was enough to prevent chromatin unfolding perhaps due to CTCF acting as a sink for 
parylation or acquiring an increased insulation property. Unfortunately the ability of Tale-
Delta to also act as insulator in this context remains unexplained. 
  






Figure Ch6- 1 CTCF does not impact chromatin decondensation upon Belmont 
peptide targeting. 
Boxplots representing Shh-SBE6 squared interprobe distances after tSBE2-BP with 
and without tNE-CTCF transfections for two biological replicates. Asterisks on FISH 
data represent Mann-Whitney U test significance between Tales- BP and eGFP 
transfected or ESC populations, ** for p-values <0.01. 
  











Table 18 P-values from eGFP and Tale-CTCF and Tale-BP transfected ESC 
Mann-Whitney U tests on FISH distances distribution 
Exact p-values of Mann-Whitney U tests significance between ESC and Tale-BP 
revealing the number of replicates. 
 
  





6.2 Shh TAD boundary 
Chromatin has been described as segmented into topologically associated domains (TADs) 
that span several megabases and that are segregated by insulator elements as discussed in 
Chapter 1. TADs have been described to play an important role in regulating long-range 
enhancer promoter interplay (Lupiáñez et al., 2015). By disrupting TAD boundaries, 
inverting CTCF sites sense and creating chromosomal rearrangements, enhancer and 
promoter communication are completely rewired and this leads to ectopic gene activation 
that results in pathogenic phenotypes (Gómez-Marín et al., 2015; Guo et al., 2015; Lupiáñez 
et al., 2015; Tsujimura et al., 2015). This leads to the suggestion that more than specific 
sequence interactions, a specific chromatin domain is necessary for a proper enhancer-
promoter communication (Symmons et al., 2014). This is consistent with the ability of 
enhancers to act on reporters integrated throughout a TAD (Anderson et al., 2014). Therefore 
TAD boundaries are thought to be important for constraining enhancer/promoter 
interactions. 
Enhancers are docking site for transcription factors and can activate any responsive i.e. not 
actively repressed promoter located in a defined chromatin domain. Therefore bringing a 
strong activator such as Vp64, that recruits the whole co-activator machinery that further 
leads to the gene expression, into a defined chromatin domain could concomitantly activate 
surrounding genes that are located in the same domain. 
Chromatin conformation studies (5C and HiC), allow us to visualize two overlapping “mini-
TADs” located in the main Shh TAD, the first contains Shh and goes until just after SBE6, 
the second one starts at SBE4, contains Rnf32 and finishes with the same boundary as the 
main TAD (Figure Ch6-2A) (Dixon et al., 2012, 2015; Rao et al., 2014). Following the TAD 
(and “mini-TAD”) boundary models, it would be expected that the activation effects of Tale-
Vp64 should not be spread beyond the TAD boundaries into adjacent TADs. Thus I 
speculated that as SBE2 is located in the overlapping domain of these “mini-TAD”, it could 
potentially activate Shh and Rmf32 whereas targeting Tale-Vp64 to NE and SBE6 that are 
strictly confined in the “mini-Tad” containing Shh would not activate Rnf32. 
To assess this, I designed new Tales-Vp64 that are contiguous in the Shh TAD and that go 
beyond its boundaries to the other neighbouring TADs (Figure Ch6-2A). The Shh TAD 





possess only two genes - Shh and Rnf32 - located at the opposite ends. CRTL En2 and 
Rmb33 are located on the next TAD beyond Shh, whereas Nom1 is in the neighbouring TAD 
on the opposite side, close to Rnf32. I first looked at the profile of gene activation induced by 
Tales-Vp64 targeted to these genes in these three TADs in ESC (Figure Ch6-2B). It is 
important to note that only Shh and En2 are off in ESC. Thus the very low levels of 
activation created by tRbm33-Vp64, tRnf32-Vp64 and tNom1-Vp64 to their own target 
could be explained by the fact that these genes are already active and it is then harder to 
activate them even more. 
The qRT-PCR data highlighted two interesting results. It first appeared that only Tale-Vp64s 
targeted between Shh and SBE2 could strongly activate Shh. Secondly, as predicted, only 
tSBE2-Vp64 was able to lead to Rnf32 activation to levels as high as those achieved by Tale-
Vp64 targeted to the Rnf32 promoter.  
This data also shows that Shh and the non-coding RNA 9530036O11Rik are the easiest 
transcripts to induce by a transfection of a Tale-Vp64 to the Shh regulatory region. 
Indicating perhaps that the Shh chromatin environment could allow Shh to be expressed 
easily when strong activators come into its vicinity. This would be consistent with the need 
of a highly compacted conformation of the Shh locus and a chromatin unfolding model that 
enhances Shh transcription upon activator presence. 
Comparing qRT-PCR and 5C heat-maps allow us to draw a very clear parallel between these 
data (Figure Ch6-2A). Thus this seems to confirm that one Tale-Vp64 off-target activation 
might depend on the close chromatin conformation the target lies in. This would also be 
consistent with the view of an enhancer being a docking site for an activator and thus 
rewiring enhancer activity when moving the enhancer outside a “mini-TAD” which is 
persistent with the view of an “enhancer domain” or chromatin hub discussed in Chapter 1. 
It is also interesting to note that tRnf32-Vp64 and tNom1-Vp64 seem to bypass their 
boundary more easily. This would need further investigation on the nature of the TAD 
boundaries in order to draw a conclusion. 
To further dissect this, it would be interesting the delete the TAD boundary or remove the 
CTCF site and change their orientation to see if the domain of activation that Vp64 can reach 
differs. 






Figure Ch6- 2 Tale-Vp64 activates the surrounding chromatin. 
A) ESC 5C heatmap (chr5:28317087-30005000) with 5kb binning and smoothing 
with the median of 7 surrounding interactions frequencies displaying Tale-Vp64 
targeting represented as green triangles. B) Log2 mRNA levels for En2, Rbm33, 
Shh, long non-coding RNA 9530036O11Rik, Rnf32, Lmbr1 and Nom1 qRT-PCR 
after Tales-Vp64 are displayed as a log2 heatmap.   















7.1 Distal Shh-Brain-Enhancers regulate 
chromatin unfolding to promote Shh 
expression upon neural activation 
Studying Shh and its brain-enhancers communication during neural differentiation revealed a 
previously undescribed mechanism of enhancer-promoter communication. I was first able to 
establish two new enhancers that are active in NPC, with only one of them (which I named 
SBE6) a robust Shh activator in the forebrain (Chapter 2). I was then able to observe that 
upon neural differentiation the Shh promoter moves further away from SBE6 but not SBE2. 
A nuclear distance increase that is very specific to the Shh-SBE6 region and arises from day 
3 onward is incompatible with the common long-range chromatin-looping model. This 
distance increase is general and homogenous through the population of cells that are 
homogeneously expressing Shh.  Deleting SBE6 was enough to reduce Shh expression in 
NPC and abolish the distance increase, revealing that this neural chromatin unfolding is 
linked with enhancer activity. Furthermore this effect is specific to SBE6.1, as deleting 
SBE6.2 did not influence expression or chromatin structure in NPC. 
Subsequently I was able to show that the imaging system I used – super-resolution SIM and 
FISH – allows me to visualize a chromatin loop if a looping event occur. And using a 
synthetic biology approach, I could demonstrate that the chromatin-unfolding event does not 
simply result from activating Shh directly but that it results from a co-activation of SBE6 and 
SBE2. The chromatin unfolding occurs after a certain concentration of activator protein is 
loaded onto the Shh regulatory region. The opening of the Shh region is associated with a 
general increase in Shh expression across cells in the population. Preventing this opening by 
deleting SBE6 or synthetically blocking it by targeting CTCF to the intervening region 
impaired Shh expression. Therefore the underlying mechanism is linked with a long-range 
spreading-like. 
I later established that the recruitment of SIX3 onto SBE2 is critical for the chromatin 
unfolding to occur and that SIX3 mediated chromatin unfolding is able to enhance Shh 
activation via its Brain-enhancers, which is consistent with the results from NPC day 3 and 





SBE6 -/- NPC day 7 that are expressing Shh at low levels but are not displaying the 
chromatin unfolding. 
Taken together, it seems that preventing the chromatin unfolding negatively affected Shh 
expression levels and that promoting chromatin unfolding with SIX3 positively affected Shh 
activation when co-activators are present. These results illustrate the strong interplay 
between chromatin unfolding and robust Shh activation. This leads us to postulate that in 
holoprosencephaly cases (HPE) caused by impaired SIX3 binding, Shh haploinsufficiency 
could result from abrogated chromatin unfolding (Belloni et al., 1996; Geng et al., 2008; 
Roessler et al., 1996; Wallis et al., 1999). 
I next demonstrated that SIX3 chromatin unfolding is mediated by PARP1 poly(ADP)ribose 
activity to open up the Shh-SBE6 region, as Olaparib which blocks PARP1 catalytic activity 
was able to prevent the specific Shh-SBE6 chromatin unfolding in NPC and ESC transfected 
cells. 
These results help me to draw a model describing the chromatin architecture of the Shh 
regulatory region upon neural differentiation from ESC to NPC and Shh enhancer driven 
activation (Figure Ch7-1). In ESCs the Shh regulatory region is in a closed conformation and 
during early stages of differentiation activators lead to induction of Shh without the prior 
opening of the Shh-SBE6 region. In that first condition, the cell express Shh at low levels. 
This is observed in early differentiation to NPCs, in SBE6 deleted NPC, in tNE-CTCF 
transfected ESC and I speculate in SIX3 disrupted cases of HPE. With the full complement 
of activators loaded onto the Shh regulatory region and SIX3 recruitment followed by 
poly(ADP-ribosyl)ation of the region by PARP1, the chromatin unfolds and enhances Shh 
expression. This chromatin unfolding may make the region more accessible to factors that 
facilitate gene induction. 






Figure Ch7- 1 Shh-Brain-Enhancers promote a chromatin unfolding in Shh 
regulatory region upon a neural activation. 
In ESC, the Shh regulatory region is in a closed conformation as illustrated with the 
Shh-SBE6 FISH signal, and upon early stages of differentiation activators lead to 
Shh activation without yet opening the Shh-SBE6 region as observed in early NPC 
differentiation, in SBE6 deleted NPC or in tNE-CTCF transfected ESC. All those 
conditions display a low Shh activation. With SIX3 recruitment and by poly(ADP-
ribosyl)ing the region with PARP1, the chromatin finally unfolds which then 
enhances Shh expression. 
 





7.2 New insight on enhancer mechanisms of 
action? 
7.2.1 An assembly of transcription factor motifs 
Functional characterization of enhancers is often realised through the property of enhancers 
to be able to drive expression of a minimal reporter gene in an episomal vector - thought to 
lack physiological chromatin - or inserted as a transgene into a host genome such as 
zebrafish or mouse. By comparing chromosomal and episomal activity of enhancers, it 
seemed that the chromatin environment led to a much cleaner representation of the 
enhancer’s activity (Inoue et al., 2016). However, we cannot deny that a reporter assay 
performed on a non-integrated episomal vector gives a good and rapid indication of the 
enhancer pattern activity.  This reveals that primarily an enhancer can be summarized as a 
cluster of tissue-specific transcription factor binding sites that are the key definers of cell 
type and temporal enhancer activity. To a certain extent, this view can be illustrated by a 
recent study based on motif analysis and not sequence conservation to find new enhancers 
with similar activities. This analysis revealed that sequences required for enhancer function 
work in assemblies of transcription factor motifs, and that the order does not matter as only 
the presence of all those motifs is required the pattern activity of the enhancer (Yao et al., 
2016).  
This idea is similar to the initially popular view of enhancers as an extension of the 
promoter. Transmission of transcription machineries or signals to the neighbouring minimal 
reporter promoter in an episomal vector is the critical characteristic that all regulatory 
element share. As a docking site for tissue-specific transcription factors, enhancers serve as 
bidirectional entry sites for either RNA polymerase II or one of its subunits. This first 
provides an explanation regarding their position and orientation independence. It also 
implements the first definition of the tracking model. After serving as an anchoring site, 
tissue-specific transcription factors track along the DNA sequence or the chromatin fibre 
with insulator elements setting boundaries of the activation domain.  
  





7.2.2 Three main mechanisms? 
Regarding nearby enhancers (few kb), it is commonly accepted that their proximity to their 
target promoter is enough to induce activation after transcription factor binding and 
transcription machinery recruitment. It is generally agreed that perhaps a short tracking 
might occur to reposition the machinery on the transcription start sites, but only limited 
mechanistic dissection has been done on these enhancers in mammals. 
For distal enhancers the looping model prevails, in which the spatial co-localisation of the 
promoter and enhancer seems crucial in order to concentrate transcription factors at the 
anchoring site. It has been recently established that direct promoter-enhancer interaction is 
responsible for driving allele specific transcriptional bursting (Bartman et al., 2016; Fukaya 
et al., 2016).  
Regarding Shh, it is interesting to consider that the ZRS located 800kb upstream of Shh is in 
a permanent close conformation with Shh promoter and becomes even closer upon activation 
(Williamson et al., 2016). This subtle 3D repositioning is already different from other loci 
that undergo drastic “on/off” state of looping such as the β-globin LCR where the enhancer 
is positioned far from the promoter when inactive (Simonis et al., 2006; Tolhuis et al., 2002). 
On the contrary, Shh-ZRS, similar to the HoxD locus, are permanently located very close to 
each other, whether the gene is expressed or not and undergo co-localisation upon activation 
(de Laat and Duboule, 2013; Montavon et al., 2011). The stable loop conformation seems to 
correlate with paused RNA Polymerase II occupation and release upon direct looping and 
transcription initiation (Ghavi-Helm et al., 2014). Could we consider those two types of 
looping mechanisms similar? It seems that in one case the physical forces needed for 
accomplishing the enhancer-promoter chromatin loop will be greater as the initial distance 
between enhancer and promoter is bigger. We can also speculate that is one case in which 
the chromatin conformation should allow a dynamic movement whereas the other case 
would be in a tighter controlled conformation involving other types of protein binding to 
maintain the locked position. 
The chromatin unfolding model I describe for Shh-Brain-Enhancer seems to enhance 
activation through the recruitment of activators and it could be seen as another type of 
facilitated tracking model for a locus that is highly compacted. It is fascinating to realize that 





in the same locus Shh has different enhancers that utilise different mechanisms of regulation. 
The main question that remains is what determines the mechanism that the enhancer will 
follow. Is it a co-evolution of the transcription factors and the chromatin environment? To 
answer that it would be interesting to use genome engineering to swap the positions of ZRS 
and SBE6 or SBE2 and see if ZRS/Shh is still following the looping model or if the 
chromatin unfolding will take the lead. Unfortunately this experiment will be difficult to 
perform as no in vitro cell line model exist to study the ZRS, all the studies have to be 
performed in mouse limb tissues, and reciprocally it is quite hard to pin down what tissues 
and stage NPCs represent in the developing mouse brain. However, we could test if SBE6.1 
inserted into Lmbr1 in 46c cells follows a looping or chromatin unfolding mechanism upon 
neural differentiation. 
Moreover for brain activation of Shh in NPCs it seems that more than one enhancer is 
involved, whereas for the precise limb expression of Shh only the ZRS has been described so 
far. Therefore we should also consider “the strength” of an enhancer, if the activation is due 
to a composition of various enhancer activity or due to a single specific strong enhancer 
(Bothma et al., 2015). And if that interferes with the mechanism used for enhancer action? 
Indeed we could imagine that if the activation relies on a unique distal enhancer, it would be 
better if it is already located near the promoter in a closed conformation with paused 
polymerase awaiting to be released. However if it works with a cooperation of several 
enhancers, depending on the chromatin context it will used a tracking model, or a dynamic 
looping or even a facilitated tracking model where as a step-by-step process, proteins scan 
the chromatin as a preliminary step until the cognate promoter is met and that a stable loop is 
maintained when the tracking is complete. The facilitated tracking model observed the 
unidirectional spreading of acetylated histones H3 and H4, histone acetyltransferases 
CBP/p300, P/CAF, subunits of the human SWI/SNF or RNA polymerase II and TBP that 
synthesized short, polyadenylated, intergenic RNAs (Gribnau et al., 2000; Hatzis and 
Talianidis, 2002; Kim and Dean, 2004; Masternak et al., 2003; Spicuglia et al., 2002; Zhao 
and Dean, 2004; Zhu et al., 2007). 
Only the case-by-case study of precise enhancer-promoter interaction will help us to have a 
clearer view on how many different mechanisms exist and what determines the model, the 
chromatin conformation, the number of enhancers involved and their position, the TAD 
position or the gene position within the TAD? 





But it might take more time as many enhancers are still awaiting annotation. Recent work 
from the Stark lab estimated between at least 50,000 to 100,000 developmental enhancers in 
the 170-megabase Drosophila melanogaster genome which suggests that the 3-gigabase 
human genome could contain up to several million enhancers (Kvon et al., 2014) as even 
only Shh seems to contain at least 30 more unannotated brain enhancers (Chapter 2). 
  





7.3 Characteristics of the chromatin unfolding 
The new mechanism I described during my thesis is so far very specific to the Shh locus in 
the context of the neural differentiation. However, we do not know whether this mechanism 
can be generalizable for other loci and what could be the rule for following that pathway of 
enhancer-promoter communication, as opposed to chromatin looping. 
I first tried to decipher which characteristics made the Shh locus special. Shh is expressed in 
neural tissues and possess many brain enhancers and with many more yet to be annotated 
(Chapter2). Also, Shh is located at a TAD border and near a large gene desert where its 
enhancers are positioned. Furthermore Shh is a strong Polycomb target. The Polycomb 
marks do not disappear upon gene expression and in ESC Ring1b-/- (Polycomb complex 
mutant), Shh is not expressed whereas many other Polycomb target become expressed 
following the removal of the repressive mark (Rob Illingworth, unpublished). This could 
potentially indicate that Shh possess several levels of repression to prevent ectopic activation 
of the powerful morphogen.  
I picked other candidates that followed those characteristics (Figure Ch7-2A) and looked at 
the corresponding HiC data available for mouse ESC and Cortex 
(http://promoter.bx.psu.edu/hi-c/view.php) from the Ren Lab (Dixon et al., 2012, 2015; Rao 
et al., 2014). Interestingly, all three loci, Six3, Sp8 and DLX6, seem to lose some degree of 
interaction in the gene desert where there putative brain enhancers are located in the mouse 
cortex (Figure Ch7-2B, Ch7-3).  
Of course, this large scale decompaction could be due to many other factors and should be 
further dissected by FISH. However, the fact that the chromatin unfolding at the Shh locus 
seem to be present in this HiC data in mouse cortex suggests the decompaction of those other 
loci could be meaningful. 






Figure Ch7- 2 Possible loss of interaction at other developmental genes. 
A) Table with the characteristic used to pick similar loci. B) HiC data from the Ren 
Lab in mouse ESC and Cortex for Shh, Six3, Sp8 and DLX6 loci.  







Figure Ch7- 3 Putative Brain enhancers (dark yellow) for Shh similar loci. 
  





7.4 Live-cell imaging revolution  
Using fixed samples only gives a static snapshot of chromosome organisation. Having the 
ability to study the dynamics of chromosome movement of the interactions that form and 
dissolve during gene regulation in living cells will be a tremendous step forward. Toward 
that goal, tools to visualize single loci by live cell imaging are still awaiting full 
development. 
In the new mechanism I have been describing where enhancers promote a chromatin puff 
probably similar to polytene puffs observed in Drosophila, the dynamic component of that 
mechanism is still missing. Although we could see that it appears progressively during 
neural differentiation and seems perhaps stable as it could be seen also by 5C and generally 
as a distance shift in the whole population by FISH, a live-cell imaging approach would 
characterise more the kinetic of this chromatin unfolding.  
Using an GFP-tagged dCas9 with an array of 24 structurally optimized sgRNAs tiling along 
Shh, a single endogenous locus should be tracked in a living nucleus (Chen et al., 2013). 
Similarly, instead of using 24 sgRNAs, a recent study used a protein scaffold that can recruit 
several copies (24) of an antibody protein fused to a fluorescent dye (superfolder GFP, 
sfGFP (Pédelacq et al., 2006)). This SunTag complex fused to a dCas9 can be targeted using 
a single sgRNA and enable live cell tracking of a single locus (Tanenbaum et al., 2014).  
Therefore, in theory, combining those two recent imaging technologies using dCas9/CRISPR 
and Tale system should enable dual colour live visualisation of two isolated loci (Figure 
Ch7-4). I briefly undertook the cloning of a dCas9-mCherry with 24 sgRNA tilling Shh 
promoter and upstream gene body. In parallel, I cloned the SunTag protein scaffold to 
various Tale I built such as tShh, tSBE6 and tSBE2. A transfection of a Tale-SunTag 
scaffold alongside the antibody fused to a sfGFP (sfGFP-AB) would allow in theory the 
visualization of the Tale targeted locus.  
 






Figure Ch7- 4 Live-Cell Imaging theory. 
Two sequences tagged with either Tale fused with SunTag protein scaffold that 
recruits sfGFP or sgRNA tilling the sequence and recruiting dCas9-mCherry. 
  





After a brief control using the 24 Shh- sgRNA with dCas9-mCherry and tShh-SunTag and 
sfGFP-AB to monitor proper colocalization, it seemed that the system needs substantial 
optimisation and will be pursued by other members of the lab.  
This system will be likely to be cleaner in a stable line, as the system requires a co-
transfection of 27 plasmids (24 Shh sgRNAS, dCas-mCherry, tShh-SunTag, sfGFP-AB) 
resulting in many cells lacking the full cocktail and therefore the poor number of cells 
possessing 2 loci to visualise. Furthermore, integrated plasmids will decrease the background 
and noise as the expression will be lower and cleaner. Unfortunately creating those cell lines 
and following the enhancer-promoter communication upon differentiation would be another 
project in its own right, but will be an important development in the future of the enhancer 
field.  






Chapter 8: Materials & Methods 
  





8.1 Cell culture 
46c mouse embryonic stem cells (mESCs), derived from E14tg2A, contain a GFP insertion 
into the Sox1 locus (Ying et al., 2003). 46c and Ring1B−/−  ESC were grown in GMEM 
supplemented with 10% fetal bovine serum (FBS), 1,000 units/ml LIF, nonessential amino 
acids, sodium pyruvate, 2-β-mercaptoethanol, L-glutamine, and Penicillin/Streptomycin. 
ESCs were cultured and differentiated into NPCs with N2B27 medium as described  
previously (Pollard et al., 2006; Taylor et al., 2013). ESCs were transfected and sorted 
following (Therizols et al., 2014) protocol. Olaparib treatment was performed as follows, 
10µM Olaparib (stock 100 mM in DMSO) diluted in ESC or NPC media was added on 
1x106  cells 24h after transfection or 5h after FACS for NPC, cells were treated for 1h30 and 
media was changed and cells were fixed for FISH 
ESCs were transfected with plasmids using Lipofectamine® 2000 Reagent (Invitrogen cat. 
N°11668) following the manufacturer recommendations. 1x106 ESCs were transfected in a 
6-well plate with 2.5µg of circular plasmid and 7µl of Lipofectamine. Medium was changed 
5h after transfection. Transfected cells were sorted based on eGFP expression by FACS 24h 
after transfection and re-seeded on slides or 6-well-plates. To sort GFP+ve cells after 
transfection or differentiation, cells were trypsinized and resuspended in PBS + 10% 
medium. Flow cytometric analysis was performed using the 488nm laser of a BD 
FACSAriaII SORP (Becton Dickinson) with 525/50 nm bandpass filters. BD FACSDiva 
software (Becton Dickinson, Version 6.1.2) was used for instrument control and data 
analysis.  
8.2 Quantitative analysis of gene expression  
RNA was prepared from approximately 1x106 46c mESCs using the RNeasy mini kit 
(Qiagen) according to the manufacturer’s protocol, including a DNaseI (Qiagen) treatment 
for 15 minutes at room temperature. cDNA was synthesized from 2 µg purified RNA with 
Superscript II reverse transcriptase (Invitrogen) primed with random hexamers (Promega). 
Real-time PCR was carried out on the Roche LightCycler 480 Real-Time PCR System using 
a Lightcycler 480 Sybr Green detection kit (Roche) as described previously (Therizols et al., 
2014). Primers sets for qRT-PCR were: 






Expression RT-qPCR primers 
Gapdh Fw ATCACCATCTTCCAGGAGCGAG 
Gapdh Rv GACCCTTTTGGCTCCACCCTTC 
Oct4 (Pou5f1) Fw CGAGAACAATGAGAACCTTC 
Oct4 (Pou5f1) Rv CCTTCTCTAGCCCAAGCTGAT 
Nestin Fw GATCGCTCAGATCCTGGAAG 
Nestin Rv AGGTGTCTGCAAGCGAGAGT 
Shh Fw  ACGATTTAAGGAACTCACCC 
Shh Rv  TTGTCTTTGCACCTCTGAG 
En2 Fw GGTCTACTGCACGCGCTATTCT 
En2 Rv AAACTCAGCCTTGAGCCTCTGG 
Rbm33 (Pr8) Fw GCTTCCTACACAGCCGTCTGTT 
Rbm33 (Pr8) Rv GGAACAGACTTCTGATTGGCTGC 
9530036O11Rik Fw GCCTGAAACACACAGAATGC 
9530036O11Rik RV GATGGGAGAACTCAGCCAAG 
Rnf32 Fw GCAGCTAGATGAAAGGTGTGGC 
Rnf32 Rv AGTGGAGTCAGGCAGATGGAAC 
Lmbr1 Fw GGAGGAAAAAGGCTTCAGCTTGG 
Lmbr1 Rv GTCTCATCAACCAGCAGGCAAAG 
Nom1 Fw GGCTCTGAAGAACAATGACCTGC 
Nom1 Rv AGATGCGAAGCCGAGTCTCAGA 
ChIP qPCR primers 
tNE Fw CAAGAAAACATGGGTCTAGGG 
tNE Rv TGAATTGGAACATTTCTTCAGG 
Actin Fw CCTCGATGCTGACCCTCATCC  
Actin Rv GACACTGCCCCATTCAATGTCTC  
 
Table 19 Primers sets for qRT-PCR 
 





The real-time thermal cycler was programmed as follows: 15 min Hotstart; 44 PCR cycles 
(95°C for 15 s, 55°C for 30 s, 72°C for 30 s). The relative mRNA expression for each primer 
set in each sample was measured by the Lightcycler software and normalized to the mean for 
Gapdh from at least 2 biological replicates and technical triplicates. Finally, the log2 of the 
ratio relative to eGFP transfected ESCs was calculated when mentioned. 
8.3 Computational analysis of the SBE6 region 
Evolutionary conservation of the SBE6 region was assessed using the “Vertebrate Multiz 
Alignment & Conservation/Multiz Alignments and Conserved elements” tracks in the UCSC 
genome browser (Kent et al., 2002). This delineated the following sub-regions for further 
analysis:  
SBE6.1: Chr5:28889688-28890461, SBE6.2: Chr5: 28893935-28895000 (mm9)  
rVISTA (Loots et al., 2002) was used to align the mouse and human orthologous sequences, 
with the default sequence aligner (LAGAN) and default parameters. Transcription factor 
binding sites (TFBS) for known forebrain TFs (Nord et al., 2015) available on the rVISTA 
server were selected (Arx, Maf, Dlx5, Pbx1, ER81, Six3, Vax1). 
JASPAR (Mathelier et al., 2016) was used independently on the mouse and human core 
sequences, searching for potential neural activity present in the Jaspar Core Vertebrata 
matrices list (DLX6, PBX1, ETV1, Six3, SP8, and VAX1) with the default parameters 
(Relative profile score threshold 80%). Hits were then highlighted on the rVista alignment.  
8.4 Zebrafish enhancer reporter assay 
The putative SBE6.1 and SBE6.2 enhancer were cloned by PCR amplification of the relevant 
fragment and flanking sequence from mouse genomic DNA, using Phusion high fidelity 
polymerase (NEB) and the following primers: 
Sbe6.1 Fw B4 : 
AGGGGAGAACTTTGTATAGAAAAGTTGGCGCGCCCACCTGCTTCTCTGAGGAA 
Sbe6.1 Rv B1R : AGGGGACTGCTTTTTTGTACAAACTTGCTTAGGCCATTGTGCCCAC 
Sbe6.2 Fw B4 : 
AGGGGAGAACTTTGTATAGAAAAGTTGGCGCGCTGAAGTCAAGGGCCTGGTACT 





Sbe6.2 Rv B1R : AGGGGACTGCTTTTTTGTACAAACTTGATCAGCCCTCCAGTTTGACT 
-veCTRLs 
 Sbe6.1 Fw B4 : 
AGGGGAGAACTTTGTATAGAAAAGTTGGCGCGCCGAGTGCAGGTGTTTGTGAA 
Sbe6.1 Rv B1R : AGGGGACTGCTTTTTTGTACAAACTTGCCTCAACACAGCATTGCCAA 
Sbe6.2 Fw B4 : 
AGGGGAGAACTTTGTATAGAAAAGTTGGCGCGCAGAGAGTGAAGATTCCCAGCT 
Sbe6.2 Rv B1R : 
AGGGGACTGCTTTTTTGTACAAACTTGTGAGGCAGTGTCTATCTTTTGAC 
attB4 and attB1r sequences (bold) were included in the PCR primers for use with the 
Gateway recombination cloning system (Invitrogen, 12538120). The amplified fragment was 
first cloned into the Gateway pP4P1r entry vector and sequenced using M13 forward and 
reverse primers for verification. The elements in the pP4P1r vector were combined with a 
pDONR221 construct containing either a Gata2 promoter-eGFP- polyA or a Gata2 promoter 
mCherry- polyA cassette (Bhatia et al., 2015), and recombined into a destination vector with 
a Gateway R4-R2 cassette flanked by Tol2 recombination sites. 
Reporter plasmids were isolated using Qiagen miniprep columns and were further purified 
using a Qiagen PCR purification column (Qiagen), and diluted to 50 ng/µl with 
DNAse/RNAse free water. Tol2 transposase RNA was synthesized from a NotI-linearized 
pCS2-TP plasmid using the SP6 mMessage mMachine kit (Ambion), and similarly diluted to 
50 ng/µl. Equal volumes of the reporter construct(s) and the transposase RNA were mixed 
immediately prior to injections. 1–2 nl of the solution was micro-injected per zebrafish 
(Danio rerio) embryo at the 1- to 2-cell stage for up to 200 embryos. Embryos were screened 
for fluorescence at 1–5 days post-fertilization i.e. 24–120 hpf (hours post fertilization) and 
raised to adulthood by Shipra Bhatia. Germline transmission was identified by mating of 
sexually mature adults to wild-type fish and examining their progeny for fluorescence. F1 
embryos from 3–5 F0 lines showing the best representative expression pattern for each 
construct were selected for confocal imaging. A few positive embryos were also raised to 
adulthood and F1 lines were maintained by outcrossing. A summary of the number of 
independent lines analysed for each construct and their expression sites is included in Table 





2. Imaging of zebrafish reporter transgenic embryos was carried out as previously described 
(Bhatia et al., 2015) 
8.5 Mouse Enhancer LacZ Reporter assay 
For mouse transgenics, the same PCR amplicons were used for the generation of enhancer-
reporter constructs and the generation, the blastocysts injection and the analysis of transgenic 
lines were carried out as previously described (Ravi et al., 2013) injected by the CBS-IGMM 
Operations and Transgenic Facility. The two E11.5 SBE6.1-LacZ embryos were dissected in 
PBS and left in LacZ fix for 1h (1% Formaldehyde, 0.2% glutaraldehyde, 2mM MgCl2, 
5mM EGTA, 0.02% NP40) then washed twice for 5 min with PBS+0.02%NP40 and 
embryos were incubated overnight in the dark at 37°C in the X-gal Staining Solution (5mM 
K3Fe(CH)6, 5mM K4Fe(CH)63H2O, 2mM MgCl2, 0.01% Nadeoxycholate, 0.02% NP40, 0.5 
mg/ml X-gal). Embryos were then fixed with 4% PFA in PBS. 
8.6 Mouse In situ hybridisation  
Mouse in situ hybridisation was performed with DIG-labelled gene-specific antisense probes 
as previously described (Hecksher-Sørensen et al., 1998). The Shh probe was provided by 
Andy McMahon (Echelard et al., 1993). 
8.7 Deletion of SBE6 from the 46c ESC genome. 
46c ESCs deletions were produced using the Crispr/cas9 system. SBE6.1 and SBE6.2 
specific gRNA primers were cloned into the cas9 plasmid pX458 following protocols from 
the Zhang lab (Cong et al., 2013; Ran et al., 2013a, 2013b).  46C ESCs were transfected with 
the resulting plasmids (2.5µg) using Lipofectamine® 2000 Reagent (7µL) (Invitrogen cat. 
N°11668) following the manufacturer’s recommendations as described in (Therizols et al., 
2014). Single transfected cells (96) were sorted based on GFP expression from pX458 after 
48h and cultured for seven days in a 96 well plate. DNA extraction and genotyping were 
performed 7 days after sorting using overnight incubation at 55°C with lysis buffer (10mM 
Tris pH 7.5, 10mM EDTA, 10mM NaCl, 0.5% SDS, 1mg/ml ProteinaseK) followed by 
ethanol precipitation and washes. Genomic DNA was amplified with the following primers:  





SBE6.1 Fw: TTTTGGAAGCTTAAATGCCCAT 
SBE6.1 Rv: CCACCACAAGCACATTCAT 
SBE6.2 Fw: GCCTCCATGAAGTCCAATGG 
SBE6.2 Rv: CCACCCTTGCTACTCAGGAA 
Amplification was done using DreamTaq Green PCR Master Mix (ThermoFisher K1081) 
following the manufacturer’s protocol and PCR products were assessed by agarose gel 
electrophoresis. Amplified products were later sequenced to further confirm homozygote 
deletions. 
 
SBE6.1 Downstream Fw CACCGgtcacattctccgtcattcag 
SBE6.1 Downstream Rv AAACctgaatgacggagaatgtgacC 
SBE6.1  Upstream Fw CACCGgtaggccagattacttgcaag 
SBE6.1 Upstream Rv AAACcttgcaagtaatctggcctacC 
SBE6.2 Downstream Fw CACCGgtctgtttgtagagaccttac 
SBE6.2 Downstream Rv AAACgtaaggtctctacaaacagacC 
SBE6.2 Upstream Fw CACCGgttagacactccagttttgtc 
SBE6.2 Upstream Rv AAACgacaaaactggagtgtctaacC 
 
Table 20 gRNA targeting primers for deletions 
8.8 Crosslinked Chromatin Immunoprecipitation  
Harvested ESCs (5 - 15x106) were fixed in media by the addition of an equal volume of 2% 
methanol-free formaldehyde (Thermo Scientific Pierce PN28906; final concentration of 1%) 
and incubation at RT for 10 min followed by 5 min incubation with 125mM glycine at room 
temperature. Cells were washed in PBS. All buffers were supplemented with the following 
additives just prior to use (0.2 mM PMSF, 1 mM DTT, 1x Protease inhibitors (Calbiochem, 
539134-1SET) and 1x phosphatase inhibitors (Roche, PhosSTOP, 04906837001)). Cell 





pellets were resuspended in lysis buffer 1 (50mM Tris-HCl pH 8.1, 10mM EDTA and 20% 
SDS) and incubated for 10 min at 4°C. Lysates were diluted 1:10 in ChIP dilution buffer 
(0.1% Triton X-100, 2mM EDTA, 150mM NaCl, 20mM and Tris-HCl pH8.1) and sonicated 
using a bioruptor (Diagenode) at 4°C for 15 cycles of 30 sec (30 sec pause between pulses) 
set to high. The sonicated extract was centrifuged at 16000g for 10 min at 4°C and the 
supernatant transferred to a fresh tube and supplemented with BSA and triton X-100 to final 
concentrations of 25µg/ml and 1% respectively. 5% of the chromatin was retained as an 
input reference and the remainder incubated overnight at 4ºC on a rotating wheel with CTCF 
Antibody (Millipore 07-729) pre-coupled to protein G or Sheep Anti-Rat IgG Dynabeads 
respectively (Life Technologies; 10004D and 11035 respectively; 10µgs of antibody bound 
to 40µl of stock dynabeads per IP). Bead-associated immune complexes were washed 
sequentially with wash buffers A, B and C each for 2 x 5 mins at 4ºC on a rotating wheel 
followed by 2 washes in TE buffer at RT (wash buffer A - 1% Triton X-100, 2mM EDTA, 
150mM NaCl, 20mM and Tris-HCl pH8.1; wash buffer B - 1% Triton X-100, 0.1% Sodium-
Deoxycolate, 0.1% SDS, 1mM EDTA, 500mM NaCl, 20mM and Tris-HCl pH8.1; wash 
buffer C – 1% NP40, 0.1% Sodium-Deoxycolate, 1mM EDTA, 250mM LiCl, 20mM and 
Tris-HCl pH8.1). Chromatin was released from the beads by incubation with elution buffer 
(0.1 M NaHCO3 and 1 % SDS) for 15 mins at 37 ºC followed by the addition of RNaseA 
and Tris pH6.8 (final concentration of 20mg/ml and 100mM respectively) and incubation at 
65ºC for 2 hours following by the addition of 50µgs of proteinase K and incubation at 65ºC 
for 8 hours to degrade proteins and reverse the cross-links. Purified DNA was isolated using 
QIAquick PCR Purification Kit (Qiagen). Quantitative PCR was performed on a 
LightCycler480 (Roche) using the LighCycler sybr green master mix (Roche) according to 
manufacturer’s instructions. 
8.9 Native Chromatin Immunoprecipitation  
5x106 nuclei were prepared and resuspended in NB-R (85mM NaCl, 5.5% sucrose, 10mM 
TrisHCl pH7.5, 3mM MgCl2, 1.5mM CaCl2, 0.2mM PMSF, 5mM sodium butyrate, 5µM 
Sirtinol and 1mM DTT added fresh prior to use) as previously described (Gilbert et al. 
2003). Nuclei corresponding to 1x108 cells were digested with 50-80 Boehringer units of 
MNase (Sigma) for 10 min at RT in the presence of 20 µg RNase A to obtain a chromatin 
ladder enriched in tri-, tetra-, and some pentanucleosomes. The reaction was stopped by 





adding equal volume of Stop Buffer (215 mM NaCl, 10 mM TrisHCl pH 8, 20 mM EDTA, 
5.5 % Sucrose, 2 % Triton X-100, 0.2 mM PMSF 1 mM DTT and complete protease 
inhibitor cocktail) and incubated on ice overnight. Between 50-150 µg released chromatin 
were precleared with Protein G Sepharose (GE Healthcare) for 2 hr and mixed with 10 µg 
prebound H3K27me3 antibody (Millipore 07-449), H3K27ac antibody (Millipore 07-360) or 
H3K4me1 (Abcam ab8895) in the presence of 100 µg BSA and incubated for 3 hr at 4 °C. 
Beads were then washed 3x with Wash Buffer (150 mM NaCl, 10 mM TrisHCl pH 8, 2 mM 
EDTA, 1% NP40, 1 % Sodium deoxycholate, 0.2mM PMSF, 1mM DTT and protease 
inhibitor cocktail) and once in TE. Bound complexes were eluted with 0.1 M NaHCO3, 1 % 
SDS at RT. Immunoprecipitated and input DNA were purified with Proteinase K 
(Genaxxon) and QIAGEN PCR purification kit. 
For RNA on chip, chromatin from nuclei was first prepared as for Native Chromatin 
Immunoprecipitation without RNase A and RNA was then extracted using TRIzol® Reagent 
(ThermoFisher 15596026) following manufacturer’s protocol. 250 ng of each sample RNA 
was amplifies using WTA2 Complete Whole Transcriptome Amplification kit (Sigma) 
following manufacturer’s protocol. 
8.10 Nimblegen ChIP-on-chip from Figure Ch2-2 & Ch5-7 
Ten nanograms (optimal) of input or ChIP DNA were amplified using the WGA2 whole 
genome amplification kit (Sigma). Amplified material was labelled with Cy3 or Cy5 by 
random priming according to the NimbleGen ChIP-chip protocol (Roche). In total, 2 or 3 
biological replicates with dye swaps were hybridized for 20 h and washed according to 
manufacturer´s protocol. A custom 3x720K mouse tiling array (NimbleGen, Roche) 
containing 179,493 unique probes from different genomic regions, with each probe 
represented by 4 replicates was used. Arrays were scanned on a NimbleGen MS 200 
Microarray scanner (Roche) using 100% laser power and 2 µm resolution. Raw signal 
intensities were quantified from TIFF images using MS 200 Data Collection software. 
Arrays were scanned on a NimbleGen MS 200 Microarray scanner (Roche) using 100% laser 
power and 2µm resolution. Raw signal intensities were quantified from TIFF images using 
MS 200 Data Collection software. 





Microarray data were analysed in R using the bioconductor packages Beadarray and Limma 
according to the Epigenesys NimbleGen ChIP-on-chip protocol 43. Scale normalization was 
used within replicates, to control inter-array variability. Each condition was represented by 
two biological replicates hybridised as dye swap experiments and enrichment scores are 
defined as log2 ChIP/Input signal. 
 
8.11 Agilent ChIP-on-chip from Figure Ch5-8 & Ch5-9 
One microgram of input or ChIP DNA were amplified using the WGA2 whole genome 
amplification kit (Sigma). All the amplified material was labelled with Cy3 or Cy5 by 
random priming using SureTag DNA Labelling kit according to the Agilent ChIP-chip 
protocol. Samples were hybridized and washed according to manufacturer´s protocol. A 
custom 8x60K mouse tiling array (Agilent Technologies) containing 51,504 probes was 
used. Arrays were scanned on a NimbleGen MS 200 Microarray scanner (Roche) using 
100% laser power and 2 µm resolution. Raw signal intensities were quantified from TIFF 
images using MS 200 Data Collection software and extracted using Agilent Feature 
extraction software. 
For nuclear RNA on chip, median foreground and background signal intensities from 
microararys were read into R using the package Limma (Ritchie et al., 2015). Signals were 
background corrected using normexp method and then quantile normalized to remove 
techincal variation. Only probes whose signal was 10% above 95 percentile of negative 
control probes in at least 1 array were kept for further analysis. ChIP Microarray data were 
analysed in R using the bioconductor packages Beadarray and Limma according to the 
Epigenesys NimbleGen ChIP-on-chip protocol 43. Scale normalization was used within 
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Table 21 Agilent 60K Chip-chip tiling array, genome assembly mm9 
8.12 TALE design and assembly 
TALE DNA binding domains specific to the promoters of Shh, En2, Rbm33, Rnf32 and 
Nom1 and SBE6.1, SBE2, NE sequences were assembled following the methods described 
in (Ding et al., 2013). Briefly, DNA binding domains specific for 15 nucleotide sequences 
were generated by the modular assembly of 4 pre-assembled multimeric TALE repeat 
modules (three 4-mer and one 3-mer) into a modified TALEN backbone in which the 
BamHI-BsrGI fragment containing hFokI2-2A-eGFP was replaced by a gBlocks® (IDT) 
fragment encoding VP64-2A-eGFP. The BamHI-BglII fragment containing VP64 of the 
Tale-Vp64 plasmid was deleted to generate Tale-∆ (Figure Ch8-1).  
The BamHI-NheI fragment containing VP64 was replaced by double strand oligonucleotide 
encoding the Belmont peptide DELQPASIDP peptide (A. E. Carpenter et al, 2005) to 
generate Tale-BP. The BamHI-NheI cloning site was further used to fuse the Tale with the 
SA domain of LDB1 and the VWA domain of Med25 from gBlocks® (IDT) and CTCF, 
SIX3 and PARP1 from GeneArt® (Life Technologies).  
  






Figure Ch8- 1 tShh-Vp64 construct map. 
Exemple of construct used for tShh-Vp64. RVDs sequence recognize 15 nucleotide. 
The Tale fusion can be cut/paste using BamH1 and Nhe1 sites and Tale-Delta can 
be created using BamH1 and BglII that are compatible.  





8.13 Fosmid probes and Nick translation 
Fosmid were minipreped after growing overnight at 37°C in L-broth containing 
chloramphenocol (12.5 µg/ml). Bacteria pellets were resuspended in 200 µl GTE buffer (50 
mM glucose, 25 mM Tris pH8, 10 mM EDTA) containing lyzozyme and mixed vigorously, 
then incubated for 5 minutes at room temperature before adding 400 µl lysis buffer (0.2 M 
NaOH, 1% SDS) mixed by inversion and incubated again on ice for 5 minutes. The reaction 
was then stopped by adding 300 µl acetate buffer (5M potassium acetate 60 ml, Acetic acid 
11,5 ml and Distilled water 28,5 ml) and incubating for 5 minutes on ice. Following 
centrifugation at 12000g for 5 minutes at 4°C, fosmids DNA were recovered by 
phenol:chloroform extraction and resuspended in 25 µl TE. RNase A (1µg) was added and 
incubated for 5 minutes at 37°C.  
Fosmid probes were labelled, Nick translation, as followed, 2 µl Nick translation salts (0.5M 
Tris pH7.5, 0.1 M MgSO4, 1 mM DT, 0.5 mg/ml BSA fraction V (Sigma)) + 2.5 µl 0.5 mM 
dATP + 2.5 µl 0.5 mM dCTP + 2.5 µl 0.5 mM dGTP + 2.5 µl bio-16-dUTP (Roche) or 1.5 
µl digoxygenin-11-dUTP + 1 µl 0.5 mM dTTP or Directly labelled with green-dUTP 
(Abbott Molecular 02N32-050, 00884999002913) or red-dUTP (ChromaTide Alexa Fluor 
594-5-dUTP C11400) + 6 µl miniprep DNA (0.5-1 µg) + 1 µl DNase I (1:500) (Invitrogen) 
+ 1 µl DNA polymerase I (Invitrogen). The mix was incubated for 90 minutes at 16°C. The 
reaction was stopped by adding 3 µl EDTA and 2µl 20% SDS, then 65 µl TE was added 
before purifying through a Quick spin column (Pharmacia).  
Fosmid Probes 
 Coordinates  
 Whitehead 
(Sanger)  
target chr start end 
length 
(bp) fosmid ID clone 
Dpp6 chr5 27932527 27975636 43109 G135P600264D6  
WI1-
1085J14  
CTRL chr5 28411516 28449628 38112 G135P60453C9 
WI1-
2806K8 
Shh chr5 28754458 28795879 41421 G135P64333A4 
WI1-
574O18 
SBE6 chr5 28887686 28924744 37059 G135P67311F4  
WI1-
442E17 
SBE4 chr5 29107140 29147593 40453 G135P600205H10  
WI1-
2751A06 





SBE2/3 chr5 29195832 29239355 43523 G135P603171G8 
WI1-
1275C09 




Table 22 Fosmid probes used for 3D-FISH.  
8.14 2D-FISH 
10-15x106 cells were swollen in 0.5% trisodium citrate/0.25% KCl followed by fixation and 
3 washes in methanol acetic acid (MAA – 3:1 vol/vol). Slides were incubated in 100 µg/ml 
RNase A in 2 x SCC for 1 hour, washed in 2 x SCC and dehydrated through an alcohol 
series. Slides were denatured in 70% formamide/2 x SCC for 75 s at 70°C. Between 80-120 
ng of biotin- and digoxigenin-labeled fosmid probes were used per slide, with 8-12 µg of 
mouse Cot1 DNA (Invitrogen) and 10 µg salmon sperm DNA. Probes were denatured at 
70°C for 5 minutes, reannealed with Cot1 DNA for 15 minutes at 37°C and hybridized to the 
denatured slides overnight at 37°C. Slides were washed 4 x 3 minutes in 2X SSC at 45°C, 4 
x 3 minutes in 0.1X SSC at 60°C and transferred to 4X SCC, 0.1% Tween 20. Slides were 
counterstained in 0.5 µg/ml DAPI. The BAC used to highlight Shh regulatory region is 
RP24-323C22 coordinates chr5:28,832,721-29,003,817 in mm9 
8.15 3D-FISH 
1x106 ESCs or NPCs were seeded on slides for 5h. Cells were fixed in 4% PFA for 10 
minutes at room temperature and then permeabilized using 0,5% Triton X for 10 minutes. 
Approximately 150 ng of labelled fosmid probes were used per slide, together with 15 µg of 
mouse Cot1 DNA (GIBCO BRL) and 10 µg salmon sperm DNA. Probes were denatured at 
70°C for 5 min, reannealed with CotI DNA for 15 min at 37°C and hybridized to the 
denatured slides overnight. DNA was denatured at 80°C for 20 minutes. For dig- or biotin- 
labelled probes, the last 4X SCC, 0.1% Tween 20 incubation was followed by an extra 5 
minutes incubation with blocking buffer (4X SCC, 5% Marvel) and biotinylated probes were 
detected using fluorochrome-conjugated avidin (FITC or Texas Red) (Vector Laboratories) 
then biotinylated antiavidin (Vector Laboratories) followed by fluorochrome-conjugated 





avidin. Digoxigenin-labeled probes were detected using FITC-conjugated antidigoxigenin 
(Vector Laboratories) followed by FITCconjugated anti-sheep (Vector Laboratories). 
8.16 Image Capture and Analysis 
For 2D FISH, slides were imaged using a Hamamatsu Orca AG CCD camera (Hamamatsu 
Photonics (UK) Ltd, Welwyn Garden City, UK) and a Zeiss Axioplan II fluorescence 
microscope with Plan-neofluar objectives, a 100W Hg source (Carl Zeiss, Welwyn Garden 
City, UK) and Chroma #83000 triple band pass filter set (Chroma Technology Corp., 
Rockingham, VT) with the excitation filters installed in a motorised filter wheel (Prior 
Scientific Instruments, Cambridge, UK). 
3D-FISH slides were first imaged with a Hamamatsu Orca AG CCD camera (Hamamatsu 
Photonics), Zeiss Axioplan II fluorescence microscope with Plan Apochromat objectives, a 
Lumen 200 W metal halide light source (Prior Scientific Instruments) and Chroma 
#89014ET single excitation and emission filters (Chroma Technology Corp.). Images were 
deconvolved using a calculated PSF with the constrained iterative algorithm of Volocity 
(PerkinElmer).  
Super-resolution images were acquired using structured illumination microscopy following 
published protocol (Gustafsson et al., 2008). Samples were prepared on high precision cover-
glass (Zeiss, Germany). 3D SIM images were acquired on a N-SIM (Nikon Instruments, UK) 
using a 100x 1.49NA lens and refractive index matched immersion oil (Nikon Instruments). 
Samples were imaged using a Nikon Plan Apo TIRF objective (NA 1.49, oil immersion) and 
an Andor DU-897X- 5254 camera using 405, 488, 561 and 640nm laser lines. Z-step size for 
Z stacks was set to 0.120 um as required by manufacturers software. For each focal plane, 15 
images (5 phases, 3 angles) were captured with the NIS-Elements software. SIM image 
processing, reconstruction and analysis were carried out using the N-SIM module of the 
NIS-Element Advanced Research software. Images were reconstructed using NiS Elements 
software (Nikon Instruments) from a z stack comprising of no less than 1um of optical 
sections. In all SIM image reconstructions the Wiener and Apodization filter parameters 
were kept constant.  





Image analysis was carried out using the Quantitation module of Volocity (PerkinElmer). 
Reconstructed SIM data was directly uploaded an analyzed on Volocity. The statistical 
significance of differences in mean-squared interprobe distances was assessed using the 
nonparametric Mann-Whitney U test to examine the null hypothesis. Each data set consisted 
of 20 to 50 nuclei (40 to 100 loci). Biological replicates are shown under their p-values. 
The data analysis is done using Volocity, widefield images were deconvolved using point 
spread function (PSF) set up for the 3D-widefield microscope. Reconstructed SIM data was 
directly uploaded an analyzed on Volocity. 
8.17 Single Cell qRT-PCR 
RNA reverse transcription and cDNA pre-amplification from single cells were performed as 
previously described (Dalerba et al. 2011) with some modifications. Each well of a 96-well 
PCR plate was loaded with 5 µl 2X Reaction Mix, 0.2 µl Superscript III RT/Platinum Taq 
Mix (with RNaseOUT Ribonuclease Inhibitor) (Invitrogen Cells Direct One-Step qRT-PCR 
kit, Life Technologies), 2.5 µl primer mix (containing 200 nM of each gene-specific primer), 
1.3 µl H2O. Single-cell suspensions from transfection or NPC differentiation were sorted 
using their GFP reporter into separate wells of the 96-well PCR plate. 32 cells were sorted 
into one well, to be used for serial dilution for generation of qRT-PCR standard curves. RNA 
reverse transcription and 22 cycles of cDNA pre-amplification were performed as previously 
described (Dalerba et al. 2011). The cDNA was diluted 1:5 in H2O and qRT-PCR were 
performed as above using 9 µl of this diluted cDNA. 
8.18 Chromatin nicking with bleomycin 
1x106 Cells in six-well plates (for DNA extraction) or on slides (for FISH analysis) were 
treated with bleomycin (300 µM) for 10 min (Naughton et al., 2013). Slides were then 
washed and fixed with 4%PFA to proceed to the FISH. For DNA extraction cells were lysed 
in 150 mM NaCl, 1% SDS, 10 mM EDTA and incubated for 1 h at 55 °C with 100 µg 
ml−1 proteinase K. DNA was purified by phenol-chloroform extraction and recovered by 
ethanol precipitation. DNA was suspended in 50 mM NaOH, 1 mM EDTA, 3% Ficoll, 
0.02% bromocresol green and 0.04% xylene cyanol and fractionated on a 0.7% agarose gel 





in 50 mM NaOH, 1 mM EDTA at 2 V cm−1 with buffer circulation for 20 h. The gel was 
stained with ethidium bromide in 1× TAE and imaged on a FLA5100 laser scanner (Fuji). 
8.19 3C library preparation 
Cells were fixed with 1% formaldehyde for 10 min at room temperature. Cross-linking was 
stopped with 125 mM glycine for 5 min at room temperature followed by 15 min on ice. 
Cells were centrifuged at 400g for 10 min at 4°C, supernatants were removed, and cell 
pellets were flash-frozen on dry ice. 
Cell pellets were treated as previously described (Dostie and Dekker, 2007; Ferraiuolo et al. 
2010). Briefly, 10-15x106 fixed cells were incubated for 15 min on ice in 200 µL of lysis 
buffer (10 mM Tris at pH 8.0, 10 mM NaCl, 0.2% NP40, supplemented with fresh protease 
inhibitor cocktail). Cells were then disrupted on ice with a dounce homogenizer (pestle B; 2 
× 20 strokes); cell suspensions were transferred to Eppendorf tubes and centrifuged at 
2000g for 5 min. Supernatants were removed, the cell pellets were washed twice with 100 
µL of 1× EcoRI buffer (New England Biolabs), and the cell pellet was resuspended in 100 
µL of 1× EcoRI buffer and divided into two Eppendorf tubes. We added 1× EcoRI buffer 
(337 µL) to each tube, and the mixture was incubated for 10 min at 65°C with 0.1% SDS. 
Forty-four microliters of 10% Triton X-100 was added before overnight digestion with 400 
U of HindIII. The restriction enzyme was then inactivated by adding 86 µL of 10% SDS and 
incubation for 30 min at 65°C. Samples were then individually diluted into 7.62 mL of 
ligation mix (750 µL of 10% Triton X-100, 750 µL of 10× ligation buffer, 80 µL of 10 
mg/mL of BSA, 80 µL of 100 mM ATP, 3000 cohesive end units of T4 DNA ligase) and 
incubated at for 2 h 16°C. 
3C libraries were incubated overnight at 65°C with 50 µL of Proteinase K (10 mg/mL) and 
an additional 50 µL of Proteinase K the following day for 2 h. The DNA was purified by one 
phenol and one phenol–chloroform extraction and precipitated with 0.1 vol (800 µL) of 3 M 
NaOAc (pH 5.2) and 2.5 vol of cold EtOH (20 mL). After at least 1 h at −80°C, the DNA 
was centrifuged at 20,000g for 25 min at 4°C, and the pellets were washed with cold 70% 
EtOH. DNA was resuspended in 400 µL of TE (pH 8.0) and transferred to Eppendorf tubes 
for another phenol–chloroform extraction and precipitation with 40 µL of 3 M NaOAc (pH 
5.2) and 1.1 mL of cold EtOH. DNA was recovered by centrifugation and washed eight 





times with cold 70% EtOH. Pellets were then dissolved in 100 µL of TE (pH 8.0) and 
incubated with1 µL of 10 mg/mL RNase A for 15 min at 37°C. 
8.20 5C primer and library design 
5C primers covering the USP22 (mm9, chr11: 60,917,307–61,017,307) and Shh (mm9, chr5: 
28317087-30005000) regions were designed using my5C.primer (Lajoie et al. 2009) and the 
following parameters: optimal primer length of 30 nucleotides (nt), optimal TM of 65°C, and 
default primer quality parameters (mer: 800, U-blast: 3, S-blasr: 50). Primers were not 
designed for large (>20-kb) and small (<100-bp) restriction fragments, low-complexity and 
repetitive sequences, or when there were sequence matches to more than one genomic target. 
TheUSP22 regions was used to assess the success of each 5C experiment but was not used 
for further data normalization or quantification. 
The universal A-key (CCATCTCATCCCTGCGTGTCTCCGACTCAG-[5C-specific]) and 
the P1-key tails ([5C-specific]-ATCACCGACTGCCCATAGAGAGG) were added to the 
forward and reverse 5C primers, respectively. Reverse 5C primers were phosphorylated at 
their 5′ ends.  
8.21 5C library preparation 
5C libraries were prepared and amplified with the A-key and P1-key primers as described 
previously (Fraser et al. 2012). Briefly, 3C libraries were first titrated by PCR for quality 
control (single band, absence of primer dimers, etc.) and to verify that contacts were 
amplified at frequencies similar to that usually obtained from comparable libraries (same 
DNA amount from the same species and karyotype) (Dostie and Dekker 2007, Fraser et al. 
2010). In general, we used 1–11 µg of 3C library per 5C ligation reaction. 
5C primer stocks (20 µM) were diluted individually in water on ice and mixed to a final 
concentration of 0.002 µM. Mixed diluted primers (1.7 µL) were combined with 1 µL of 
annealing buffer (10× NEBuffer 4 [New England Biolabs]) on ice in reaction tubes. Salmon 
testis DNA (1.5 µg) was added to each tube, followed by the 3C libraries and water to a final 
volume of 10 µL. Samples were denatured for 5 min at 95°C and annealed for 16 h at 48°C. 
Ligation with 10 U of Taq DNA ligase was performed for 1 h at 48°C. One-tenth (3 µL) of 





each ligation was then PCR-amplified individually with primers against the A-key and P1-
key primer tails. We used 26 or 28 cycles based on dilution series showing linear PCR 
amplification within that cycle range. The products from two to four PCR reactions were 
pooled before purifying the DNA on MinElute columns (Qiagen). 
5C libraries were quantified on agarose gels and diluted to 0.0534 ng/µL (for Xpress 
template kit version 2.0) or 0.0216 ng/µL (for ion PGM template OT2 200 kit). One 
microliter of diluted 5C library was used for sequencing with an ion PGM sequencer. 
Samples were sequenced onto ion 318 chips following either the ion Xpress template kit 
version 2.0 and ion sequencing kit version 2.0 protocols or the ion PGM template OT2 200 
kit and ion PGM sequencing 200 kit version 2.0 protocols as recommended by the 
manufacturer (Life Technologies). 
8.22 5C data analysis 
Analysis of the 5C sequencing data was performed as described earlier (Berlivet et al. 2013). 
The sequencing data were processed through a Torrent 5C data transformation pipeline on 
Galaxy (https://main.g2.bx.psu.edu). Data were normalized by dividing the number of reads 
of each 5C contact by the total number of reads from the corresponding sequence run. All 




of reads  
Number of 
Interactions 
Number of used 
normalized reads  
ESC biological replicate 1 45024284  116,281   1,950  
ESC biological replicate 2 42947512 116,281 1,924 
NPC biological replicate 1-technical replicate 1 92081330   
NPC biological replicate 1-technical replicate 2 2079276   
NPC biological replicate 1-Average   116,281   1,879  
NPC biological replicate 2-technical replicate 1 3984330   
NPC biological replicate 2-technical replicate 2 20101490   
NPC biological replicate 2-Average   116,281   1,877  





tSBE6-Vp64 biological replicate 1 90452930  116,281   1,954  
tSBE2-Vp64 biological replicate 1 1.01E+08 116,281   1,909 
 
tSBE6+tSBE2-Vp64 biological replicate 1-technical 
replicate 1 68323948   
tSBE6+tSBE2-Vp64 biological replicate 1-technical 
replicate 2 79792180   
tSBE6+tSBE2-Vp64 biological replicate 1 Average   116,281   1,926  
 
tSBE6+tSBE2-Vp64 biological replicate 2-technical 
replicate 1 19389432   
tSBE6+tSBE2-Vp64 biological replicate 2-technical 
replicate 2 24309904   
tSBE6+tSBE2-Vp64 biological replicate 2 Average   116,281   1,864  
 
Table 23 5C sequencing technical and biological replicates reads. 
 
  















Score Relative score predicted site sequence 
MA0761.1 ETV1 5.396 0.81765789 AGCGTATGTG 
MA0761.1 ETV1 5.299 0.81582659 GAAGGAAATA 
MA0882.1 DLX6 6.97 0.89451043 CCAATTTT 
MA0722.1 VAX1 4.727 0.81707625 CCAATTTT 
MA0747.1 SP8 7.728 0.82568109 CCCAGCCCCACC 
MA0722.1 VAX1 4.376 0.80711244 TTCAATAC 
MA0747.1 SP8 6.661 0.80585165 GACATCCCCCGT 
MA0761.1 ETV1 6.509 0.8386707 GCCGGACACA 
MA0761.1 ETV1 6.995 0.8478461 TGCGGAAGGG 
MA0747.1 SP8 9.489 0.85840802 ACAACGCCCTCC 
MA0722.1 VAX1 4.936 0.82300912 CAAATAAC 
MA0882.1 DLX6 3.671 0.80896883 GCAAATAA 
MA0761.1 ETV1 8.063 0.86800933 AACGGAAGGT 
MA0761.1 ETV1 4.485 0.80045873 GACGGAAAAC 
MA0747.1 SP8 6.4 0.80100116 GCTCCTCCTCCT 
MA0722.1 VAX1 5.21 0.83078713 CTCATGGC 
MA0722.1 VAX1 6.426 0.86530564 CAAATGAT 
MA0747.1 SP8 6.635 0.80536846 ACAAAGCCCGCT 





MA0631.1 Six3 12.164 0.83658066 AAAAGGGGATCATAAGC 
MA0722.1 VAX1 5.308 0.83356905 CTTATGAT 
 







predicted site sequence 
MA0747.1 SP8 7.953 0.82986255 ACCCCACCCAGA 
MA0747.1 SP8 7.145 0.81484645 CCCACCCCACCC 
MA0747.1 SP8 8.476 0.83958214 GCCCACCCCACC 
MA0747.1 SP8 6.641 0.80547997 GCCACCTCTCCT 
MA0882.1 DLX6 6.926 0.89336953 GCAATTTC 
MA0722.1 VAX1 4.386 0.80739631 CCCATGAT 
MA0882.1 DLX6 3.763 0.81135435 GACATTAT 
MA0882.1 DLX6 5.218 0.84908185 CCAATAAT 
MA0722.1 VAX1 5.064 0.82664264 CCAATAAT 
MA0722.1 VAX1 5 0.82482588 CCAATGGT 
MA0722.1 VAX1 4.873 0.82122074 CAAATGGC 
MA0882.1 DLX6 6.534 0.88320515 GCAATTTT 
MA0882.1 DLX6 5.186 0.84825211 ACAATGAA 
MA0722.1 VAX1 6.058 0.85485925 TTCATTGT 
MA0722.1 VAX1 4.537 0.81168273 CTCAATAC 





MA0882.1 DLX6 3.514 0.80489789 CTCATCAC 
MA0722.1 VAX1 4.642 0.81466336 CTCATCAC 
MA0747.1 SP8 8.445 0.83900602 CCCCAGCCCACA 
MA0761.1 ETV1 4.574 0.802139 AACGGCAGCA 
MA0747.1 SP8 7.937 0.82956521 CCCACACCCTCA 
MA0747.1 SP8 6.723 0.80700388 AACCCTCCCCAA 
MA0747.1 SP8 6.402 0.80103832 ACCAACCCTCCC 
MA0761.1 ETV1 6.107 0.83108117 CCCGGATGAC 
MA0761.1 ETV1 9.018 0.88603919 TGCGGAAGTC 
Table S 1 Jaspar scores for forebrain TFBS in SBE6.1 and SBE6.2 in human. 
  





 Type Genomic sequence (5' to 3') 
HindIII HindIII  
position position 




    
3 R CTTCCAGTATTGGGTTACAGTTAATGGAGT 28317087 28319149 
5 F AGCATAGAGTGTGTGTAGGTGCTGCCTAAG 28319935 28324734 
7 R CTTTCTCTCATCCCTACACTAACCAGGCCT 28325862 28331585 
8 F GGTAAGAGTCCCAAAGAACAGCTTGTTAAG 28331586 28333893 
9 R CTTGACACACCTACCCTCTAAGTAATCAAT 28333894 28336649 
10 F AACACCTCTAGCATGATAGCACTTTGCAAG 28336650 28340960 
11 R CTTAGGATGTGCCTCTACTGTGGGGG 28340961 28344675 
12 F CAAAACCCTAGAAGCCACAGGGACCAAG 28344676 28347365 
13 R CTTGCCAGTTTATCTAGGTAGCCTGCCAG 28347366 28348911 
18 F GGAGACCCACACTAAGGGCCTCAAG 28355883 28370234 
19 R CTTGGATTGGCGTGGCTCTGAGTCAT 28370235 28373716 
20 F TGTGTTTTAGGGATGAGGGATTCTTTAAAG 28373717 28374948 
25 R CTTCCTTTCTGGTATCTATTGACCTTCCCT 28385728 28388130 
27 F TTTGATAGTGCTGTTTCCTGTGGCTAGAAG 28388373 28403099 
30 R CTTCTCCTGTAAGATGGCAATTTATTTATT 28416843 28419608 
31 F TTCTAAATATAATCCAGAGAGAAGGCTAAG 28419609 28428926 
32 R CTTTGTCATTCCACCATGGTTGTGGTGAAC 28428927 28447705 
34 F CAATAAAGGTAGAACTTGGGCCCAGTGAAG 28452395 28454456 
35 R CTTGAGCTCACATATGGGACACTCTTGACA 28454457 28458325 
38 F ATGGGGCCGGATTTAACTCAACAATCAAAG 28463308 28463573 
41 R CTTCTCTAGCTAGGCCAGCATAATGTACCG 28469222 28469868 
42 F AAAAATAAAAAGGAGGCCTGGATTCTGAAG 28469869 28470959 
44 R CTTAGCTCAAAATGTAGGAAATGGCCATTC 28476584 28484052 
45 F AAAATCTCCCTGGAGTCAAAGGGTTAAAAG 28484053 28486216 
46 R CTTGTGAACAGTCCCACCAGGTCACTG 28486217 28491939 
47 F CCACCCCCAGTATCTGCAACCTCAAG 28491940 28496579 





49 R CTTAAGGTGGGGGTGACACAGTCCAAAG 28504618 28506235 
50 F GCAAGAGCCCACCAGGGTCAAG 28506236 28509301 
52 R CTTCAGTTTGGGTGACACATGCAGGACAAA 28509323 28510999 
53 F GTGATGTCTCCCCTGTGAGCAGGAAG 28511000 28511814 
56 R CTTATCCTCTTCTGTGTCTAGTTGAAGTGG 28511842 28514356 
57 F TTCTCATGTCAAGATCCACATAATATCAAG 28514357 28515715 
58 R CTTGTTGAGCTCATGTAAATGCCTATGGAT 28515716 28528247 
59 F TTACATATCAGCTGCTGTATCCATCACAAG 28528248 28532168 
61 R CTTGAAAAGCACAGATAAAAATGCCATTTG 28534318 28537153 
62 F CACAGGGCTCTTTCATAGCCTAAGAACAAG 28537154 28541461 
63 R CTTCCTTGGGCAAGTGGTATCTTCCTTAGC 28541462 28542832 
64 F CACAGTCACCCCCTGTACCCCAAAG 28542833 28543234 
65 R CTTTGACAAAGTGATGCATCTAAGATCCTA 28543235 28543365 
68 F GGTACTTCTACAGTGGGGGAGGATGTAAAG 28547549 28547729 
69 R CTTCTCATATGACTCTGGTTTCTTGGCCCA 28547730 28548357 
73 F TCTATGTATAAGCCACACCAAGGAAAGAAG 28559901 28566954 
74 R CTTAGCATGGGACTCAGAAAACAAAATAGG 28566955 28570463 
75 F TGGCAAATCAGAAAAACTCTTTGGATTAAG 28570464 28571000 
76 R CTTGAAATTGAAGTATCTCTCTCAGCACCT 28571001 28572084 
77 F GAGTTCAAGAGCCCCCAAATCCCTCTAAG 28572085 28576299 
78 R CTTCCAGAAGATCTGCAGCAACTCTCTCTC 28576300 28577015 
79 F GGAGGCAGAGCCTCTGAGTCACAAG 28577016 28580658 
80 R CTTGAAGCATGTGTGGACTCCCATTCTTCT 28580659 28581218 
81 F CTCCAGACTGAGACCTTCCTGAGACCAAAG 28581219 28585322 
83 R CTTGCGGTTGTAGCTAAGAGTGAATTTGAA 28585390 28593411 
84 F GGAAAGGTACTCTGGGGTGCATCACAAAG 28593412 28595934 
86 R CTTTGGGGTGGGAACAAGGAGACTTCAC 28604862 28605362 
90 F GACCTGACACCTTTGGGATGAAAGTGTAAG 28611343 28619284 
92 R CTTGACAGAGGAGCCTAAAAGGTGACTTAA 28619329 28620319 
93 F ATTGGCTATGTAGATGAAGATGGTCCCAAG 28620320 28627997 
94 R CTTTCATTGAGACACTCCCTCAGCCTCAGT 28627998 28631580 





95 F CGTGTTACAGTTAGCTACACCCTCAAAAAG 28631581 28635856 
96 R CTTAGCAGTTTCTGTAAAAAATAAAAGTAC 28635857 28638808 
97 F GTAGCGTTCGCGCGCCTCAAG 28638809 28643392 
98 R CTTGTGCAGTACTAAATCATAATGCCATAA 28643393 28646446 
99 F TAGCATAGGGGTTATGGATGGACTCAAAAG 28646447 28647705 
100 R CTTTAAAAGGTACAATGATAGAAGAAATAG 28647706 28650692 
101 F TGAGTTTTCAGTAACCACTATAAAAAGAAG 28650693 28651422 
102 R CTTCCTATGGCTGAGAACTGCTTAGATAAT 28651423 28652423 
103 F GCTGATTCCTTTGCTGACTGGAGTGTGAAG 28652424 28656081 
106 R CTTTTGGTTGTTTCAACCATTTTTCACTTA 28662072 28668894 
107 F GTCTTCTTATCCCTGGGTAAATTGTTAAAG 28668895 28669869 
109 R CTTCCTCTCTCAGGAAACCAGTCTTCTGAG 28676542 28681826 
111 F CAGCATGGCTGTGAGGGAAAGTAGCTAAG 28681874 28682959 
112 R CTTCCAACAGTACATTATCCTAAGCGTCTA 28682960 28684009 
114 F CAATTTCAGTGCCAGCCTCTCTCGGTAAG 28685148 28687114 
115 R CTTACACCAATTAACTTCTTAGAAGTAGAC 28687115 28688407 
117 F CCTGTTTGCACTGTGTCTTCTCACAGGAAG 28689808 28693301 
118 R CTTAAATCACGAAGTACTGAGGCTTACCAA 28693302 28698428 
119 F AAAAGAAAAAGAATCACCATGACTCTTAAG 28698429 28705774 
120 R CTTATTCACAGGCCATTCTGGTAGGAACAT 28705775 28710085 
121 F CATGGTAACATCGTGTGTAGATAGAAAAAG 28710086 28710865 
122 R CTTATGTGGAGAACTAACACCATCATAAAT 28710866 28715944 
123 F AACTTTGTGGCACCTTTCTCCTCCAGAAAG 28715945 28717043 
124 R CTTTACCACTGCGGAAGGGGGAAAACA 28717044 28718937 
128 F CCTTCTGTGTGATCATCTGACACATAAAAG 28723250 28724961 
129 R CTTATACTGGGTGGAGGTCAATTCTGGACT 28724962 28731808 
130 F GTTGCAGACTGAGGGGCTCCAGAAG 28731809 28735435 
131 R CTTTAACCTGGCTCTGCTCTCAGAATGAGG 28735436 28738817 
132 F ATTTTCTTGTGGCATTATTAGGCAGGTAAG 28738818 28743466 
133 R CTTTAATGTTCTGGTTTGTTGTTGTTCTAA 28743467 28748045 
134 F CCTGCAGTCAGGGAACCGAGAGAAG 28748046 28750565 





139 R CTTTTATGTGGCTCTGCTTTTGTATTACAA 28759100 28763978 
140 F ATATTTGGATGTTCTGTCAGTGGCCTGAAG 28763979 28767078 
143 R CTTGTTCCCCGTACCCACATAAAAGGCC 28770697 28780563 
144 F CCAGAGACCCCTCCATCTGCTCAAAG 28780564 28782634 
145 R CTTTTCCCTCACCCCATTGAAAGAAGGGAG 28782635 28789524 
147 F CATCTGATTGGCCAAGCCGCACAAG 28789547 28793709 
149 R CTTACTACCAGTCCTTTGCTCTGTCTAATA 28794058 28797606 
151 R CTTGGCTAACATTGGACAACCCAAGTGTTT 28798546 28799298 
152 F TAGAAAAGATGCTGGGAACCTCATTCTAAG 28799299 28801546 
154 R CTTCTGGACACCCAGAAATGTGCGTCTC 28805019 28805807 
155 F GTGGAGCCATCATGGAAATTGCATGGAAG 28805808 28806894 
158 R CTTCTCCTAAGAACAGCTAGACCTATGCAC 28821671 28827662 
162 F AGAACCACAGGATACCCATAAGAGCCAAAG 28837190 28843289 
163 R CTTCAAAGCTGCAGTGCTTTGAAGTGTCTG 28843290 28847606 
168 F ATATCTACACCAGCTTTCTAAAATGGAAAG 28870608 28876511 
169 R CTTTATTGCCAGGTCAAATGATTTAAACAT 28876512 28878134 
170 F CTGTGATCTGAAGGTGTAAGCTGAGATAAG 28878135 28878784 
171 R CTTTGAAGGAGACCCTATTTCCTATGTGGG 28878785 28879286 
173 F GGTGTGCAGCCAGTGTGCATATTAGACAAG 28879305 28880400 
174 R CTTTATTCACCTCTGACATGCAAGCCAACA 28880401 28880839 
176 F GGCTGCAAAAGTTGGGTCTCATTTGTGAAG 28882358 28883821 
177 R CTTTGGAAGGCTGGGTGGTCAGC 28883822 28884803 
178 F CTTGGGTAAAGCTATACTGGATGCGGCAAG 28884804 28887360 
179 R CTTCCAAAATTCTATTTTGGGAAAAAATGA 28887361 28889232 
180 F TTACCTAGGTAACTGCTGCCCTTTCAGAAG 28889233 28895175 
181 R CTTCCAGAAACTGTTTACTTCCTTCTGGAG 28895176 28899338 
191 F TTGTTATTCCTGGGAGACTTAATTGGCAAG 28923745 28923931 
193 R CTTCCAGGTCACGTTAAAGATATTTCAGTA 28925837 28929215 
197 F CCACAACCTGCCCCTACGGTGTAAAG 28942022 28945936 
198 R CTTAGAAGGACCCTAGAATGGTCCCCTGAA 28945937 28949569 
199 F GGTATGGGATATCCTTTGGGGTTCACTAAG 28949570 28950647 





200 R CTTTGAATGAGGTCAATAAAAATCTACCTC 28950648 28951388 
201 F CTTCACTCCCTCAGTTACCAAGCCACAAAG 28951389 28952477 
204 F CAGGATGCCTTAGGAGACACGAGGAAG 28954090 28954407 
207 R CTTTTCAAAAAGCCACATGAAAATCTACTA 28971638 28978794 
212 F CAGGCACCTAAGTGTTAGAGAAGTTGGAAG 28997868 29000514 
213 R CTTATGAGTGCAAGGTCTGCCCAGGTTG 29000515 29003765 
214 F TACAAGTCTCATCTGAGCCCTCCAAAAAAG 29003766 29004021 
215 R CTTAGTTGTTCCTTCAGTGTCAGTTACTTC 29004022 29005070 
216 F GATGGGTCTTTCAGAGTCTGTTCCCTGAAG 29005071 29006498 
217 R CTTTTATTAAAAGGCCATGGGGCCATGGAG 29006499 29008669 
218 F TGTTCACCAAAATTTATTCTAAAAGGCAAG 29008670 29011994 
219 R CTTCTAATGAACCTGCTCCTGACCGCATG 29011995 29013866 
220 F CAAGATTACCCTGAAGTGCCGGTACAGAAG 29013867 29014066 
221 R CTTCAGGAGTCTAACTGCAATAATAATGCA 29014067 29020057 
222 F GCTCTGTGTGTCCTTCAGCTCTCTGAAG 29020058 29022523 
223 R CTTTGCTGTTGGTCAAAGGTAGCAGCTGA 29022524 29028120 
224 F AGCAGGCTTCCTCCTAGGATTATAATGAAG 29028121 29029629 
225 R CTTCGGGCCCCGGAGGGAGG 29029630 29032468 
226 F CTGAGTCTCAAGCAGCTAGCTTTCAGAAAG 29032469 29038542 
227 R CTTTTGAGAGGTGTGAGACAATCAAAATAA 29038543 29039555 
230 F CTTCCCAGGCTTTGAAGGGAACACACTAAG 29048476 29050003 
231 R CTTCAATTTGTGAGCCTCTACAAAACCTCA 29050004 29051239 
232 F GGTCCACTGGCAGCCCAAGAAG 29051240 29058423 
233 R CTTCCTTTTCATCTTGAATCAGCCTATAGA 29058424 29060961 
234 F AGTGTTTAGGGTTCTAAGGACATGGCAAAG 29060962 29068732 
237 R CTTTCTCCCAGTGATGCTGTTAGTTGTTCC 29078836 29081207 
238 F AGTTTCCTTGAAAATCATGGCCCAGCAAAG 29081208 29082327 
239 R CTTGCAATACTTCCAAGAGAAAGAGAACAC 29082328 29083134 
241 F TCACACACCTGGCAGCTGGACAAG 29084039 29096781 
242 R CTTTCAATTACTGCTCTAGCACAATGCCTG 29096782 29100883 
243 F AAGATAAAAACCTTCCATCTTAGAACAAAG 29100884 29101246 





244 R CTTGAAAAGAGGAATATTCGGGAATGGAGG 29101247 29109459 
245 F TAGGAAAAGGGACTTAATTTGTCATCAAAG 29109460 29111881 
246 R CTTAGATCTGGTGGTAGAAGGGATACTGGA 29111882 29113252 
247 F CGTATAGACTTAAATGAATTAGAACAAAAG 29113253 29117196 
248 R CTTTGCTGTCTGCTCAGAGGAGAACTCTGT 29117197 29119739 
251 F AGAAGGATTGTTTTATTCCTGTCCTTAAAG 29130489 29131877 
252 R CTTAGGCCATGAAGGAAGATGGCTTTGACA 29131878 29136802 
254 F GTTTTTTTCTGGCACAAGCTACCACTTAAG 29137043 29154044 
255 R CTTCCAATGATCCTCTCTGCTCCAATGAAA 29154045 29155707 
256 F TTTATTCTAACACTTATCCCATCCTGCAAG 29155708 29159386 
258 R CTTGGGGACCATTTAAAATATGTTCTAGAT 29159409 29160128 
259 F CTATATTTATTTAAAGTACAAAAACCTAAG 29160129 29166826 
260 R CTTGCCATGTAAGATGGGATATCTGGCCAG 29166827 29168466 
261 F GCACCGAGACCAGCTTCTGAGATCAAG 29168467 29173627 
262 R CTTATTTATCAAGTACAGTTGCTCAAGTAT 29173628 29173865 
263 F CATTAAACTGTGTTGAACCTATTTATTAAG 29173866 29174415 
264 R CTTGCAGCTCCAGACATTTACCCATCTCTG 29174416 29179395 
265 F TGGCACCTCAAATTGAGACCTTGCTTTAAG 29179396 29180591 
266 R CTTCCTCCTTACCCCGGCTGCTAATC 29180592 29184579 
267 F AGTGTTTCTATTTTTATGCTGAGTCCCAAG 29184580 29185047 
268 R CTTTGATATTACAGTGATGAATTGATATGT 29185048 29185852 
269 F TGAGAACAGTATTTTACTTAATTTGAGAAG 29185853 29188276 
271 R CTTAGACTTCCTTTTAGAACATTCTTGGTT 29188338 29191726 
272 F TTGAAAGCTGATTTCAAACAATGATTAAAG 29191727 29196352 
274 R CTTATCAACAACACCTGCATTTTAAAAGAC 29198345 29199536 
275 F AGCTATCATTTGGTTAAAAACTGTTAGAAG 29199537 29203806 
276 R CTTCATGCTGGCAGACAAAGTAAATTCGGG 29203807 29203920 
278 F GGCACATGCTGGGTCCCAGATAAG 29206157 29209241 
279 R CTTCCTTGTAAATATCTGGAATAGAAAGAG 29209242 29216468 
280 F CATGGGAGGTGTCAAACGGATTGGTGAAG 29216469 29220327 
281 R CTTGGAGATTTCCAGGTCTGCTTCTACATT 29220328 29223230 





283 F GCCACAGTCTGGAAGCACAGATCCAAG 29230618 29233018 
284 R CTTCCATCAGATCTGTGTTGTCCAAGAATC 29233019 29236380 
285 F CCAGGGTCATCTATGTGCATGCTCACAAG 29236381 29237108 
287 R CTTGCTAACACCGTTTGAGGTGGAGATGC 29237129 29240127 
288 F TGTCATCCCTTGTTCTAGTTTGACTCTAAG 29240128 29243266 
289 R CTTCTCCTGGTCATCATCTGGCCAGTATCA 29243267 29246728 
290 F GCGTAGTAAACACGGGGGTTATAAGCTAAG 29246729 29247568 
291 R CTTGGCTACACTGCATTTCCTTGTATTATA 29247569 29250429 
292 F GGGAGCAATTCTTAAGAGTGCTTTTCTAAG 29250430 29250736 
295 R CTTTGAAGATTTCCAAGAGTTCAAACCCAG 29253038 29259186 
296 F CTAGGTTTCTTGGGGAGAAGGGCTATGAAG 29259187 29262463 
297 R CTTGAAAAGTGAAGAGATATCCTACAGAAT 29262464 29264721 
298 F GGAGCAGCCAGTAGCCCCAGAAG 29264722 29268159 
299 R CTTGCTTTGCCATTGGACCCTTGTCAG 29268160 29268267 
300 F TGATGCTATCTCTCTTCAAAGGAGGAGAAG 29268268 29270862 
301 R CTTTAAAGCAACAATATGATATGCATCATC 29270863 29272035 
303 F TGGTAAGAAAATGAAATGTAAGGTACGAAG 29277402 29281527 
304 R CTTCCATCTTTTTTCATTTAGAAGCACCAG 29281528 29287941 
309 F GATGGATCTGGAAGGAGGGACACCAAAAG 29292944 29296257 
313 R CTTTAAATTCCTGCTTGTAAAAATTGTTTT 29305044 29309647 
314 F CCAGCCTGTGATGACAGGTGGTAGAAG 29309648 29310307 
316 F ACCTTTCCTCTTCCTAACTGCCATGCAAAG 29310490 29311401 
317 R CTTGACCTCAGTATTCTGTACTCACTCCCC 29311402 29315522 
319 F GCCCCTGAAGATATAGCACAGTCTTGCAAG 29317749 29319160 
320 R CTTGCACGTCTCCATTCATCTTGACTAAAG 29319161 29319272 
321 F TCAAACCATACAGCTGAATATGGAGAGAAG 29319273 29320195 
324 R CTTAAATCTAATAAGATGAAGGAAAATAAC 29321894 29331157 
325 F CACAGCTCCTGCACATCTGGGGAAG 29331158 29332122 
326 R CTTCCAACACCAAATGTGGTTCAATTACGC 29332123 29347103 
327 F CCATTTAAGGCCTGCCCAGCTCAAG 29347104 29352141 
330 F AGATCTGTGCAACTTTCTTCAAGCCACAAG 29356572 29358986 





331 R CTTGGATGCCTTTGATCCCCTTATAACTTA 29358987 29363174 
342 F TCACCACATGTTGAACTCTGGATGGGAAAG 29384407 29389154 
345 R CTTCTACGTAGTAGATTTTTATATGGAATT 29401642 29402954 
346 F TTTGGTTTGGTTTTCTGGGTTGAGGGGAAG 29402955 29404268 
349 R CTTCCCTCCTGGGAATGCTGTGTGG 29406181 29407971 
350 F AGCCTCCAGCTAAATGCCAACAAATGAAAG 29407972 29411033 
351 R CTTAGGATAGGAAGGAATTAGTGATACAGT 29411034 29411488 
353 F CAAATACAAAAAATCTGCCAAACAACAAAG 29411528 29412802 
354 R CTTGGAAACTGCACCATGGAACTCTCACTT 29412803 29413667 
355 F CCCTCTTCTCTTTCAAAGATGGAAAGTAAG 29413668 29419014 
359 R CTTTCTTGAGAAGGAGTTTTCATTCTAGTA 29425367 29425485 
361 F TTACTTATTTGTGACATGGTATCTAAAAAG 29426352 29436153 
362 R CTTCAGGGGAGTGAAAGAATTAAGATTTCT 29436154 29438524 
366 R CTTGCCCCCACAGGGCAGGC 29454397 29457357 
367 F GACCACATCCTGTCTAAACCCTGCCAAG 29457358 29463943 
370 R CTTTGGTATGAGGTAATAAAAATAATTGAA 29466664 29471070 
371 F CTGGCTGTCCTTTGCCACCAAACAAAG 29471071 29483618 
372 R CTTCGTGGTTGTATGCCTGTAATTGTGTTT 29483619 29486276 
373 F GTTCTTTCAGTGATAGATGAGAAGTGTAAG 29486277 29487932 
375 R CTTTCAAGGTTGCAGGTTACAAAATTATTA 29492359 29495456 
376 F TCAAGGAAGGCTACAAGAGGAGAGGCAAG 29495457 29497960 
378 R CTTTGTGAGGACGTGAGTCCGGCTG 29508039 29514012 
379 F GGATATTGTCTCCAATGGTTATGTTAAAAG 29514013 29518402 
382 R CTTTTGGATGCCATTAGCTAGACCTGAGTT 29519437 29521324 
383 F GTTGGCCTGCTATTAATCTGCTTCTACAAG 29521325 29521533 
385 R CTTAACTTACTTCACTAGATTTACTTCTGG 29527218 29527530 
386 F GTAGGCTTGAGCACTTACCAGCAGTGAAAG 29527531 29527778 
387 R CTTTCTACAAACTGGGAAAACCAGCCTTTG 29527779 29530051 
388 F CAGCTGAGAAGACCCAGCACAAATCCAAG 29530052 29530237 
390 R CTTATGAAGTTTTTCAGTTAAAAGTCACAT 29531243 29534953 
391 F AGAGCCACAGTGAACAATGTCTCTAGCAAG 29534954 29536943 





393 R CTTTTACTGGTTTAATATCCTTCCAGGCTT 29537971 29539101 
394 F CTAAAGGTCTTCTTGAGAGGAGCACTGAAG 29539102 29543893 
395 R CTTTACTTTCTGTCACCTTAAAGGTGAAAA 29543894 29545876 
399 F CAGGCTTCTGCCTGCAGAACCAAG 29555730 29559300 
400 R CTTCTCCTAGCACCAACCTTATGATCCTGG 29559301 29560638 
402 F GGAGTAAATGCTACATGACTGCCTGGGAAG 29560665 29560851 
403 R CTTGGTCTTTAATGTAGGCATGATGGGGTA 29560852 29561928 
404 F TAGTTATCCCGTGAGAAAGGTACACTCAAG 29561929 29563972 
405 R CTTGGCAGTTTGATTAATGCATGCTTAAGC 29563973 29566252 
407 R CTTGGGTACCAGTTGCATAAGCGTGG 29567141 29570404 
408 F GACCTGACACTGTTGATGACATTAACAAAG 29570405 29571012 
409 R CTTCCCAACCAAGGTGGGTGGG 29571013 29574785 
410 F CCTCACAACTTCTTTGTAGCAAGTGATAAG 29574786 29577091 
411 R CTTGCGAACAGAATAAAGGACGCATTTACC 29577092 29577561 
412 F ATTATTTTAATGTAGTTAGTAATTTGAAAG 29577562 29579620 
414 R CTTAGCTTCCATTTGTTGGGAAGAGTGGTG 29582421 29582838 
415 F TATATATACTTATGAACATGTTTGTAAAAG 29582839 29584474 
417 R CTTACTTCAGAATTAGGAAAACACAAAGCA 29584537 29585000 
418 F AGCAAAAGCATTAAGTGTAGCAGTGGAAAG 29585001 29590052 
419 R CTTTCCATTCTGAGTCTAGTGACTTAAAGG 29590053 29595530 
421 F TACCCTTATCAGAATGAAGTGTGCACAAAG 29595576 29595777 
425 R CTTGTCACTGCCCATTACCTGACTGTGC 29606038 29607875 
426 F CTATGGATGTTAACCAATAAGCTACAGAAG 29607876 29613408 
429 R CTTCTTATTGGAAAAATTGAAATTTTTCCT 29622314 29623626 
431 F ACATCCATAAGATTATTTCCGATGATCAAG 29626315 29628597 
432 R CTTCATATCTAACATTTGACTCATTGAGAG 29628598 29629851 
435 F TGCTCTACCATGCGTGAAGGTGATATAAAG 29632212 29635239 
436 R CTTAGAACATTAGGAATCATCACTAACTCT 29635240 29637005 
437 F ATAAATCTAACAAACTAAAAATCAGTCAAG 29637006 29638519 
438 R CTTGCTGCCCTCACCTGTGTTGGTAA 29638520 29640675 
439 F CTCATTTCATTTACCTCACTCCTTTAGAAG 29640676 29641133 





440 R CTTGCTTTTGTTGTAGGGATTTTACTTCCT 29641134 29642803 
441 F CATACAAAAGCCAGTTTTCTCAATGTGAAG 29642804 29649071 
444 R CTTGCCACAGCCTAGTTTGAGCCTTAGG 29652798 29652907 
447 F TTCACATGTAACAAAGCCAAATTTATGAAG 29656939 29658283 
453 R CTTGAGTGAGGCTTTATTTTTAGCATTTGG 29677935 29691941 
457 F GAGCCACTGCAGGGCTGGAAG 29701562 29703903 
458 R CTTCAATAAACAAGTGAGGGCGGGTGCA 29703904 29705290 
459 F ACATTTCTGTTGCAGGGCTATTCATGGAAG 29705291 29706210 
460 R CTTAGAATACTTAGTACTTGGTTTACACCT 29706211 29709705 
461 F GGTAACAAGAATAGCATTGAAAATTCTAAG 29709706 29713030 
463 R CTTGGCACTCTTTCAGGAAAGAAAGGACAG 29713093 29716181 
464 F CACCAGCCACCATCAACTACACAAAGAAG 29716182 29720154 
465 R CTTTGGTGTGTAGTACTTTGGAGTGATAAG 29720155 29727114 
466 F CTGAATTTAGGTGTATGTTTACTCAGTAAG 29727115 29730837 
468 R CTTTGGGGATCCTCTGTAAGTGGTTGCTC 29741658 29748329 
470 F CATAATAAAACTGAAAGGAGATGACCCAAG 29750154 29752052 
472 R CTTTCTCAATTGATTCTGAAAGGGAAAATG 29755324 29755456 
474 F TAGTACTTTAGCTAATGGCATTCACTGAAG 29757662 29764922 
476 R CTTCCTCGTTCCAGATGGGGTCTGG 29766525 29768740 
477 F TGAAATGTCCCACAAAGGATTATCAGGAAG 29768741 29769326 
478 R CTTGAGGTTTTCATATCAACAAGGCTCAGT 29769327 29770690 
479 F GGTGAGCTAGTCAGAGCAGTGCTGAAAAG 29770691 29772235 
481 R CTTGTCTTTGAGAGCCCGGTGCCT 29774284 29777533 
482 F TGGCCATTTTATATCTACTTAGGAGAAAAG 29777534 29781541 
483 R CTTTTTCCAAGTCAGGTTAGTAAAAGCAGA 29781542 29782720 
484 F GACCCCAAGGCACCCAACTTCAAG 29782721 29784642 
487 F TTCTGAGCTCCTGTTTTCCCTCAGAGTAAG 29786563 29787575 
488 R CTTATACCTTTATGACCCATAATGCACAGA 29787576 29797222 
489 F GGTTGGAGAGTTTGGAGGCTGAACACAAG 29797223 29805362 
490 R CTTGATTTCTCAAACTACTTATTGATTCGT 29805363 29806188 
491 F GTTTGTTGTGTAGGGGATGTGATCCAAAAG 29806189 29807449 





492 R CTTTCTAAAAAGGGAGGAAGGAAATCCAAG 29807450 29809879 
493 F ATTTGCCACTCAAAATCTGCACTTTCCAAG 29809880 29815593 
494 R CTTCCCTGCTGTAGGGGAGAGCG 29815594 29816516 
495 F GGAGGGGGGAGGTGGGAACAAG 29816517 29820938 
496 R CTTGATGAAGATCTTGGCATGGCAATGCAC 29820939 29835163 
497 F AAGACTCAGTTATACCAATGGTTCAATAAG 29835164 29835981 
498 R CTTCTTTGCGGAATTCCTAGGACGCTAATG 29835982 29836156 
499 F GGTGCAGGGAAAGTTGATAAGGGCAAAG 29836157 29838218 
500 R CTTGCCGCCAGGAAGCTAATTCCTC 29838219 29839237 
504 R CTTTCAGAAATGGAAGACTTTTTTAATTCT 29844732 29845798 
505 F TTCAGCTTTGTCTTGGTGTGTGGACTAAAG 29845799 29846398 
506 R CTTGAATGAGGAAACATAGGCTGAGAGGCC 29846399 29848887 
507 F GTACTGAGCCTAGCAGAGGAAGCTCAAG 29848888 29849213 
508 R CTTTCTACAGCCATGCCATTTACAGAAGCC 29849214 29850560 
510 R CTTCTACCTGCTAACAAACTTTCTCCTGTC 29851352 29854911 
511 F AGTGACCTAGATCTTCCCCTACACTTTAAG 29854912 29855302 
512 R CTTGCGCCTTTCCAGCAGTCTTGAAACATA 29855303 29859544 
513 F CATCATCTGTGCCATTTCTTAGCCCCAAAG 29859545 29863829 
514 R CTTATCCACCATGGCCCCAAGATTATCTTT 29863830 29864649 
517 F CTCTGAAACATGCAACCACACAGGCAAAG 29870040 29874795 
518 R CTTAACCAAGTAACACTACCAACTGGAGAC 29874796 29884457 
521 F TTTTTTTTCCCATTAGGCGAAATTTTAAAG 29896489 29896823 
522 R CTTCATCTGACCTCGTTTGCACGAAGCTC 29896824 29897292 
523 F TAAAACTTGCAGCAACTTTCCTGTGTTAAG 29897293 29900118 
525 F AATATGGTTTCCTTATGATGTAGCTTTAAG 29902876 29906098 
526 R CTTCCAAGTTTCTGAAGCATCCTCACCAGA 29906099 29907124 
527 F TTGTGATCAAATTTACATGTCTAAGCTAAG 29907125 29909799 
529 R CTTTTGACTAGTGGACTTTATCTGCTCTCA 29911938 29913290 
530 F TTCCTTTAGCTTTATATATTGATGGAGAAG 29913291 29913607 
532 R CTTCAGTTATACAAAGTTCTTTCATGCCCC 29913932 29918392 
533 F AGATCTCTCTACTTGTTGATTAATAGCAAG 29918393 29927218 





535 R CTTAGGTATAAAAGAAAATCTTTAAATACC 29931042 29938025 
536 F AAGTTAATTGAATGAAAATGATCAACTAAG 29938026 29947212 
537 R CTTTCTGACCAAAGTTGACAACAGCACTAT 29947213 29949609 
538 F CATGTGTTGTAGAGGCTGGGAACCACAAG 29949610 29953599 
539 R CTTTTGTTTATGGTCTGGAATGTACCCATT 29953600 29958998 
540 F CATGTGGGTTAACAGTGAGTTAAGCCCAAG 29958999 29960405 
542 R CTTCAGCCCCTTGCCTTGATGCC 29960412 29963242 
543 F TAGACATGTGAATTTTATTCTTGGAGGAAG 29963243 29963692 
544 R CTTTGAAAGACCCATGTCATAGTACGTGTT 29963693 29963925 
546 F GATTTTTTTTTCCTAGGGGTTTATTTCAAG 29967853 29970155 
547 R CTTAGGCTCAAAGATGACTGCAGAGGAGAG 29970156 29977864 
548 F AAGGAAAAAAAAAGAATAAGGTTTCAGAAG 29977865 29978715 
549 R CTTGCAAGCTAGCTAGCCCAAGGGATAC 29978716 29979319 
550 F TGTACAGTATAAGCACCCCTATAGCCAAAG 29979320 29988808 
551 R CTTTCAATTTTTCCACATCCTGCCCAACAC 29988809 29991479 
553 R CTTTCCAGTATTGCTGGAGCTGTAGTCCGA 29995277 29996459 
554 F GCAACTCAGTGAAATTAACCAAAGATGAAG 29996460 30001398 
555 R CTTTCCAGGCATAAAGCAGAGACAGGCAAA 30001399 30005000 
     
     USP22 
(chr.11; 
mm9) 
    
1 R CTTTGAGACTAGACCGAAGTCTCCAGAATC 60917307 60918190 
2 F GGGAGGAAGATAAAAAGATGGGGATGGAAG 60918191 60924238 
5 F CTGTCAGTCTCCTGCTGCCACTAACAAG 60932406 60937638 
6 R CTTGAGGAGACAGCACTGCTGGTAGATAG 60937639 60942991 
9 F GTGTCAAGGAGGCAGACCTTCAGGAAG 60949684 60966226 
10 R CTTACTGTGGGCTACCCATTTGTACTCTTA 60966227 60970541 
11 F AACCCATCTCTAACAATCCCTTTGTAAAAG 60970542 60976197 
12 R CTTTTATTTATAAGAGATCTTAGCTAATGA 60976198 60977387 
14 F GCAGGAGTCTAAGCCACCAGGGAAG 60977797 60977935 





16 R CTTTTTTCCAAATAGTAACCCACAGGGCCA 60981479 61000571 
17 F ACTTTTCCCAAAATCCAAGCTGACTTCAAG 61000572 61003268 
 
Table S 2 Mouse 5C primers for Shh and USP22 regions 
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The concept of gene regulation is being refined as our understanding of the role of enhancer elements grows. Although
described more than 30 years ago, the mechanisms through which these cis-regulating elements operate remain under debate.
With the recognition that most of the human genetic variation contributing to common disease risk lies outside of genes and
probably in enhancers, unraveling these mechanisms becomes ever more important. Originally, a popular view was to consider
regulatory elements as an entry site for the transcription machinery that could scan the intervening chromatin until the cognate
core promoter was located. Now, the most prominent model for distal enhancer–promoter interaction involves direct enhanc-
er/promoter contacts with a looping out of intervening chromatin. However, a rising awareness of the importance of chromatin
architecture and organization forces us to consider enhancer–promoter communication in light of the polymer folding
properties of chromatin. Here, we discuss how three-dimensional chromatin folding, topological domains, and the constrained
motion, plasticity, and accessibility of chromatin could offer a structural basis for regulatory domains that greatly enhances the
probability of enhancer–promoter and transcription factor–promoter interactions and gene activation.
The definition of a gene has evolved significantly over
the past 35 years. In metazoans, and particularly in mam-
mals, the functional genetic unit now goes far beyond the
genomic region that encodes an mRNA. 50 elements ad-
jacent to the transcription start site encompass the core
promoter and serve as the docking site for the RNA poly-
merase II preinitiation complex (PIC). However, addition-
al layers of complexity have emerged, including multiple
alternative promoters, alternative exons, and cis-regulato-
ry sequences positioned upstream, downstream, or even
within an intron of the transcription unit.
Although the core promoter determines where tran-
scription begins, the cis-regulatory sequences—or en-
hancers—stimulate promoters in a time and tissue-
specific manner and increase the efficiency of transcrip-
tion in a position- and orientation-independent manner.
However, both enhancer and gene activation are associat-
ed with similar events—that is, recruitment of transcrip-
tion factors, coactivators, and RNA polymerase II and
production of RNA (albeit short and unstable at enhancers)
(Koch et al. 2011). Therefore, enhancers have long been
seen as simple extensions of promoters as both lead to
assembly of an active transcription complex and are often
bound by the same components (Andersson et al. 2015).
The first enhancer described was the 72-bp tandem
repeat of SV40 DNA, which was identified as a sequence
located !100 nt upstream of the core early viral promoter
(Fig. 1) and whose deletion reduced gene expression and
abolished virus viability (Benoist and Chambon 1981;
Gruss et al. 1981). Later, the SV40 enhancer was found
to comprise three main segments, each of which provides
cell type specificity (Schirm et al. 1987). In parallel, it
was discovered that the SV40 enhancer could work when
associated with other diverse promoters. Surprisingly, it
could also act over considerable distances (.10 kb) and
its activity appeared to rely on the sequence of the inter-
vening chromatin rather than the distance (Banerji et al.
1981; Mellon et al. 1981; Moreau et al. 1981).
Other sequences with equivalent function in mam-
malian cells were soon identified (Conrad and Botchan
1982; Banerji et al. 1983), including locus control re-
gions (LCRs)—which define regulatory domains that
are groups of enhancers. The first LCR element identified
25-kb upstream of the human 1-, g-, d-, and b-globin
genes (Fig. 1) shared characteristics of the SV40 enhancer
including clustered DNase I hypersensitive sites (DHSs)
(Grosveld et al. 1987; for review, see Li et al. 2002).
Now, human and mouse Mendelian genetics have re-
vealed enhancers located up to 1 million base pairs (meg-
abase/Mb) 50 or 30 of target genes (Fig. 1), often with
other intervening genes located in-between, or embedded
within the introns of nearby genes (Noonan and Mc-
Callion 2010). Thus, the functional unit of gene regula-
tion in the mammalian genome, for coding regions that
are themselves often ,10 kb in size, can be of the order
of 2 Mb in size.
Since they were first described, many of the molecular
characteristics of enhancers have been established includ-
ing transcription factor binding, coactivator recruitment,
DHS, distinctive histone marks, and eRNA production.
Here, we specifically consider the regulatory domains in
which enhancers operate and how these domains may be
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integrated in specific chromatin conformations that influ-
ence enhancer–promoter communication.
cis-ACTING ELEMENTS
For the most part, enhancers function in cis. Exceptions
include the ability of enhancers to work between homol-
ogous chromosomes in Drosophila cells that show so-
matic pairing (Schoborg et al. 2013) and the infrequent
interaction of multiple enhancers—located on different
chromosomes—with murine olfactory receptor genes,
as the basis for stochastic choice in olfactory receptor
gene expression in olfactory neurons (Markenscoff-Papa-
dimitriou et al. 2014).
The requirement for a target gene and its enhancer to be
located in cis, in order for gene activation to be robust, is
evidenced by the Mendelian genetic disorders that arise
when translocations separate enhancer and promoter onto
different chromosomes (Kleinjan and van Heyningen
2005; Benko et al. 2009; Lango Allen et al. 2014; Rainger
et al. 2014).
Genetic evidence indicates that enhancers can act over
1 Mb of intervening chromatin. However, their range may
not be much greater than this. Chromosomal inversions
that increase the genomic distance between an enhancer
and its target gene can, in some cases, abrogate enhancer
function (Lettice et al. 2011).
Chromosome structural rearrangements have set the
likely limits of enhancer function in the human genome
and indicate that correct enhancer function usually de-
pends on the enhancer being present within a range of
!1 Mb in cis with its target gene. However, it is important
to remember that enhancers are not constrained to have to
work at a distance. Both enhancer reporter assays (Bhatia
et al. 2015) and localized transposon hopping (Anderson
et al. 2014; Symmons et al. 2014) show that endogenous
mammalian enhancers that act at long range in their nor-
mal chromosomal context are quite capable of also acting
at short range. It is within this framework that we now
consider possible mechanisms of enhancer function in
the context of three-dimensional chromatin conformation.
SPREADING OF A SIGNAL: LINKING
AND TRACKING MODELS
The original view of regulatory element action was that
it provided a precise docking site for RNA polymerase II
or other components of the transcriptional machinery,
followed by tracking of these factors on the chromatin
fiber until they met the cognate core promoter and acti-
vated it in a time- and position-dependent manner.
Exploration of tracking-like mechanisms at several loci,
such asb-globin, has reported the unidirectional spreading
of histone H3 and H4 acetylation, the CBP/p300 histone
acetyltransferases, P/CAF, subunits of the SWI/SNF
chromatin remodeling complex, or RNA polymerase II
and TBP with accompanying synthesis of short, polyade-
nylated, intergenic RNAs (Gribnau et al. 2000; Hatzis and
Talianidis 2002; Spicuglia et al. 2002; Masternak et al.
2003; Kim and Dean 2004; Zhao and Dean 2004; Wang
et al. 2005; Zhu et al. 2007). These studies implicate track-
ing as the primary step for enhancer–promoter interaction
and speculate that a stable enhancer–promoter loop is only
formed when the tracking is complete (Fig. 2A). However,
the formation of stable enhancer–promotercomplexes has
not always been convincingly shown. The linking hypoth-
esis differs from the tracking mechanism, as the proteins
involved do not scan all of the intervening chromatin but
instead oligomerize to spread the signal (Fig. 2B).
In these examples of enhancer–promoter communica-
tion, the genomic distance separating the two elements is
modest (generally ,20 kb) and, from both kinetic and
spatial perspectives, it is hard to imagine how one-dimen-
sional tracking or linking mechanisms could operate over
much larger (e.g., 1-Mb) distances and over intervening
genes.
Figure 1. Different scales of enhancer and promoter distances. (Top) Proximal enhancers can be located a few tens of bp from their
target promoter. An example of this is the SV40 early promoter. (Middle) Enhancers such as the b-globin locus control region (LCR)
are located tens of kilobases from their target promoters. (Bottom) Some developmental enhancers can be located hundreds or even
1000 kb from their target gene, often with other, unrelated genes, in between. The Shh limb enhancer (ZRS) is an example of this.
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BRIDGING THE DIVIDE: THE
CHROMOSOME LOOPING MODEL
The current favored model for long-range enhancer–
promoter communication involves direct homotypic or
heterotypic interactions between enhancer- and promot-
er-bound proteins to form a chromatin loop that juxtapos-
es enhancer and promoter at the loop base and that loops
out the intervening chromatin (Fig. 2C; Su et al. 1991).
Elegant chromosome engineering experiments at the
b-globin locus have shown that forcing a chromosome
loop between an enhancer and its target promoter is suf-
ficient to trigger gene expression in erythroid cells, in
which some other key transcription factors required for
b-globin expression are already bound (Deng et al. 2012,
Deng et al. 2014). However, the extent to which endog-
enous enhancers and promoters form relatively stable
chromatin loops is currently unclear.
Much of the evidence for enhancer–promoter loops
comes from the detection of enhancer–promoter ligation
products in the chromosome conformation capture (3C)
technique and its derivatives (4C, 5C, Hi-C, etc.) (Tolhuis
et al. 2002; Palstra et al. 2003; Montavon et al. 2011; Jin
et al. 2013). However, such assays do not have the ability
to determine the frequency at which such interactions take
place, to determine the molecular nature of such interac-
tions, or to determine whether the interactions are the
cause or consequence of enhancer-driven gene activation.
In some instances fluorescence in situ hybridization
(FISH) has shown the spatial juxtaposition of distant
enhancers and promoters at frequencies high enough
(30% or more of alleles) to be interpreted as the base of
a chromosome loop (Williamson et al. 2012; Lettice et al.
2014). However in other cases, visual assays do not pro-
vide evidence for relatively stable chromosome loops
(Williamson et al. 2012). This does not exclude the exis-
tence of very transient enhancer–promoter contacts, but
we would argue that such infrequent contacts should not
be described as chromatin loops.
How enhancers and promoters find each other in nu-
clear space is not known, but it seems most likely that it
occurs as a consequence of the rapid, but constrained,
diffusion (diffusion coefficient of !1 ! 1024 mm2/
sec) that characterizes chromatin motion in living human
cells (Chubb et al. 2002). This implies that enhancers and
their cognate promoters must both be located within a
small enough nuclear volume to be compatible with the
radius of constraint for chromatin motion. For the geno-
mic loci measured to date, this constraint (,0.5 mm)
could encompass loci that are up to !1 Mb from each
other (Fig. 3A,B).
The formation of a stable chromatin loop has an entro-
pic cost to polymer dynamics as it would need to over-
come inherent diffusion. It would be interesting to
investigate the strength of binding energies between en-
hancer- and promoter-bound proteins that would be re-
quired to stabilize chromatin loops of various sizes. This
may be even more of an issue for enhancers located close
to promoters, where the persistence length of the chroma-
Figure 2. Enhancer and promoter communication mechanisms. Activating signals, such as transcription factors, bind enhancers
recruiting other proteins, such as coactivators, that may track along the chromatin fiber until they meet their cognate promoter (A:
tracking model) or oligomerize and form a protein bridge to meet their cognate promoter (B: linking model). Enhancer elements may
be brought to the vicinity of their cognate promoter by direct interaction and looping out of the intervening chromatin region (C:
looping model), or enhancers may just be constrained within the same nuclear domain as their target genes with protein and chromatin
constrained diffusion then being sufficient to activate gene expression (D: nuclear domain model).
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tin polymer may be a further energetic barrier to loop
formation.
KEEPING IT CONCENTRATED:
REGULATION WITHIN NUCLEAR DOMAINS
The activation of gene expression requires the forma-
tion of protein–protein and protein–DNA complexes, the
efficiency of which will be dependent on the laws of mass
action and so will be very sensitive to local concentration
of both proteins and DNA. Chromatin packaging may
therefore be an important determinant of regulatory
domains. In vivo analysis of the binding regimes of tran-
scription factors shows that some use facilitated diffusion
(i.e., 3D diffusion interspersed with local 1D sliding
along the chromatin fiber). This greatly reduces their
search space to give an efficient means of finding
their specific binding sites (Chen et al. 2014; Izeddin
et al. 2014; Woringer et al. 2014; Normanno et al.
2015). A transcription factor bound at an enhancer might
then rather efficiently, by oversampling the local volume,
be able to find a promoter-proximal binding site located
Figure 3. Chromatin compaction and constrained motion and its influence on transcription factor diffusion. (A) FISH image illus-
trating a highly compact chromatin conformation of an inactive enhancer (red) and its cognate promoter (green), despite their being
separated by several hundred kilobases, in the cell nucleus of a nonexpressing cell type. Scale bar, 5 mm. (B) Schematic representation
of constrained chromatin motion (0.5 mm average range) where chromatin can only sample a small proportion of the nuclear volume or
indeed of the chromosome territory (pale blue). Enhancers and their cognate promoters must be close enough to each other in nuclear
space to be able to encounter each other through constrained diffusion. Scale bar, 5 mm. (Chubb and Bickmore 2003.) (C ) Compact
chromatin domains, such as topologically associated domains (TADs), and their viscoelastic properties, can affect the dimensionality
of transcription factor diffusion and create compact volumes that can locally concentrate transcription factors, RNA polymerase, and
coactivators.
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within the same chromatin domain, obviating any need
for a specific enhancer–promoter chromatin loop (Figs.
2D, 3C).
A second mode by which chromatin packing might
affect enhancer function is by reducing the volume in
which proteins involved in transcription (e.g., coacti-
vators, components of the PIC) are free to diffuse and
to form complexes with each other (excluded volume
effect) (Woringer et al. 2014). Interestingly, !1 Mb
chromatin domains containing genes subject to com-
plex developmental regulation that is driven by suites
of enhancers appear to have a very compact chromatin
structure, even in nonexpressing tissues (Fig. 3A; Wil-
liamson et al 2012; Lettice et al. 2014). This suggests
that they may have evolved to facilitate both excluded
volume and facilitated diffusion effects. Because of
the viscoelastic properties of the nuclear environment,
compact chromatin domains have been shown to affect
chromatin motion and to dramatically reduce the first
encounter time for distant genomic regions (Lucas
et al. 2014).
A domain model for enhancer function may help to
explain how primary and shadow enhancers, by both be-
ing contained in the same compact nuclear domain, could
provide robustness to gene regulation during develop-
ment, particularly when key molecules required for spe-
cific gene activation are limiting in the nucleus (Bothma
et al. 2015; Lam et al. 2015). It also provides a plastic
environment within which new enhancers can evolve
to drive new patterns of gene regulation, or within which
existing enhancers can relocate (Villar et al. 2015),
without having to disrupt and rewire preexisting defined
chromatin loops mediated by other enhancers in the same
domain.
How such chromatin domains remain compact is un-
clear. It has been suggested that closed DNA domains
could be formed by supercoiling with architectural pro-
teins bound at the ends of these domains hindering the
axial rotation that would relieve supercoiling (Duncan
et al. 1994; Ner et al. 1994; Yang et al. 1995; Gilbert
and Allan 2014). Indeed several studies have shown
that enhancers and their target promoters tend to be lo-
cated within the same topologically associated domains
(TADs)—as defined from HiC data (Jin et al. 2013). In
addition, reporter assays show that the influence of an
enhancer declines sharply beyond the TAD domain boun-
dary (Anderson et al. 2014; Symmons et al. 2014). Con-
versely, disrupting TAD boundaries can rewire enhancer
and promoter communication leading to inappropriate
gene activation (Lupiáñez et al. 2015).
What forms TAD boundaries is not completely clear,
but convergently oriented CTCF sites, which also recruit
cohesin, have been shown to be one important factor
(Guo et al. 2015). The mechanistic basis for this is un-
clear, but it suggests the propagation of a directional sig-
nal from the boundary CTCF site in toward the TAD.
Conceptually, this has some similarity to linking/track-
ing models of enhancer–promoter communication. How-
ever, the nature of that signal is unknown and it is likely
that not all boundaries are the same.
CONCLUSION
Characterization of mammalian genomes using chro-
mosome conformational capture techniques and mi-
croscopic imaging strongly support a model in which
three-dimensional chromatin structures are organized
into domains within which DNA–DNA and protein–
DNA interactions are facilitated. It is within this frame-
work that possible mechanisms of enhancer activation
must be considered. Therefore, it becomes imperative
that methods are developed that will allow the biophys-
ical properties of chromatin domains and of transcription
factor and chromatin motion to be quantified and manip-
ulated in physiologically relevant systems.
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